,words,labels,sentence_id,full sentence
579,Over,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
580,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
581,years,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
582,",",O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
583,doubts,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
584,have,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
585,arisen,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
586,concerning,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
587,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
588,use,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
589,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
590,milk,B-AG.01.e,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
591,as,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
592,a,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
593,calcium,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
594,source,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
595,in,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
596,the,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
597,prevention,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
598,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
599,osteoporosis,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
600,",",O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
601,particularly,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
602,because,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
603,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
604,potential,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
605,offsetting,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
606,effects,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
607,of,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
608,protein,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
609,and,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
610,phosphorus,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
611,.,O,19.0,"Over the years , doubts have arisen concerning the use of milk as a calcium source in the prevention of osteoporosis , particularly because of potential offsetting effects of protein and phosphorus ."
929,Polyphenols,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
930,may,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
931,also,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
932,enhance,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
933,insulin,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
934,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
935,dependent,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
936,glucose,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
937,uptake,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
938,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
939,activate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
940,5,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
941,',O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
942,adenosine,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
943,monophosphate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
944,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
945,activated,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
946,protein,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
947,kinase,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
948,(,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
949,AMPK,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
950,),O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
951,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
952,modify,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
953,the,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
954,microbiome,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
955,and,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
956,have,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
957,anti,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
958,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
959,inflammatory,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
960,effects,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
961,.,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
974,Further,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
975,intervention,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
976,studies,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
977,are,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
978,essential,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
979,to,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
980,clarify,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
981,the,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
982,conflicting,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
983,findings,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
984,and,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
985,confirm,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
986,or,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
987,refute,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
988,the,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
989,anti,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
990,-,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
991,diabetic,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
992,effects,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
993,of,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
994,dietary,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
995,polyphenols,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
996,.,O,30.0,Further intervention studies are essential to clarify the conflicting findings and confirm or refute the anti - diabetic effects of dietary polyphenols .
1102,The,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1103,risk,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1104,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1105,specific,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1106,types,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1107,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1108,cancer,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1109,is,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1110,also,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1111,directly,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1112,influenced,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1113,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1114,regardless,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1115,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1116,the,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1117,magnitude,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1118,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1119,adiposity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1120,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1121,by,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1122,physical,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1123,inactivity,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1124,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1125,consumption,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1126,of,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1127,red,B-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1128,meat,I-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1129,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1130,processed,B-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1131,meat,I-AG.01.d,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1132,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1133,ultra,B-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1134,-,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1135,processed,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1136,foods,I-AG.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1137,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1138,dairy,B-AG.01.e,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1139,products,I-AG.01.e,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1140,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1141,alcohol,B-AG.01.y.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1142,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1143,whole,B-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1144,grain,I-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1145,cereals,I-AG.01.i,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1146,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1147,nuts,B-AG.01.h.01.f,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1148,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1149,vegetables,B-AG.01.h.02,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1150,",",O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1151,and,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1152,fruits,B-AG.01.h.01,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1153,.,O,35.0,"The risk of specific types of cancer is also directly influenced , regardless of the magnitude of adiposity , by physical inactivity , consumption of red meat , processed meat and ultra - processed foods , dairy products , alcohol , whole grain cereals , nuts , vegetables , and fruits ."
1405,It,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1406,has,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1407,been,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1408,suggested,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1409,that,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1410,the,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1411,isoflavone,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1412,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1413,genistein,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1414,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1415,",",O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1416,may,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1417,have,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1418,some,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1419,role,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1420,as,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1421,a,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1422,chemopreventive,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1423,agent,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1424,against,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1425,cancer,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1426,in,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1427,humans,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1428,.,O,43.0,"It has been suggested that the isoflavone , genistein , , may have some role as a chemopreventive agent against cancer in humans ."
1522,Levels,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1523,of,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1524,isoflavones,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1525,in,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1526,fermented,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1527,soybean,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1528,products,I-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1529,",",O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1530,miso,B-AG.01.n.02,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1531,(,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1532,bean,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1533,paste,I-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1534,),O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1535,and,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1536,natto,B-AG.01.n,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1537,(,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1538,fermented,B-AG.01.h.02.g,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1539,soybeans,I-AG.01.h.02.g,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1540,),O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1541,",",O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1542,were,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1543,38.5,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1544,to,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1545,229.1,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1546,micrograms,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1547,/,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1548,g,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1549,food,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1550,for,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1551,genistein,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1552,and,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1553,71.7,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1554,to,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1555,492.8,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1556,micrograms,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1557,/,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1558,g,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1559,food,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1560,for,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1561,genistin,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1562,.,O,47.0,"Levels of isoflavones in fermented soybean products , miso ( bean paste ) and natto ( fermented soybeans ) , were 38.5 to 229.1 micrograms / g food for genistein and 71.7 to 492.8 micrograms / g food for genistin ."
1901,When,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1902,further,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1903,subclassified,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1904,into,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1905,botanical,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1906,groups,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1907,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1908,those,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1909,in,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1910,the,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1911,highest,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1912,tertile,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1913,of,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1914,leguminosae,B-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1915,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1916,dried,B-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1917,beans,I-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1918,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1919,string,B-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1920,beans,I-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1921,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1922,peas,B-AG.01.h.02.g,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1923,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1924,0.80,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1925,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1926,0.67,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1927,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1928,0.96,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1929,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1930,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1931,rosaceae,B-AG.01.h.01,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1932,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1933,apples,B-AG.01.h.01.c,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1934,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1935,peach,B-AG.01.h.01.e,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1936,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1937,nectarines,B-AG.01.h.01.e,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1938,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1939,plums,B-AG.01.h.01.e,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1940,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1941,pears,B-AG.01.h.01.d,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1942,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1943,strawberries,B-AG.01.h.01.b,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1944,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1945,0.60,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1946,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1947,0.49,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1948,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1949,0.73,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1950,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1951,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1952,solanaceae,B-AG.01.h.02,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1953,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1954,peppers,B-AG.01.h.02.f,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1955,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1956,tomatoes,B-AG.01.h.02.f,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1957,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1958,0.82,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1959,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1960,0.69,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1961,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1962,0.98,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1963,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1964,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1965,umbelliferae,B-AG.01.h.02,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1966,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1967,carrots,B-AG.01.h.02.a,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1968,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1969,0.73,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1970,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1971,0.60,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1972,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1973,0.89,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1974,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1975,had,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1976,decreased,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1977,risk,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1978,of,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1979,head,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1980,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1981,neck,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1982,cancer,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1983,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1984,but,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1985,no,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1986,significant,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1987,associations,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1988,were,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1989,seen,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1990,for,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1991,9,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1992,other,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1993,botanical,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1994,groups,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1995,.,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1996,Results,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1997,from,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1998,this,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
1999,large,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2000,prospective,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2001,observational,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2002,study,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2003,are,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2004,consistent,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2005,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2006,previous,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2007,case,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2008,-,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2009,control,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2010,studies,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2011,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2012,support,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2013,the,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2014,hypothesis,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2015,that,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2016,total,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2017,fruit,B-AG.01.h.01,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2018,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2019,vegetable,B-AG.01.h.02,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2020,intake,B-X,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2021,is,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2022,associated,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2023,with,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2024,reduced,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2025,risk,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2026,of,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2027,head,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2028,and,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2029,neck,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2030,cancer,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2031,.,O,60.0,Results from this large prospective observational study are consistent with previous case - control studies and support the hypothesis that total fruit and vegetable intake is associated with reduced risk of head and neck cancer .
2355,Furthermore,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2356,",",O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2357,ginger,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2358,administration,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2359,corrected,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2360,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2361,HFD,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2362,-,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2363,induced,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2364,changes,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2365,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2366,concentrations,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2367,of,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2368,intermediates,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2369,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2370,glycolysis,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2371,and,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2372,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2373,TCA,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2374,cycle,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2375,.,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2578,For,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2579,people,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2580,lacking,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2581,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2582,LP,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2583,trait,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2584,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2585,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2586,fermentation,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2587,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2588,milk,B-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2589,into,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2590,yogurt,B-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2591,and,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2592,related,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2593,products,I-AG.01.e,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2594,(,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2595,a,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2596,process,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2597,known,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2598,for,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2599,≥8500,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2600,y,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2601,),O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2602,aids,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2603,milk,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2604,digestion,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2605,through,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2606,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2607,breakdown,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2608,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2609,some,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2610,lactose,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2611,and,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2612,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2613,provision,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2614,of,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2615,β,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2616,-,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2617,galactosidase,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2618,",",O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2619,which,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2620,remains,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2621,active,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2622,in,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2623,the,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2624,gastrointestinal,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2625,tract,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2626,.,O,84.0,"For people lacking the LP trait , the fermentation of milk into yogurt and related products ( a process known for ≥8500 y ) aids milk digestion through the breakdown of some lactose and the provision of β - galactosidase , which remains active in the gastrointestinal tract ."
2774,The,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2775,goal,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2776,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2777,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2778,First,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2779,Global,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2780,Summit,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2781,on,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2782,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2783,Health,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2784,Effects,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2785,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2786,Yogurt,B-AG.01.e,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2787,was,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2788,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2789,review,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2790,and,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2791,evaluate,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2792,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2793,strength,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2794,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2795,current,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2796,scientific,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2797,knowledge,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2798,with,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2799,regard,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2800,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2801,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2802,health,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2803,benefits,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2804,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2805,yogurt,B-AG.01.e,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2806,and,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2807,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2808,identify,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2809,areas,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2810,where,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2811,further,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2812,research,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2813,is,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2814,needed,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2815,.,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2862,When,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2863,assessing,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2864,a,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2865,complex,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2866,food,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2867,matrix,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2868,",",O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2869,rather,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2870,than,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2871,specific,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2872,nutrients,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2873,",",O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2874,scientists,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2875,and,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2876,consumers,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2877,are,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2878,faced,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2879,with,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2880,new,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2881,challenges,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2882,as,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2883,to,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2884,how,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2885,a,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2886,food,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2887,item,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2888,'s,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2889,quality,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2890,or,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2891,necessity,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2892,would,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2893,be,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2894,judged,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2895,as,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2896,part,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2897,of,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2898,an,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2899,individual,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2900,'s,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2901,whole,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2902,diet,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
2903,.,O,90.0,"When assessing a complex food matrix , rather than specific nutrients , scientists and consumers are faced with new challenges as to how a food item 's quality or necessity would be judged as part of an individual 's whole diet ."
3471,In,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3472,this,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3473,study,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3474,",",O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3475,intake,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3476,of,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3477,total,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3478,vegetables,B-AG.01.h.02,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3479,was,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3480,shown,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3481,to,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3482,have,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3483,a,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3484,protective,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3485,effect,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3486,",",O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3487,whereas,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3488,high,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3489,nitrate,B-AG.01.h.02,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3490,-,I-AG.01.h.02,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3491,containing,I-AG.01.h.02,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3492,vegetables,I-AG.01.h.02,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3493,increased,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3494,the,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3495,risk,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3496,of,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3497,GC,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3498,.,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
4380,It,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4381,would,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4382,be,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4383,important,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4384,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4385,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4386,future,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4387,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4388,investigate,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4389,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4390,origins,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4391,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4392,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4393,differences,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4394,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4395,wine,B-AG.01.y.01.a,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4396,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4397,levels,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4398,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4399,relation,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4400,to,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4401,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4402,vine,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4403,varieties,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4404,",",O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4405,and,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4406,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4407,bioavailability,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4408,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4409,the,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4410,newly,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4411,extracted,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4412,stilbene,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4413,delta,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4414,-,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4415,viniferin,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4416,in,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4417,plasma,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4418,after,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4419,consumption,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4420,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4421,different,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4422,types,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4423,of,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4424,wines,B-AG.01.y.01.a,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4425,.,O,138.0,"It would be important in the future to investigate the origins of the differences in wine stilbene levels in relation to the vine varieties , and the bioavailability of the newly extracted stilbene delta - viniferin in plasma after consumption of different types of wines ."
4539,Samples,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4540,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4541,the,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4542,most,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4543,commonly,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4544,available,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4545,foods,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4546,of,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4547,unknown,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4548,composition,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4549,were,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4550,collected,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4551,(,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4552,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4553,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4554,eight,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4555,home,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4556,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4557,made,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4558,and,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4559,twenty,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4560,-,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4561,four,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4562,industrial,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4563,),O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
4564,.,O,143.0,Samples of the most commonly available foods of unknown composition were collected ( twenty - eight home - made and twenty - four industrial ) .
5115,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5116,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5117,used,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5118,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5119,induce,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5120,colon,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5121,cancer,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5122,in,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5123,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5124,;,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5125,while,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5126,olive,B-AG.01.f,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5127,oil,I-AG.01.f,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5128,was,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5129,given,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5130,to,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5131,separate,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5132,group,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5133,of,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5134,rats,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5135,along,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5136,with,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5137,DMH,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5138,treatment,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5139,.,O,163.0,DMH was used to induce colon cancer in rats ; while olive oil was given to separate group of rats along with DMH treatment .
5163,Potent,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5164,anti,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5165,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5166,inflammatory,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5167,",",O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5168,anti,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5169,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5170,angiogenic,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5171,and,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5172,pro,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5173,-,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5174,apoptotic,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5175,activity,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5176,of,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5177,olive,B-AG.01.f,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5178,oil,I-AG.01.f,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5179,was,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5180,explored,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5181,by,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5182,gene,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5183,expression,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5184,and,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5185,immunohistochemical,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5186,studies,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5187,.,O,165.0,"Potent anti - inflammatory , anti - angiogenic and pro - apoptotic activity of olive oil was explored by gene expression and immunohistochemical studies ."
5262,Furthermore,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5263,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5264,the,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5265,inverse,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5266,relationship,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5267,between,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5268,gene,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5269,expression,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5270,and,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5271,DNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5272,methylation,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5273,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5274,deviant,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5275,miRNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5276,pattern,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5277,and,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5278,miRNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5279,silencing,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5280,mediated,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5281,by,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5282,aberrant,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5283,DNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5284,methylation,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5285,was,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5286,also,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5287,seen,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5288,in,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5289,DMH,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5290,-,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5291,treated,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5292,rats,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5293,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5294,which,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5295,was,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5296,potentially,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5297,reversible,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5298,upon,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5299,olive,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5300,oil,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5301,treatment,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5302,.,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5407,Several,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5408,milk,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5409,peptides,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5410,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5411,been,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5412,shown,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5413,to,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5414,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5415,antihypertensive,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5416,effects,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5417,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5418,animal,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5419,and,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5420,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5421,clinical,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5422,studies,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5423,.,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5469,The,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5470,future,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5471,challenge,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5472,is,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5473,to,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5474,identify,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5475,the,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5476,antihypertensive,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5477,components,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5478,in,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5479,milk,B-AG.01.e,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5480,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5481,their,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5482,mechanisms,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5483,of,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5484,action,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5485,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5486,thus,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5487,to,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5488,find,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5489,more,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5490,possibilities,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5491,for,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5492,using,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5493,these,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5494,constituents,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5495,and,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5496,products,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5497,as,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5498,a,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5499,dietary,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5500,treatment,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5501,of,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5502,hypertension,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5503,.,O,177.0,The future challenge is to identify the antihypertensive components in milk and their mechanisms of action and thus to find more possibilities for using these constituents and products as a dietary treatment of hypertension .
5541,A,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5542,total,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5543,of,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5544,"1,586",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5545,cases,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5546,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5547,their,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5548,age-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5549,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5550,sex-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5551,",",O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5552,and,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5553,race,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5554,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5555,matched,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5556,neighborhood,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5557,controls,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5558,were,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5559,interviewed,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5560,in,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5561,-,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5562,person,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5563,from,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5564,1987,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5565,to,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5566,1999,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5567,.,O,180.0,"A total of 1,586 cases and their age- , sex- , and race - matched neighborhood controls were interviewed in - person from 1987 to 1999 ."
5973,Rats,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5974,were,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5975,fed,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5976,a,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5977,high,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5978,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5979,fat,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5980,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5981,sucrose,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5982,(,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5983,HFS,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5984,),O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5985,diet,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5986,with,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5987,or,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5988,without,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5989,supplementation,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5990,of,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5991,different,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5992,polyphenolic,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5993,plant,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5994,extracts,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5995,(,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5996,almond,B-AG.01.h.01.f,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5997,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5998,apple,B-AG.01.h.01.c,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
5999,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6000,cinnamon,B-AG.01.l.03,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6001,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6002,orange,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6003,blossom,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6004,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6005,hamamelis,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6006,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6007,lime,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6008,blossom,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6009,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6010,grape,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6011,vine,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6012,",",O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6013,and,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6014,birch,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6015,),O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6016,for,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6017,56,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6018,-,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6019,64,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6020,days,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6021,.,O,194.0,"Rats were fed a high - fat - sucrose ( HFS ) diet with or without supplementation of different polyphenolic plant extracts ( almond , apple , cinnamon , orange blossom , hamamelis , lime blossom , grape vine , and birch ) for 56 - 64 days ."
6152,Tomato,B-AG.01.h.02.f,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6153,also,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6154,contain,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6155,other,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6156,active,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6157,compounds,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6158,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6159,namely,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6160,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6161,neoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6162,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6163,lutein,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6164,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6165,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6166,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6167,cryptoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6168,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6169,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6170,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6171,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6172,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6173,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6174,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6175,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6176,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6177,cyclolycopene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6178,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6179,and,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6180,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6181,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6182,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6183,5,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6184,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6185,6,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6186,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6187,epoxide,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6188,.,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6866,Some,O,224.0,Some considerations can be drawn from this viewpoint .
6867,considerations,O,224.0,Some considerations can be drawn from this viewpoint .
6868,can,O,224.0,Some considerations can be drawn from this viewpoint .
6869,be,O,224.0,Some considerations can be drawn from this viewpoint .
6870,drawn,O,224.0,Some considerations can be drawn from this viewpoint .
6871,from,O,224.0,Some considerations can be drawn from this viewpoint .
6872,this,O,224.0,Some considerations can be drawn from this viewpoint .
6873,viewpoint,O,224.0,Some considerations can be drawn from this viewpoint .
6874,.,O,224.0,Some considerations can be drawn from this viewpoint .
6875,Milk,B-AG.01.e,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6876,and,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6877,dairy,B-AG.01.e,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6878,products,I-AG.01.e,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6879,are,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6880,an,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6881,optimal,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6882,source,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6883,of,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6884,calcium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6885,as,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6886,well,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6887,as,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6888,of,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6889,other,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6890,limiting,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6891,nutrients,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6892,(,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6893,e.g.,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6894,",",O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6895,potassium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6896,and,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6897,magnesium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6898,),O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6899,",",O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6900,with,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6901,important,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6902,effects,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6903,on,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6904,bone,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6905,health,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6906,.,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6907,Bioactive,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6908,components,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6909,occurring,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6910,in,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6911,milk,B-AG.01.e,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6912,and,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6913,dairy,B-AG.01.e,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6914,products,I-AG.01.e,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6915,may,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6916,play,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6917,an,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6918,essential,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6919,role,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6920,on,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6921,bone,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6922,metabolism,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6923,",",O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6924,as,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6925,shown,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6926,by,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6927,in,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6928,vivo,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6929,and,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6930,in,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6931,vitro,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6932,studies,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6933,on,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6934,colostrum,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6935,acidic,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6936,proteins,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6937,and,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6938,milk,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6939,basic,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6940,proteins,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
6941,.,O,226.0,"Bioactive components occurring in milk and dairy products may play an essential role on bone metabolism , as shown by in vivo and in vitro studies on colostrum acidic proteins and milk basic proteins ."
7196,On,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7197,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7198,other,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7199,hand,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7200,",",O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7201,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7202,addition,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7203,of,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7204,sugar,B-AG.01.l.02,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7205,to,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7206,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7207,bold,B-AG.01.ad,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7208,coffee,I-AG.01.ad,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7209,did,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7210,not,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7211,further,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7212,increase,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7213,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7214,MG,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7215,level,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7216,in,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7217,the,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7218,samples,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7219,.,O,238.0,"On the other hand , the addition of sugar to the bold coffee did not further increase the MG level in the samples ."
7269,Due,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7270,to,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7271,the,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7272,overconsumption,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7273,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7274,exogenous,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7275,MG,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7276,",",O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7277,drinking,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7278,an,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7279,excess,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7280,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7281,any,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7282,type,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7283,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7284,coffee,B-AG.01.ad,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7285,poses,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7286,health,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7287,risks,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7288,.,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7591,For,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7592,colon,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7593,cancer,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7594,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7595,as,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7596,in,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7597,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7598,previous,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7599,analysis,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7600,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7601,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7602,major,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7603,risk,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7604,factor,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7605,was,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7606,saturated,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7607,fat,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7608,",",O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7609,individual,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7610,food,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7611,items,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7612,or,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7613,groups,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7614,failing,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7615,to,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7616,make,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7617,a,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7618,significant,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7619,contribution,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7620,to,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7621,the,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7622,risk,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7623,.,O,252.0,"For colon cancer , as in the previous analysis , the major risk factor was saturated fat , individual food items or groups failing to make a significant contribution to the risk ."
7813,Thus,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7814,",",O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7815,these,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7816,results,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7817,confirm,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7818,the,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7819,previous,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7820,report,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7821,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7822,showing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7823,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7824,significant,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7825,effect,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7826,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7827,saturated,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7828,fat,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7829,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7830,increasing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7831,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7832,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7833,colon,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7834,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7835,but,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7836,suggest,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7837,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7838,contribution,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7839,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7840,meats,B-AG.01.d,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7841,to,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7842,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7843,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7844,rectal,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7845,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7846,.,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7847,We,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7848,developed,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7849,a,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7850,comprehensive,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7851,composition,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7852,database,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7853,of,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7854,629,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7855,cereal,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7856,-,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7857,based,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7858,gluten,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7859,free,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7860,(,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7861,GF,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7862,),O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7863,products,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7864,available,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7865,in,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7866,Spain,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7867,.,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7961,Xanthan,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7962,gum,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7963,was,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7964,the,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7965,most,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7966,frequently,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7967,employed,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7968,fiber,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7969,",",O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7970,appearing,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7971,in,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7972,34.2,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7973,%,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7974,of,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7975,the,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7976,GF,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7977,products,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7978,",",O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7979,followed,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7980,by,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7981,other,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7982,commonly,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7983,used,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7984,such,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7985,as,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7986,hydroxypropyl,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7987,methylcellulose,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7988,(,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7989,23.1,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7990,%,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7991,),O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7992,",",O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7993,guar,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7994,gum,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7995,(,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7996,19.7,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7997,%,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7998,),O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
7999,",",O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8000,and,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8001,vegetable,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8002,gums,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8003,(,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8004,19.6,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8005,%,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8006,),O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8007,.,O,266.0,"Xanthan gum was the most frequently employed fiber , appearing in 34.2 % of the GF products , followed by other commonly used such as hydroxypropyl methylcellulose ( 23.1 % ) , guar gum ( 19.7 % ) , and vegetable gums ( 19.6 % ) ."
8522,A,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8523,significant,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8524,direct,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8525,trend,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8526,in,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8527,risk,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8528,was,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8529,found,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8530,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8531,bread,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8532,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8533,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8534,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8535,1.94,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8536,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8537,the,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8538,highest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8539,versus,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8540,the,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8541,lowest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8542,intake,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8543,quintile,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8544,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8545,",",O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8546,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8547,a,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8548,modest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8549,excess,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8550,of,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8551,risk,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8552,was,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8553,observed,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8554,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8555,pasta,B-AG.01.i,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8556,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8557,rice,B-AG.01.i,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8558,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8559,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8560,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8561,1.29,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8562,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8563,",",O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8564,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8565,milk,B-AG.01.e,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8566,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8567,yoghurt,B-AG.01.e,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8568,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8569,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8570,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8571,1.27,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8572,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8573,.,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8697,Kurakkan,B-AG.01.i,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8698,(,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8699,Eleusine,B-AG.01.i,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8700,coracana,I-AG.01.i,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8701,),O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8702,flour,B-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8703,roti,I-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8704,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8705,rice,B-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8706,flour,I-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8707,roti,I-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8708,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8709,atta,B-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8710,flour,I-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8711,roti,I-AG.01.n.10,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8712,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8713,boiled,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8714,breadfruit,B-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8715,(,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8716,Artocarpus,B-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8717,altilis,I-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8718,/,I-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8719,Artocarpus,I-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8720,communis,I-AG.01.h.01,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8721,),O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8722,and,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8723,boiled,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8724,legumes,B-AG.01.h.02.g,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8725,(,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8726,mungbean,B-AG.01.h.02.g,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8727,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8728,cowpea,B-AG.01.h.02.g,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8729,and,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8730,chickpea,B-AG.01.h.02.g,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8731,),O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8732,were,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8733,categorized,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8734,as,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8735,low,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8736,-,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8737,GI,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8738,foods,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8739,(,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8740,relative,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8741,to,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8742,white,B-AG.01.n.11,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8743,bread,I-AG.01.n.11,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8744,;,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8745,Prima,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8746,Crust,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8747,Top,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8748,),O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8749,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8750,and,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8751,the,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8752,corresponding,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8753,GI,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8754,(,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8755,+,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8756,/-,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8757,standard,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8758,error,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8759,of,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8760,the,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8761,mean,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8762,),O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8763,values,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8764,were,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8765,70+/-8,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8766,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8767,69+/-7,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8768,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8769,67+/-9,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8770,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8771,64+/-7,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8772,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8773,57+/-6,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8774,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8775,49+/-8,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8776,and,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8777,29+/-5,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8778,",",O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8779,respectively,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8780,.,O,287.0,"Kurakkan ( Eleusine coracana ) flour roti , rice flour roti , atta flour roti , boiled breadfruit ( Artocarpus altilis / Artocarpus communis ) and boiled legumes ( mungbean , cowpea and chickpea ) were categorized as low - GI foods ( relative to white bread ; Prima Crust Top ) , and the corresponding GI ( + /- standard error of the mean ) values were 70+/-8 , 69+/-7 , 67+/-9 , 64+/-7 , 57+/-6 , 49+/-8 and 29+/-5 , respectively ."
8856,The,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8857,GI,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8858,values,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8859,significantly,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8860,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8861,P<0.01,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8862,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8863,and,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8864,negatively,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8865,correlated,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8866,with,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8867,the,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8868,insoluble,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8869,dietary,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8870,fibre,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8871,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8872,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8873,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8874,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8875,0.780,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8876,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8877,",",O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8878,soluble,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8879,dietary,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8880,fibre,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8881,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8882,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8883,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8884,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8885,0.712,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8886,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8887,and,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8888,protein,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8889,(,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8890,rho,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8891,=,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8892,-,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8893,0.738,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8894,),O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8895,contents,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8896,in,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8897,grams,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8898,per,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8899,100,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8900,g,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8901,digestible,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8902,starch,B-AG.01,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8903,containing,I-AG.01,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8904,foods,I-AG.01,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
8905,.,O,290.0,"The GI values significantly ( P<0.01 ) and negatively correlated with the insoluble dietary fibre ( rho = - 0.780 ) , soluble dietary fibre ( rho = - 0.712 ) and protein ( rho = - 0.738 ) contents in grams per 100 g digestible starch containing foods ."
9075,Interestingly,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9076,",",O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9077,lactalbumin,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9078,and,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9079,lactoferrin,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9080,decreased,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9081,hepatic,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9082,lipidosis,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9083,partly,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9084,through,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9085,downregulation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9086,of,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9087,lipogenic,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9088,and/or,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9089,upregulation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9090,of,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9091,β,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9092,-,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9093,oxidation,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9094,transcripts,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9095,",",O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9096,and,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9097,differentially,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9098,modulated,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9099,cecal,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9100,bacterial,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9101,populations,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9102,.,O,299.0,"Interestingly , lactalbumin and lactoferrin decreased hepatic lipidosis partly through downregulation of lipogenic and/or upregulation of β - oxidation transcripts , and differentially modulated cecal bacterial populations ."
9144,Specific,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9145,beverage,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9146,intake,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9147,may,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9148,be,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9149,associated,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9150,with,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9151,the,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9152,risk,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9153,of,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9154,renal,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9155,cell,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9156,cancer,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9157,through,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9158,a,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9159,diluting,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9160,effect,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9161,of,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9162,carcinogens,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9163,",",O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9164,alterations,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9165,of,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9166,hormone,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9167,levels,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9168,",",O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9169,or,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9170,other,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9171,changes,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9172,in,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9173,the,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9174,renal,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9175,tubular,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9176,environment,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9177,",",O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9178,but,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9179,few,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9180,prospective,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9181,studies,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9182,have,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9183,examined,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9184,these,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9185,associations,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9186,.,O,302.0,"Specific beverage intake may be associated with the risk of renal cell cancer through a diluting effect of carcinogens , alterations of hormone levels , or other changes in the renal tubular environment , but few prospective studies have examined these associations ."
9262,A,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9263,total,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9264,of,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9265,"1,478",O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9266,incident,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9267,renal,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9268,cell,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9269,cancer,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9270,cases,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9271,were,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9272,identified,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9273,during,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9274,a,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9275,follow,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9276,-,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9277,up,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9278,of,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9279,7,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9280,-,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9281,20,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9282,years,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9283,across,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9284,studies,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9285,.,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9400,No,O,309.0,"No clear associations were observed for milk , soda or juice ."
9401,clear,O,309.0,"No clear associations were observed for milk , soda or juice ."
9402,associations,O,309.0,"No clear associations were observed for milk , soda or juice ."
9403,were,O,309.0,"No clear associations were observed for milk , soda or juice ."
9404,observed,O,309.0,"No clear associations were observed for milk , soda or juice ."
9405,for,O,309.0,"No clear associations were observed for milk , soda or juice ."
9406,milk,B-AG.01.e,309.0,"No clear associations were observed for milk , soda or juice ."
9407,",",O,309.0,"No clear associations were observed for milk , soda or juice ."
9408,soda,B-AG.01.aa,309.0,"No clear associations were observed for milk , soda or juice ."
9409,or,O,309.0,"No clear associations were observed for milk , soda or juice ."
9410,juice,B-AG.01.y,309.0,"No clear associations were observed for milk , soda or juice ."
9411,.,O,309.0,"No clear associations were observed for milk , soda or juice ."
9903,The,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9904,greater,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9905,protective,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9906,effect,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9907,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9908,leaf,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9909,extracts,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9910,was,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9911,in,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9912,correlation,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9913,with,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9914,the,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9915,levels,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9916,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9917,phenolics,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9918,and,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9919,antioxidant,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9920,capacity,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9921,.,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
10067,Excessive,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10068,alcohol,B-AG.01.y.01,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10069,consumption,B-X,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10070,among,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10071,smokers,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10072,appears,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10073,to,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10074,be,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10075,associated,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10076,with,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10077,an,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10078,elevated,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10079,risk,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10080,of,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10081,cancers,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10082,of,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10083,the,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10084,oral,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10085,cavity,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10086,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10087,esophagus,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10088,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10089,larynx,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10090,",",O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10091,and,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10092,respiratory,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10093,tract,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10094,.,O,338.0,"Excessive alcohol consumption among smokers appears to be associated with an elevated risk of cancers of the oral cavity , esophagus , larynx , and respiratory tract ."
10112,No,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10113,definitive,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10114,conclusions,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10115,were,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10116,reached,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10117,for,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10118,other,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10119,dietary,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10120,factors,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10121,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10122,including,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10123,total,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10124,calories,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10125,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10126,cholesterol,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10127,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10128,fiber,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10129,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10130,and,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10131,selenium,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10132,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10133,nor,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10134,could,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10135,the,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10136,quantitative,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10137,contribution,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10138,of,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10139,diet,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10140,to,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10141,overall,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10142,cancer,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10143,risk,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10144,be,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10145,estimated,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10146,.,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10230,For,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10231,these,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10232,effects,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10233,",",O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10234,the,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10235,CONTAM,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10236,Panel,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10237, ,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10238,identified,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10239,a,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10240,lowest,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10241,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10242,observed,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10243,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10244,adverse,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10245,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10246,effect,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10247,level,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10248,of,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10249,1,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10250,mg,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10251,total,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10252,potato,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10253,GAs,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10254,/,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10255,kg,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10256,body,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10257,weight,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10258,(,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10259,bw,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10260,),O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10261,per,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10262,day,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10263,as,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10264,a,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10265,reference,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10266,point,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10267,for,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10268,the,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10269,risk,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10270,characterisation,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10271,following,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10272,acute,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10273,exposure,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10274,.,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10332,The,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10333,acute,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10334,dietary,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10335,exposure,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10336,to,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10337,potato,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10338,GAs,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10339,was,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10340,estimated,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10341,using,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10342,a,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10343,probabilistic,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10344,approach,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10345,and,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10346,applying,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10347,processing,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10348,factors,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10349,for,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10350,food,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10351,.,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10352,Due,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10353,to,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10354,the,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10355,limited,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10356,data,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10357,available,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10358,",",O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10359,a,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10360,margin,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10361,of,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10362,exposure,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10363,(,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10364,MOE,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10365,),O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10366,approach,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10367,was,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10368,applied,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10369,.,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10426,For,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10427,tomato,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10428,and,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10429,aubergine,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10430,GAs,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10431,",",O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10432,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10433,risk,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10434,to,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10435,human,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10436,health,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10437,could,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10438,not,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10439,be,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10440,characterised,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10441,due,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10442,to,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10443,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10444,lack,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10445,of,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10446,occurrence,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10447,data,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10448,and,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10449,the,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10450,limited,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10451,toxicity,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10452,data,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10453,.,O,352.0,"For tomato and aubergine GAs , the risk to human health could not be characterised due to the lack of occurrence data and the limited toxicity data ."
10490,Milk,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10491,beverages,B-AG.01,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10492,derived,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10493,from,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10494,plant,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10495,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10496,based,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10497,protein,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10498,have,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10499,attracted,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10500,the,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10501,interest,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10502,of,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10503,consumers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10504,and,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10505,researchers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10506,as,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10507,a,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10508,health,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10509,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10510,promoting,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10511,functional,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10512,food,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10513,.,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10696,Furthermore,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10697,",",O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10698,the,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10699,effect,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10700,of,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10701,processing,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10702,",",O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10703,possible,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10704,comparative,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10705,study,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10706,and,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10707,potential,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10708,applications,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10709,in,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10710,healthcare,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10711,have,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10712,been,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10713,discussed,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10714,.,O,362.0,"Furthermore , the effect of processing , possible comparative study and potential applications in healthcare have been discussed ."
10889,A,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10890,higher,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10891,modern,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10892,score,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10893,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10894,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10895,1,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10896,SD,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10897,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10898,predicted,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10899,an,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10900,annual,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10901,decrease,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10902,in,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10903,2h,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10904,-,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10905,PG,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10906,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10907,0.015,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10908,mmol,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10909,/,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10910,L,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10911,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10912,P,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10913,<,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10914,0.01,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10915,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10916,regardless,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10917,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10918,glucose,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10919,tolerance,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10920,status,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10921,.,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
11593,Intradermal,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11594,skin,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11595,testing,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11596,with,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11597,mixed,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11598,spice,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11599,dust,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11600,allergen,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11601,demonstrated,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11602,positive,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11603,skin,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11604,reactions,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11605,in,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11606,73.3,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11607,%,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11608,of,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11609,exposed,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11610,and,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11611,in,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11612,33.3,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11613,%,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11614,of,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11615,control,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11616,workers,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11617,(,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11618,P,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11619,less,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11620,than,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11621,0.001,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11622,),O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11623,.,O,388.0,Intradermal skin testing with mixed spice dust allergen demonstrated positive skin reactions in 73.3 % of exposed and in 33.3 % of control workers ( P less than 0.001 ) .
11624,Increased,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11625,IgE,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11626,serum,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11627,levels,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11628,were,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11629,found,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11630,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11631,36.8,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11632,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11633,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11634,exposed,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11635,and,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11636,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11637,9.7,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11638,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11639,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11640,the,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11641,control,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11642,workers,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11643,(,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11644,P,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11645,less,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11646,than,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11647,0.01,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11648,),O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11649,.,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
12449,The,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12450,magnitude,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12451,estimation,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12452,scale,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12453,data,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12454,were,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12455,log,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12456,-,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12457,transformed,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12458,",",O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12459,and,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12460,all,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12461,data,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12462,were,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12463,analyzed,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12464,by,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12465,ANOVA,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12466,with,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12467,Fisher,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12468,'s,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12469,least,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12470,significant,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12471,difference,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12472,for,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12473,means,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12474,separation,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12475,.,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12828,There,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12829,is,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12830,inadequate,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12831,evidence,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12832,for,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12833,a,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12834,cancer,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12835,-,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12836,preventive,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12837,effect,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12838,of,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12839,the,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12840,consumption,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12841,of,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12842,fruits,B-AG.01.h.01,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12843,and,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12844,vegetables,B-AG.01.h.02,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12845,for,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12846,all,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12847,other,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12848,sites,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12849,.,O,427.0,There is inadequate evidence for a cancer - preventive effect of the consumption of fruits and vegetables for all other sites .
12932,A,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12933,review,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12934,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12935,the,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12936,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12937,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12938,food,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12939,allergy,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12940,in,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12941,a,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12942,birth,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12943,cohort,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12944,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12945,620,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12946,Australian,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12947,infants,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12948,at,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12949,high,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12950,risk,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12951,for,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12952,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12953,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12954,atopic,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12955,disease,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12956,has,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12957,recently,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12958,been,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12959,completed,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12960,.,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
13040,Despite,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13041,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13042,different,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13043,methodology,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13044,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13045,reports,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13046,from,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13047,several,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13048,Asian,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13049,centres,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13050,suggest,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13051,a,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13052,similar,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13053,frequency,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13054,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13055,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13056,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13057,these,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13058,foods,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13059,in,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13060,young,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13061,children,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13062,although,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13063,hypersensitivity,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13064,to,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13065,shellfish,B-AG.01.d.07,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13066,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13067,seafood,B-AG.01.d.07,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13068,was,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13069,more,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13070,common,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13071,than,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13072,for,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13073,nuts,B-AG.01.h.01.f,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13074,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13075,peanut,B-AG.01.h.01.f,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13076,and,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13077,wheat,B-AG.01.i,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13078,",",O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13079,if,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13080,seafoods,B-AG.01.d.07,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13081,are,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13082,part,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13083,of,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13084,the,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13085,staple,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13086,infant,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13087,diet,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13088,.,O,433.0,"Despite a different methodology , reports from several Asian centres suggest a similar frequency of hypersensitivity to these foods in young children although hypersensitivity to shellfish and seafood was more common than for nuts , peanut and wheat , if seafoods are part of the staple infant diet ."
13299,Postprandial,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13300,serum,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13301,insulin,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13302,concentration,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13303,AUC,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13304,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13305,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13306,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13307,during,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13308,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13309,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13310, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13311,+,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13312, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13313,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13314,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13315,compared,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13316,with,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13317,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13318,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13319,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13320,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13321,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13322, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13323,=,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13324, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13325,0·001,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13326,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13327,and,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13328,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13329,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13330,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13331,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13332,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13333, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13334,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13335, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13336,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13337,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13338,",",O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13339,which,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13340,in,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13341,turn,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13342,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13343,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13344,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13345,than,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13346,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13347,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13348,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13349,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13350,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13351, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13352,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13353, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13354,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13355,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13356,.,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13530,The,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13531,amounts,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13532,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13533,gluten,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13534,were,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13535,calculated,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13536,as,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13537,the,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13538,amount,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13539,of,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13540,cereal,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13541,protein,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13542, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13543,×,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13544, ,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13545,0·80,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13546,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13547,wheat,B-AG.01.i,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13548,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13549,oats,B-AG.01.i,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13550,",",O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13551,×0·65,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13552,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13553,rye,B-AG.01.i,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13554,and,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13555,×0·50,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13556,for,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13557,barley,B-AG.01.i,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13558,.,O,450.0,"The amounts of gluten were calculated as the amount of cereal protein   ×   0·80 for wheat and oats , ×0·65 for rye and ×0·50 for barley ."
13559,Dietary,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13560,intake,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13561,was,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13562,recorded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13563,daily,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13564,for,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13565,seven,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13566,consecutive,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13567,days,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13568,in,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13569,pre,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13570,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13571,coded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13572,food,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13573,records,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13574,supplemented,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13575,with,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13576,open,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13577,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13578,answer,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13579,possibilities,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13580,.,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13857,A,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13858,class,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13859,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13860,food,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13861,allergens,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13862,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13863,well,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13864,recognized,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13865,clinical,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13866,importance,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13867,is,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13868,that,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13869,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13870,seed,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13871,storage,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13872,2S,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13873,albumins,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13874,.,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13875,They,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13876,have,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13877,been,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13878,identified,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13879,in,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13880,the,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13881,most,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13882,diffused,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13883,edible,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13884,seeds,B-AG.01,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13885,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13886,nuts,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13887,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13888,such,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13889,as,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13890,mustard,B-AG.01.l.03,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13891,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13892,sesame,B-AG.01,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13893,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13894,Brazil,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13895,nut,I-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13896,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13897,walnut,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13898,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13899,peanut,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13900,.,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13901,In,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13902,particular,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13903,",",O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13904,a,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13905,strong,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13906,correlation,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13907,between,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13908,IgE,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13909,-,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13910,binding,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13911,to,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13912,these,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13913,proteins,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13914,and,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13915,food,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13916,-,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13917,induced,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13918,anaphylaxis,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13919,has,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13920,been,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13921,demonstrated,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13922,for,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13923,Brazil,B-AG.01.h.01.f,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13924,nut,I-AG.01.h.01.f,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13925,and,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13926,sesame,B-AG.01,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13927,seeds,I-AG.01,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
13928,.,O,463.0,"In particular , a strong correlation between IgE - binding to these proteins and food - induced anaphylaxis has been demonstrated for Brazil nut and sesame seeds ."
14066,If,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14067,these,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14068,ingredients,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14069,contain,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14070,gluten,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14071,residues,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14072,",",O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14073,then,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14074,they,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14075,should,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14076,be,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14077,avoided,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14078,by,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14079,celiac,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14080,sufferers,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14081,.,O,469.0,"If these ingredients contain gluten residues , then they should be avoided by celiac sufferers ."
14287,The,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14288,prospective,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14289,part,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14290,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14291,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14292,study,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14293,was,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14294,performed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14295,on,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14296,103,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14297,birch,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14298,pollen,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14299,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14300,hypersensitive,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14301,patients,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14302,who,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14303,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14304,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14305,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14306,free,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14307,at,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14308,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14309,time,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14310,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14311,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14312,first,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14313,visit,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14314,and,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14315,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14316,periodically,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14317,followed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14318,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14319,up,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14320,for,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14321,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14322,.,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14380,This,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14381,study,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14382,suggests,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14383,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14384,most,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14385,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14386,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14387,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14388,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14389,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14390,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14391,apple,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14392,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14393,hazelnut,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14394,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14395,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14396,whereas,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14397,only,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14398,some,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14399,apple,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14400,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14401,hazelnut,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14402,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14403,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14404,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14405,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14406,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14407,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14408,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14409,allergenic,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14410,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14411,;,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14412,moreover,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14413,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14414,it,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14415,shows,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14416,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14417,birch,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14418,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14419,specific,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14420,IgE,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14421,levels,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14422,heavily,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14423,influence,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14424,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14425,onset,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14426,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14427,OAS,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14428,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14429,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14430,whole,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14431,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14432,and,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14433,probably,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14434,play,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14435,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14436,critical,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14437,role,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14438,in,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14439,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14440,development,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14441,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14442,allergies,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14443,to,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14444,distinct,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14445,vegetable,B-AG.01.h.02,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14446,foods,I-AG.01.h.02,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14447,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14448,well,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14449,.,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14556,Questions,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14557,on,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14558,alcoholic,B-AG.01.y.01,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14559,beverages,I-AG.01.y.01,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14560,were,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14561,integrated,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14562,in,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14563,a,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14564,detailed,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14565,diet,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14566,history,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14567,interview,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14568,questionnaire,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
14569,.,O,484.0,Questions on alcoholic beverages were integrated in a detailed diet history interview questionnaire .
15300,However,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15301,",",O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15302,it,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15303,is,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15304,possible,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15305,that,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15306,changes,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15307,in,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15308,fat,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15309,preference,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15310,may,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15311,be,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15312,achieved,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15313,through,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15314,behavioral,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15315,or,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15316,pharmacological,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15317,approaches,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15318,.,O,510.0,"However , it is possible that changes in fat preference may be achieved through behavioral or pharmacological approaches ."
15342,Saturated,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15343,and,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15344,trans,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15345,fatty,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15346,acids,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15347,have,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15348,been,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15349,associated,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15350,with,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15351,the,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15352,risk,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15353,to,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15354,develop,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15355,cardiovascular,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15356,diseases,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15357,.,O,512.0,Saturated and trans fatty acids have been associated with the risk to develop cardiovascular diseases .
15358,However,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15359,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15360,health,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15361,-,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15362,promoting,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15363,effects,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15364,are,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15365,associated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15366,with,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15367,consumption,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15368,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15369,anhydrous,B-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15370,milk,I-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15371,fat,I-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15372,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15373,AMF,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15374,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15375,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15376,ruminant,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15377,trans,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15378,fatty,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15379,acids,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15380,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15381,such,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15382,as,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15383,conjugated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15384,linoleic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15385,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15386,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15387,CLA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15388,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15389,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15390,vaccenic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15391,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15392,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15393,VA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15394,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15395,contained,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15396,in,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15397,the,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15398,lipid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15399,fraction,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15400,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15401,milk,B-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15402,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15403,dairy,B-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15404,products,I-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15405,.,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,B-AG.01.h.02.g,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16327,The,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16328,objective,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16329,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16330,this,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16331,study,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16332,was,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16333,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16334,investigate,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16335,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16336,liver,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16337,proteome,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16338,of,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16339,postpartum,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16340,cows,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16341,that,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16342,were,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16343,cooled,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16344,or,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16345,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16346,stressed,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16347,during,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16348,the,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16349,dry,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16350,period,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16351,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16352,gain,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16353,insight,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16354,into,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16355,how,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16356,protein,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16357,expression,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16358,is,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16359,altered,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16360,by,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16361,prior,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16362,heat,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16363,stress,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16364,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16365,may,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16366,contribute,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16367,to,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16368,performance,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16369,and,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16370,disease,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16371,outcomes,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16372,.,O,544.0,The objective of this study was to investigate the liver proteome of postpartum cows that were cooled or heat stressed during the dry period to gain insight into how protein expression is altered by prior heat stress and may contribute to performance and disease outcomes .
16423,Liver,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16424,biopsies,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16425,were,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16426,collected,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16427,at,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16428,2,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16429,d,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16430,postpartum,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16431,",",O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16432,and,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16433,protein,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16434,content,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16435,was,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16436,analyzed,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16437,by,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16438,label,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16439,-,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16440,free,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16441,quantitative,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16442,shotgun,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16443,proteomics,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16444,(,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16445,nanoscale,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16446,liquid,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16447,chromatography,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16448,coupled,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16449,to,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16450,tandem,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16451,mass,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16452,spectrometry,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16453,),O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16454,.,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,B-AG.01.e,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,I-AG.01.e,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
17437,A,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17438,dose,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17439,of,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17440,250,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17441,microliters,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17442,of,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17443,these,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17444,solutions,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17445,was,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17446,administered,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17447,daily,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17448,to,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17449,hamsters,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17450,by,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17451,gavage,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17452,.,O,580.0,A dose of 250 microliters of these solutions was administered daily to hamsters by gavage .
17623,A,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17624,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17625,saturated,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17626,fat,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17627,/,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17628,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17629,cholesterol,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17630,diet,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17631,may,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17632,mask,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17633,the,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17634,hypercholesterolaemic,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17635,effect,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17636,of,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17637,coffee,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17638,lipids,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17639,.,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17872,A,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17873,growing,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17874,interest,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17875,has,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17876,emerged,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17877,in,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17878,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17879,beneficial,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17880,effects,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17881,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17882,plant,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17883,-,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17884,based,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17885,diets,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17886,for,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17887,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17888,prevention,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17889,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17890,cardiovascular,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17891,disease,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17892,",",O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17893,diabetes,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17894,and,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17895,obesity,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17896,.,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
18017,The,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18018,principal,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18019,classes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18020,of,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18021,red,B-AG.01.y.01.a,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18022,wine,I-AG.01.y.01.a,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18023,polyphenols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18024,include,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18025,flavonols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18026,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18027,quercetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18028,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18029,myricetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18030,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18031,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18032,flavanols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18033,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18034,catechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18035,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18036,epicatechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18037,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18038,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18039,anthocyanin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18040,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18041,stilbenes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18042,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18043,resveratrol,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18044,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18045,.,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18626,Approximately,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18627,1,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18628,%,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18629,of,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18630,the,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18631,world,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18632,'s,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18633,population,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18634,is,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18635,affected,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18636,by,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18637,CD,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18638,",",O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18639,and,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18640,the,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18641,development,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18642,of,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18643,gluten,B-AG.01.y.01.b,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18644,-,I-AG.01.y.01.b,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18645,free,I-AG.01.y.01.b,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18646,beer,I-AG.01.y.01.b,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18647,is,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18648,imperative,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18649,.,O,623.0,"Approximately 1 % of the world 's population is affected by CD , and the development of gluten - free beer is imperative ."
18733,Accordingly,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18734,",",O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18735,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18736,influential,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18737,factors,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18738,are,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18739,discussed,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18740,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18741,terms,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18742,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18743,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18744,total,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18745,substitution,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18746,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18747,malt,B-AG.01.ae,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18748,with,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18749,other,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18750,grains,B-AG.01.i,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18751,in,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18752,the,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18753,production,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18754,of,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18755,beer,B-AG.01.y.01.b,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
18756,.,O,626.0,"Accordingly , the influential factors are discussed in terms of the total substitution of malt with other grains in the production of beer ."
19279,For,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19280,meat,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19281,and,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19282,fish,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19283,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19284,pan,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19285,frying,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19286,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19287,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19288,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19289,decreased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19290,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19291,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19292,whereas,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19293,stewing,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19294,or,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19295,broiling,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19296,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19297,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19298,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19299,increased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19300,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19301,.,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19576,Consumption,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19577,of,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19578,wine,B-AG.01.y.01.a,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19579,(,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19580,OR,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19581,0.49,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19582,",",O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19583,95,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19584,%,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19585,CI,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19586,:,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19587,0.34,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19588,-,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19589,0.70,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19590,),O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19591,and,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19592,liquor,B-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19593,/,I-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19594,spirits,I-AG.01.y.01,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19595,(,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19596,OR,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19597,0.65,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19598,",",O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19599,95,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19600,%,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19601,CI,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19602,:,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19603,0.47,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19604,-,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19605,0.92,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19606,),O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19607,were,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19608,associated,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19609,with,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19610,a,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19611,significantly,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19612,reduced,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19613,risk,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
19614,.,O,654.0,"Consumption of wine ( OR 0.49 , 95 % CI : 0.34 - 0.70 ) and liquor / spirits ( OR 0.65 , 95 % CI : 0.47 - 0.92 ) were associated with a significantly reduced risk ."
20796,The,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20797,validated,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20798,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20799,-,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20800,frequency,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20801,questionnaire,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20802,included,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20803,79,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20804,questions,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20805,on,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20806,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20807,items,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20808,and,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20809,recipes,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20810,",",O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20811,categorised,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20812,into,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20813,16,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20814,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20815,groups,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20816,.,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20817,After,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20818,allowance,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20819,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20820,non,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20821,-,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20822,dietary,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20823,confounding,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20824,factors,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20825,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20826,total,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20827,energy,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20828,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20829,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20830,significant,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20831,trends,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20832,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20833,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20834,risk,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20835,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20836,colorectal,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20837,cancer,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20838,with,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20839,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20840,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20841,emerged,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20842,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20843,bread,B-AG.01.n.11,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20844,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20845,cereal,B-AG.01.n.10,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20846,dishes,I-AG.01.n.10,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20847,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20848,odds,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20849,ratio,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20850,[,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20851,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20852,],O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20853,in,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20854,highest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20855,vs.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20856,lowest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20857,quintile,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20858,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20859,1.7,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20860,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20861,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20862,potatoes,B-AG.01.h.02.a,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20863,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20864,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20865,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20866,1.2,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20867,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20868,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20869,cakes,B-AG.01.n.13,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20870,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20871,desserts,B-AG.01.n.17.a,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20872,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20873,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20874,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20875,1.1,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20876,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20877,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20878,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20879,refined,B-AG.01.l.02,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20880,sugar,I-AG.01.l.02,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20881,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20882,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20883,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20884,1.4,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20885,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20886,.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20941,Most,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20942,findings,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20943,were,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20944,similar,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20945,for,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20946,colon,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20947,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20948,rectum,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20949,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20950,but,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20951,some,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20952,negative,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20953,associations,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20954,(,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20955,i.e.,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20956,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20957,coffee,B-AG.01.ad,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20958,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20959,tea,B-AG.01.ac,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20960,",",O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20961,and,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20962,fish,B-AG.01.d.07,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20963,),O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20964,appeared,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20965,stronger,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20966,for,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20967,colon,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20968,cancer,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
20969,.,O,694.0,"Most findings were similar for colon and rectum , but some negative associations ( i.e. , coffee and tea , and fish ) appeared stronger for colon cancer ."
21174,Results,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21175,from,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21176,the,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21177,regression,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21178,were,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21179,used,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21180,to,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21181,estimate,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21182,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21183,monetary,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21184,value,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21185,of,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21186,milk,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21187,loss,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21188,related,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21189,to,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21190,SCC,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21191,as,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21192,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21193,function,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21194,of,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21195,cow,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21196,and,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21197,operation,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21198,related,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21199,explanatory,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21200,variables,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21201,for,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21202,a,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21203,representative,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21204,dairy,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21205,cow,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21206,.,O,703.0,Results from the regression were used to estimate a monetary value of milk loss related to SCC as a function of cow and operation related explanatory variables for a representative dairy cow .
21752,The,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21753,most,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21754,frequent,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21755,adverse,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21756,events,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21757,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21758,gastrointestinal,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21759,disorders,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21760,and,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21761,allergic,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21762,reactions,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21763,which,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21764,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21765,self,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21766,-,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21767,limiting,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21768,in,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21769,the,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21770,majority,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21771,of,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21772,cases,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21773,.,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21774,The,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21775,available,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21776,data,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21777,suggests,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21778,that,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21779,despite,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21780,the,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21781,safety,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21782,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21783,cinnamon,B-AG.01.l.03,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21784,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21785,as,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21786,a,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21787,spice,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21788,and/or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21789,flavoring,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21790,agent,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21791,",",O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21792,its,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21793,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21794,may,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21795,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21796,associated,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21797,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21798,significant,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21799,adverse,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21800,effects,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21801,in,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21802,medicinal,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21803,uses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21804,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21805,larger,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21806,doses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21807,or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21808,longer,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21809,duration,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21810,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21811,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21812,and,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21813,should,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21814,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21815,clinically,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21816,monitored,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21817,.,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21842,They,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21843,are,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21844,described,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21845,as,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21846,low,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21847,molecular,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21848,weight,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21849,organic,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21850,bases,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21851,with,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21852,aliphatic,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21853,",",O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21854,aromatic,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21855,",",O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21856,and,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21857,heterocyclic,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21858,structures,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
21859,.,O,727.0,"They are described as low molecular weight organic bases with aliphatic , aromatic , and heterocyclic structures ."
22064,Mangos,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22065,are,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22066,a,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22067,source,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22068,of,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22069,bioactive,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22070,compounds,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22071,with,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22072,potential,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22073,health,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22074,promoting,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22075,activity,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22076,.,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22104,Two,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22105,techniques,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22106,were,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22107,developed,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22108,for,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22109,extraction,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22110,and,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22111,fractionation,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22112,of,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22113,mango,B-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22114,fruit,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22115,peel,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22116,and,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22117,flesh,I-AG.01.h.01.e,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22118,.,O,739.0,Two techniques were developed for extraction and fractionation of mango fruit peel and flesh .
22119,Liquid,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22120,chromatography,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22121,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22122,mass,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22123,spectrometry,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22124,(,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22125,LC,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22126,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22127,MS,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22128,),O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22129,was,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22130,used,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22131,to,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22132,assess,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22133,compositional,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22134,differences,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22135,between,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22136,mango,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22137,fractions,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22138,in,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22139,flesh,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22140,extracts,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22141,.,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22793,ΔT,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22798,°,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22861,Total,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22862,carotenoids,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22863,and,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22864,ascorbic,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22865,acid,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22866,(,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22867,AA,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22868,),O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22869,were,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22870,greatly,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22871,preserved,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22872,during,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22873,vacuum,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22874,frying,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
22875,.,O,765.0,Total carotenoids and ascorbic acid ( AA ) were greatly preserved during vacuum frying .
23022,Compared,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23023,with,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23024,those,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23025,fed,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23026,the,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23027,low,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23028,fat,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23029,",",O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23030,serum,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23031,and,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23032,LDL,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23033,cholesterol,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23034,concentrations,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23035,were,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23036,significantly,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23037,lower,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23038,in,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23039,rabbits,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23040,fed,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23041,corn,B-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23042,oil,I-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23043,and,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23044,greater,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23045,in,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23046,animals,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23047,fed,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23048,corn,B-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23049,oil,I-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23050,with,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23051,added,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23052,cholesterol,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23053,or,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23054,chicken,B-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23055,fat,I-AG.01.f,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23056,.,O,770.0,"Compared with those fed the low fat , serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat ."
23096,The,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23097,significant,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23098,elevations,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23099,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23100,linoleic,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23101,acid,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23102,[,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23103,18:2(n-6,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23104,),O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23105,],O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23106,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23107,serum,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23108,and,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23109,LDL,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23110,may,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23111,partially,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23112,explain,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23113,the,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23114,high,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23115,oxidizability,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23116,of,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23117,LDL,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23118,in,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23119,rabbits,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23120,fed,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23121,corn,B-AG.01.f,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23122,oil,I-AG.01.f,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23123,.,O,773.0,The significant elevations in linoleic acid [ 18:2(n-6 ) ] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil .
23247,The,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23248,Copenhagen,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23249,Prospective,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23250,Population,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23251,Studies,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23252,demonstrated,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23253,in,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23254,the,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23255,year,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23256,2000,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23257,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23258,wine,B-AG.01.y.01.a,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23259,intake,B-X,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23260,may,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23261,have,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23262,a,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23263,beneficial,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23264,effect,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23265,on,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23266,all,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23267,cause,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23268,mortality,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23269,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23270,is,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23271,additive,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23272,to,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23273,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23274,of,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23275,alcohol,B-AG.01.y.01,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23276,.,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23277,Wine,B-AG.01.y.01.a,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23278,contains,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23279,various,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23280,poliphenolic,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23281,substances,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23282,which,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23283,may,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23284,be,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23285,beneficial,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23286,for,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23287,health,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23288,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23289,in,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23290,particular,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23291,flavonols,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23292,(,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23293,such,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23294,as,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23295,myricetin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23296,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23297,quercetin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23298,),O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23299,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23300,catechin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23301,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23302,epicatechin,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23303,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23304,proanthocyanidins,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23305,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23306,anthocyanins,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23307,",",O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23308,various,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23309,phenolic,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23310,acids,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23311,and,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23312,the,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23313,stilbene,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23314,resveratrol,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23315,.,O,780.0,"Wine contains various poliphenolic substances which may be beneficial for health and in particular flavonols ( such as myricetin and quercetin ) , catechin and epicatechin , proanthocyanidins , anthocyanins , various phenolic acids and the stilbene resveratrol ."
23453,The,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23454,effects,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23455,of,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23456,dairy,B-AG.01.e,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23457,consumption,B-X,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23458,on,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23459,the,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23460,prevention,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23461,of,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23462,type,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23463,2,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23464,diabetes,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23465,remain,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23466,controversial,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23467,and,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23468,depend,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23469,on,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23470,the,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23471,dairy,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23472,subtype,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23473,.,O,785.0,The effects of dairy consumption on the prevention of type 2 diabetes remain controversial and depend on the dairy subtype .
23646,Yogurt,B-AG.01.e,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23647,may,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23648,have,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23649,probiotic,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23650,effects,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23651,that,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23652,could,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23653,modulate,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23654,glucose,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23655,metabolism,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23656,.,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
24096,Disrupted,O,809.0,Disrupted samples became firmer with pasteurization .
24097,samples,O,809.0,Disrupted samples became firmer with pasteurization .
24098,became,O,809.0,Disrupted samples became firmer with pasteurization .
24099,firmer,O,809.0,Disrupted samples became firmer with pasteurization .
24100,with,O,809.0,Disrupted samples became firmer with pasteurization .
24101,pasteurization,O,809.0,Disrupted samples became firmer with pasteurization .
24102,.,O,809.0,Disrupted samples became firmer with pasteurization .
24328,Milk,B-AG.01.e,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24329,consumption,B-X,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24330,is,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24331,an,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24332,accepted,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24333,strategy,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24334,in,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24335,building,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24336,peak,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24337,bone,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24338,mass,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24339,and,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24340,therefore,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24341,may,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24342,reduce,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24343,the,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24344,risk,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24345,of,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24346,osteoporosis,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24347,.,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24980,Cereals,B-AG.01.i,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24981,also,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24982,contain,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24983,phytoestrogens,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24984,of,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24985,the,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24986,lignan,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24987,family,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24988,and,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24989,several,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24990,phenolic,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24991,acids,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24992,with,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24993,antioxidant,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24994,properties,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
24995,.,O,842.0,Cereals also contain phytoestrogens of the lignan family and several phenolic acids with antioxidant properties .
25150,This,O,849.0,This confirms an earlier report from a small British cohort .
25151,confirms,O,849.0,This confirms an earlier report from a small British cohort .
25152,an,O,849.0,This confirms an earlier report from a small British cohort .
25153,earlier,O,849.0,This confirms an earlier report from a small British cohort .
25154,report,O,849.0,This confirms an earlier report from a small British cohort .
25155,from,O,849.0,This confirms an earlier report from a small British cohort .
25156,a,O,849.0,This confirms an earlier report from a small British cohort .
25157,small,O,849.0,This confirms an earlier report from a small British cohort .
25158,British,O,849.0,This confirms an earlier report from a small British cohort .
25159,cohort,O,849.0,This confirms an earlier report from a small British cohort .
25160,.,O,849.0,This confirms an earlier report from a small British cohort .
25912,Both,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25913,plays,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25914,a,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25915,significant,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25916,role,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25917,in,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25918,the,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25919,reduction,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25920,of,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25921,coronary,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25922,heart,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25923,diseases,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25924,and,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25925,a,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25926,certain,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25927,type,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25928,of,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25929,cancers,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
25930,.,O,877.0,Both plays a significant role in the reduction of coronary heart diseases and a certain type of cancers .
26016,This,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26017,review,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26018,article,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26019,discusses,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26020,the,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26021,anticancer,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26022,perspectives,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26023,and,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26024,mechanisms,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26025,of,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26026,oleuropein,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26027,and,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26028,hydroxytyrosol,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26029,in,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26030,cell,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26031,cultures,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26032,and,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26033,animal,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26034,and,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26035,human,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26036,studies,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26037,.,O,882.0,This review article discusses the anticancer perspectives and mechanisms of oleuropein and hydroxytyrosol in cell cultures and animal and human studies .
26181,Epidemiological,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26182,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26183,clinical,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26184,studies,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26185,have,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26186,pointed,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26187,out,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26188,that,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26189,regular,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26190,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26191,moderate,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26192,wine,B-AG.01.y.01.a,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26193,consumption,B-X,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26194,(,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26195,one,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26196,to,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26197,two,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26198,glasses,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26199,a,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26200,day,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26201,),O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26202,is,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26203,associated,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26204,with,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26205,decreased,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26206,incidence,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26207,of,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26208,cardiovascular,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26209,disease,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26210,(,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26211,CVD,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26212,),O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26213,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26214,hypertension,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26215,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26216,diabetes,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26217,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26218,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26219,certain,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26220,types,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26221,of,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26222,cancer,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26223,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26224,including,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26225,colon,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26226,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26227,basal,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26228,cell,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26229,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26230,ovarian,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26231,",",O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26232,and,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26233,prostate,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26234,carcinoma,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26235,.,O,887.0,"Epidemiological and clinical studies have pointed out that regular and moderate wine consumption ( one to two glasses a day ) is associated with decreased incidence of cardiovascular disease ( CVD ) , hypertension , diabetes , and certain types of cancer , including colon , basal cell , ovarian , and prostate carcinoma ."
26526,Hygiene,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26527,and,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26528,milk,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26529,processing,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26530,capability,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26531,and,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26532,shelf,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26533,life,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26534,of,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26535,products,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26536,can,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26537,be,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26538,improved,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26539,.,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26656,Training,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26657,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26658,of,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26659,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26660,trainers,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26661,workshops,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26662,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26663,milk,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26664,processing,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26665,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26666,hygiene,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26667,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26668,developed,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26669,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26670,given,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26671,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26672,Rwanda,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26673,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26674,Nepal,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26675,based,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26676,on,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26677,the,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26678,rapid,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26679,needs,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26680,assessments,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26681,",",O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26682,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26683,these,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26684,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26685,well,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26686,received,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26687,.,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26688,We,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26689,concluded,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26690,that,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26691,Rwanda,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26692,and,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26693,Nepal,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26694,both,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26695,have,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26696,smallholder,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26697,dairy,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26698,farms,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26699,that,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26700,often,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26701,face,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26702,similar,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26703,challenges,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26704,such,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26705,as,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26706,lack,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26707,of,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26708,quality,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26709,feeds,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26710,",",O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26711,needs,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26712,for,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26713,basic,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26714,dairy,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26715,management,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26716,education,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26717,",",O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26718,low,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26719,cattle,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26720,productivity,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26721,",",O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26722,and,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26723,undesirable,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26724,milk,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26725,quality,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26726,.,O,905.0,"We concluded that Rwanda and Nepal both have smallholder dairy farms that often face similar challenges such as lack of quality feeds , needs for basic dairy management education , low cattle productivity , and undesirable milk quality ."
26784,The,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26785,experiment,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26786,was,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26787,conducted,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26788,in,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26789,the,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26790,summer,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26791,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26792,2006,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26793,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26794,involved,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26795,24,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26796,Friesian,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26797,cows,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26798,that,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26799,were,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26800,divided,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26801,into,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26802,3,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26803,groups,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26804,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26805,8,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26806,animals,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26807,according,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26808,to,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26809,different,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26810,type,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26811,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26812,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26813,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26814,:,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26815,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26816,traditional,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26817,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26818,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26819,no,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26820,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26821,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26822,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26823,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26824,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26825,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26826,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26827,whole,B-AG.01,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26828,flaxseed,I-AG.01,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26829,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26830,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26831,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26832,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26833,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26834,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26835,fish,B-AG.01.f,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26836,oil,I-AG.01.f,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26837,.,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
27004,In,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27005,conclusion,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27006,",",O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27007,flaxseed,B-AG.01,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27008,supplementation,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27009,improves,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27010,composition,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27011,and,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27012,nutritional,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27013,properties,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27014,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27015,milk,B-AG.01.e,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27016,from,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27017,cows,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27018,milked,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27019,during,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27020,times,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27021,of,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27022,high,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27023,ambient,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27024,temperature,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
27025,.,O,915.0,"In conclusion , flaxseed supplementation improves composition and nutritional properties of milk from cows milked during times of high ambient temperature ."
28063,Lead,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28064,and,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28065,arsenic,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28066,were,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28067,imposing,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28068,a,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28069,serious,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28070,threat,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28071,on,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28072,the,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28073,local,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28074,residents,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28075,via,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28076,vegetable,B-AG.01.h.02,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28077,consumption,B-X,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28078,.,O,953.0,Lead and arsenic were imposing a serious threat on the local residents via vegetable consumption .
28720,Satisfaction,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28721,with,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28722,milk,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28723,flavor,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28724,",",O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28725,perceived,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28726,health,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28727,benefits,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28728,derived,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28729,from,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28730,milk,B-AG.01.e,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28731,",",O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28732,and,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28733,habit,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28734,are,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28735,primary,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28736,drivers,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28737,of,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28738,lifelong,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28739,milk,B-AG.01.e,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28740,consumption,B-X,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
28741,.,O,974.0,"Satisfaction with milk flavor , perceived health benefits derived from milk , and habit are primary drivers of lifelong milk consumption ."
29273,There,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29274,are,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29275,more,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29276,than,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29277,30,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29278,spices,B-AG.01.l.03,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29279,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29280,herbs,B-AG.01.h.02.i,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29281,of,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29282,global,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29283,economic,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29284,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29285,culinary,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29286,importance,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29287,.,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29948,We,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29949,analyzed,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29950,22,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29951,sera,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29952,from,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29953,patients,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29954,with,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29955,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29956,mugwort,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29957,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29958,birch,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29959,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29960,celery,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29961,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29962,spice,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29963,syndrome,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29964,for,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29965,IgE,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29966,binding,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29967,to,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29968,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29969,spices,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29970,pepper,I-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29971,and,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29972,paprika,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29973,by,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29974,immunoblotting,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29975,.,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
30676,However,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30677,",",O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30678,the,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30679,molecular,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30680,targets,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30681,in,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30682,the,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30683,genome,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30684,are,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30685,mostly,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30686,unknown,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30687,.,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
31601,The,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31602,studies,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31603,on,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31604,tea,B-AG.01.ac,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31605,and,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31606,lung,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31607,cancer,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31608,also,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31609,suggest,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31610,an,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31611,increased,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31612,risk,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31613,with,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31614,increased,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31615,tea,B-AG.01.ac,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31616,consumption,B-X,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
31617,.,O,1071.0,The studies on tea and lung cancer also suggest an increased risk with increased tea consumption .
32042,Tea,B-AG.01.ac,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32043,",",O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32044,red,B-AG.01.y.01.a,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32045,wine,I-AG.01.y.01.a,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32046,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32047,cocoa,B-AG.01,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32048,are,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32049,good,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32050,sources,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32051,of,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32052,flavanols,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32053,and,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32054,these,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32055,highly,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32056,consumed,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32057,foods,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32058,might,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32059,contribute,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32060,to,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32061,prevent,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32062,diabetes,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32063,.,O,1086.0,"Tea , red wine and cocoa are good sources of flavanols and these highly consumed foods might contribute to prevent diabetes ."
32225,It,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32226,has,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32227,very,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32228,strong,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32229,adaptability,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32230,to,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32231,adverse,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32232,environments,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32233,with,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32234,a,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32235,very,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32236,short,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32237,growing,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32238,span,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32239,.,O,1094.0,It has very strong adaptability to adverse environments with a very short growing span .
32240,Many,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32241,varieties,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32242,are,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32243,growing,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32244,around,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32245,the,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32246,world,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32247,",",O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32248,but,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32249,mainly,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32250,in,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32251,the,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32252,north,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32253,hemisphere,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32254,.,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32314,In,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32315,this,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32316,review,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32317,we,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32318,focus,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32319,on,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32320,works,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32321,related,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32322,to,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32323,the,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32324,development,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32325,of,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32326,functional,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32327,foods,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32328,from,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32329,common,B-AG.01.i,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32330,buckwheat,I-AG.01.i,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32331,",",O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32332,Fagopyrum,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32333,esculentum,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32334,Moench,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32335,.,O,1099.0,"In this review we focus on works related to the development of functional foods from common buckwheat , Fagopyrum esculentum Moench ."
32881,Sets,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32882,of,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32883,24,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32884,-,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32885,h,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32886,dietary,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32887,recalls,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32888,were,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32889,completed,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32890,on,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32891,90,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32892,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32893,of,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32894,eligible,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32895,participants,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32896,at,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32897,1,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32898,y,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32899,and,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32900,86,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32901,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32902,at,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32903,4,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32904,y.,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32905,Using,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32906,a,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32907,conservative,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32908,imputation,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32909,analysis,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32910,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32911,at,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32912,1,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32913,y,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32914,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32915,the,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32916,intervention,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32917,group,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32918,consumed,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32919,38,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32920,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32921,more,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32922,vegetable,B-AG.01.h.02,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32923,servings,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32924,(,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32925,100,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32926,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32927,when,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32928,including,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32929,juice,B-AG.01.ab,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32930,),O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32931,than,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32932,the,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32933,comparison,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32934,group,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32935,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32936,20,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32937,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32938,more,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32939,fruit,B-AG.01.h.01,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32940,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32941,38,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32942,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32943,more,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32944,fiber,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32945,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32946,50,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32947,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32948,more,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32949,legumes,B-AG.01.h.02.g,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32950,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32951,and,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32952,30,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32953,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32954,more,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32955,whole,B-AG.01.i,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32956,grain,I-AG.01.i,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32957,foods,I-AG.01.i,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32958,",",O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32959,with,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32960,a,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32961,20,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32962,%,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32963,lower,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32964,intake,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32965,of,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32966,energy,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32967,from,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32968,fat,B-AG.01.f,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
32969,.,O,1119.0,"Sets of 24 - h dietary recalls were completed on 90 % of eligible participants at 1 y and 86 % at 4 y. Using a conservative imputation analysis , at 1 y , the intervention group consumed 38 % more vegetable servings ( 100 % when including juice ) than the comparison group , 20 % more fruit , 38 % more fiber , 50 % more legumes , and 30 % more whole grain foods , with a 20 % lower intake of energy from fat ."
33351,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33352,and,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33353,recipes,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33354,of,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33355,bamboo,B-AG.01,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33356,shoots,I-AG.01,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33357,(,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33358,bamboo,B-AG.01.y.01.b,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33359,beer,I-AG.01.y.01.b,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33360,",",O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33361,bamboo,B-AG.01.n.14,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33362,cookies,I-AG.01.n.14,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33363,),O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33364,are,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33365,consumed,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33366,worldwide,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33367,.,O,1134.0,") and recipes of bamboo shoots ( bamboo beer , bamboo cookies ) are consumed worldwide ."
33576,Rats,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33577,were,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33578,decapitated,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33579,",",O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33580,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33581,hepatic,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33582,tissue,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33583,was,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33584,used,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33585,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33586,phospholipid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33587,fatty,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33588,acid,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33589,analysis,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33590,and,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33591,for,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33592,the,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33593,preparation,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33594,of,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33595,mitochondria,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33596,.,O,1145.0,"Rats were decapitated , and hepatic tissue was used for phospholipid fatty acid analysis and for the preparation of mitochondria ."
33751,These,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33752,observations,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33753,suggest,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33754,that,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33755,the,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33756,inherent,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33757,tendency,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33758,of,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33759,the,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33760,BHE,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33761,rat,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33762,toward,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33763,looser,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33764,coupling,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33765,of,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33766,respiration,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33767,to,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33768,ATP,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33769,synthesis,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33770,is,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33771,potentiated,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33772,by,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33773,the,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33774,feeding,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33775,of,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33776,the,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33777,highly,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33778,saturated,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33779,fat,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33780,",",O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33781,hydrogenated,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33782,coconut,B-AG.01.f,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33783,oil,I-AG.01.f,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33784,.,O,1152.0,"These observations suggest that the inherent tendency of the BHE rat toward looser coupling of respiration to ATP synthesis is potentiated by the feeding of the highly saturated fat , hydrogenated coconut oil ."
33916,It,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33917,was,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33918,found,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33919,that,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33920,animals,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33921,fed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33922,beef,B-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33923,fat,I-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33924,were,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33925,most,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33926,efficient,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33927,at,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33928,converting,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33929,iron,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33930,from,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33931,turkey,B-AG.01.d.06,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33932,meat,I-AG.01.d.06,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33933,into,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33934,hemoglobin,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33935,followed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33936,by,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33937,those,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33938,fed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33939,turkey,B-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33940,fat,I-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33941,",",O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33942,corn,B-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33943,oil,I-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33944,and,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33945,pork,B-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33946,fat,I-AG.01.f,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33947,in,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33948,descending,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33949,order,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33950,.,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
34040,Among,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34041,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34042,food,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34043,items,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34044,we,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34045,examined,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34046,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34047,cheese,B-AG.01.e.02,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34048,was,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34049,most,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34050,closely,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34051,correlated,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34052,with,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34053,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34054,incidence,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34055,of,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34056,testicular,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34057,cancer,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34058,at,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34059,ages,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34060,20,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34061,-,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34062,39,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34063,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34064,followed,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34065,by,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34066,animal,B-AG.01.f,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34067,fats,I-AG.01.f,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34068,and,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34069,milk,B-AG.01.e,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34070,.,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34139,Concerning,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34140,prostatic,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34141,cancer,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34142,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34143,milk,B-AG.01.e,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34144,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34145,1961,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34146,-,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34147,90,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34148,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34149,was,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34150,most,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34151,closely,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34152,correlated,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34153,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34154,r,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34155,=,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34156,0.711,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34157,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34158,with,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34159,its,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34160,incidence,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34161,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34162,followed,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34163,by,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34164,meat,B-AG.01.d,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34165,and,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34166,coffee,B-AG.01.ad,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34167,.,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34516,Carbon,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34517,footprints,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34518,found,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34519,greenhouse,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34520,gas,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34521,(,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34522,GHG,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34523,),O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34524,emissions,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34525,averaged,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34526,0.849,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34527,kg,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34528,CO,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34529,Barley,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34530,is,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34531,one,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34532,of,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34533,the,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34534,most,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34535,important,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34536,cereal,B-AG.01.i,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34537,crops,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34538,and,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34539,arranged,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34540,globally,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34541,as,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34542,fourth,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34543,after,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34544,wheat,B-AG.01.i,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34545,",",O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34546,rice,B-AG.01.i,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34547,",",O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34548,and,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34549,corn,B-AG.01.i,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34550,.,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34942,The,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34943,formulation,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34944,containing,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34945,37,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34946,%,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34947,RBO,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34948,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34949,6,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34950,%,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34951,SPC,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34952,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34953,and,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34954,57,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34955,%,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34956,water,B-AG.01.z,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34957,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34958,which,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34959,was,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34960,located,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34961,within,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34962,the,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34963,optimum,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34964,region,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34965,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34966,was,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34967,selected,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34968,as,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34969,a,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34970,base,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34971,for,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34972,further,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34973,developing,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34974,flavored,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34975,(,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34976,sour,B-AG.01.e,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34977,cream,I-AG.01.e,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34978,&,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34979,onion,B-AG.01.h.02.e,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34980,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34981,cheddar,B-AG.01.e.02,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34982,&,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34983,sour,B-AG.01.e,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34984,cream,I-AG.01.e,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34985,",",O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34986,or,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34987,Monterrey,B-AG.01.e.02,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34988,Jack,I-AG.01.e.02,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34989,dried,I-AG.01.e.02,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34990,cheese,I-AG.01.e.02,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34991,),O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34992,products,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
34993,.,O,1191.0,"The formulation containing 37 % RBO , 6 % SPC , and 57 % water , which was located within the optimum region , was selected as a base for further developing flavored ( sour cream & onion , cheddar & sour cream , or Monterrey Jack dried cheese ) products ."
35142,An,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35143,ELISA,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35144,was,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35145,developed,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35146,using,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35147,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35148,sheep,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35149,antiroasted,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35150,walnut,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35151,serum,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35152,as,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35153,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35154,capture,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35155,reagent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35156,and,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35157,rabbit,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35158,antiroasted,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35159,walnut,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35160,serum,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35161,as,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35162,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35163,detector,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35164,reagent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35165,followed,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35166,by,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35167,addition,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35168,of,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35169,commercial,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35170,goat,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35171,anti,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35172,-,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35173,rabbit,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35174,IgG,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35175,antibody,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35176,labeled,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35177,with,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35178,alkaline,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35179,phosphatase,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35180,and,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35181,subsequent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35182,substrate,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35183,addition,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35184,.,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35221,Recoveries,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35222,of,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35223,1,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35224,to,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35225,100,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35226,ppm,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35227,walnut,B-AG.01.n.17.a,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35228,-,I-AG.01.n.17.a,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35229,in,I-AG.01.n.17.a,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35230,-,I-AG.01.n.17.a,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35231,chocolate,I-AG.01.n.17.a,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35232,ranged,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35233,from,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35234,71.6,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35235,%,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35236,to,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35237,119%+/-,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35238,7,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35239,%,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35240,to,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35241,16.5,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35242,%,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35243,.,O,1200.0,Recoveries of 1 to 100 ppm walnut - in - chocolate ranged from 71.6 % to 119%+/- 7 % to 16.5 % .
35390, ,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35391,Denmark,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35392,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35393,Sweden,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35394,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35395,and,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35396,Switzerland,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35397,have,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35398,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35399,highest,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35400,risk,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35401,of,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35402,ovarian,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35403,cancer,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35404,in,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35405,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35406,world,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35407,.,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35559, ,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35560,Using,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35561,the,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35562,case,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35563,control,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35564,data,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35565,",",O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35566,others,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35567,found,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35568,an,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35569,increased,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35570,risk,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35571,for,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35572,total,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35573,lactose,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35574,intake,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35575,in,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35576,women,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35577,who,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35578,never,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35579,used,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35580,oral,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35581,contraceptives,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35582,(,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35583,OCs,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35584,),O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35585,.,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35781,The,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35782,influence,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35783,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35784,mastitis,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35785,on,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35786,milk,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35787,perchlorate,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35788,levels,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35789,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35790,where,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35791,there,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35792,is,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35793,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35794,increase,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35795,in,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35796,mammary,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35797,vascular,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35798,permeability,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35799,and,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35800,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35801,influx,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35802,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35803,blood,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35804,-,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35805,derived,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35806,components,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35807,into,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35808,milk,B-AG.01.e,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35809,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35810,remains,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35811,unknown,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35812,.,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
36305,The,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36306,intervention,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36307,group,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36308,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36309,n,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36310,=,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36311,121,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36312,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36313,received,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36314,individual,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36315,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36316,counselling,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36317,aimed,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36318,at,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36319,reducing,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36320,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36321,fat,B-AG.01.f,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36322,intake,B-X,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36323,to,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36324,20,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36325,-,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36326,25,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36327,%,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36328,energy,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36329,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36330,E%,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36331,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36332,",",O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36333,whereas,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36334,no,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36335,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36336,advice,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36337,was,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36338,given,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36339,to,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36340,women,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36341,in,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36342,the,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36343,control,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36344,group,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36345,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36346,n,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36347,=,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36348,119,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36349,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36350,.,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36351,For,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36352,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36353,52,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36354,%,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36355,of,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36356,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36357,women,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36358,in,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36359,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36360,intervention,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36361,group,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36362,that,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36363,completed,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36364,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36365,study,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36366,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36367,total,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36368,fat,B-AG.01.f,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36369,intake,B-X,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36370,decreased,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36371,from,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36372,36,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36373,to,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36374,23,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36375,E%,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36376,(,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36377,P,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36378,less,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36379,than,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36380,or,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36381,equal,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36382,to,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36383,0.01,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36384,),O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36385,and,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36386,from,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36387,37,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36388,to,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36389,34,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36390,E%,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36391,(,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36392,P,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36393,less,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36394,than,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36395,or,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36396,equal,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36397,to,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36398,0.01,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36399,),O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36400,for,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36401,the,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36402,control,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36403,group,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36404,.,O,1244.0,For the 52 % of the women in the intervention group that completed the study the total fat intake decreased from 36 to 23 E% ( P less than or equal to 0.01 ) and from 37 to 34 E% ( P less than or equal to 0.01 ) for the control group .
36612,Patterns,O,1252.0,Patterns of cancer are also changing .
36613,of,O,1252.0,Patterns of cancer are also changing .
36614,cancer,O,1252.0,Patterns of cancer are also changing .
36615,are,O,1252.0,Patterns of cancer are also changing .
36616,also,O,1252.0,Patterns of cancer are also changing .
36617,changing,O,1252.0,Patterns of cancer are also changing .
36618,.,O,1252.0,Patterns of cancer are also changing .
36938,There,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36939,are,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36940,many,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36941,kinds,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36942,of,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36943,diseases,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36944,of,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36945,the,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36946,liver,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36947,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36948,caused,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36949,by,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36950,viruses,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36951,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36952,such,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36953,as,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36954,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36955,A,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36956,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36957,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36958,B,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36959,and,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36960,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36961,C,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36962,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36963,or,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36964,by,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36965,certain,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36966,drugs,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36967,and,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36968,poisons,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36969,including,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36970,excessive,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36971,alcohol,B-AG.01.y.01,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36972,consumption,B-X,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36973,.,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37559,To,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37560,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37561,extent,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37562,that,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37563,fruit,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37564,and,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37565,vegetable,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37566,potassium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37567,is,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37568,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37569,surrogate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37570,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37571,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37572,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37573,",",O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37574,this,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37575,cohort,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37576,did,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37577,not,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37578,have,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37579,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37580,dietary,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37581,intake,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37582,pattern,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37583,allowing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37584,for,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37585,measurement,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37586,or,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37587,interpretation,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37588,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37589,the,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37590,potential,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37591,effect,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37592,of,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37593,a,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37594,high,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37595,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37596,bicarbonate,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37597,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37598,containing,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37599,diet,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37600,on,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37601,long,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37602,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37603,term,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37604,steady,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37605,-,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37606,state,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37607,calcium,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37608,balance,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
37609,.,O,1286.0,"To the extent that fruit and vegetable potassium is a surrogate for high bicarbonate , this cohort did not have a dietary intake pattern allowing for measurement or interpretation of the potential effect of a high - bicarbonate - containing diet on long - term steady - state calcium balance ."
38725,Our,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38726,study,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38727,included,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38728,22,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38729,case,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38730,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38731,control,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38732,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38733,cohort,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38734,studies,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38735,with,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38736,a,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38737,total,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38738,of,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38739,2548,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38740,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38741,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38742,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38743,lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38744,cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38745,patients,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38746,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38747,9362,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38748,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38749,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38750,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38751,controls,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38752,from,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38753,North,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38754,America,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38755,",",O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38756,Europe,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38757,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38758,Asia,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38759,within,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38760,the,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38761,International,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38762,Lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38763,Cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38764,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38765,(,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38766,ILCCO,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38767,),O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38768,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38769,SYNERGY,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38770,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38771,.,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38772,Alcohol,B-AG.01.y.01,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38773,consumption,B-X,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38774,was,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38775,categorized,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38776,into,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38777,amounts,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38778,consumed,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38779,(,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38780,grams,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38781,per,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38782,day,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38783,),O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38784,and,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38785,also,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38786,modelled,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38787,as,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38788,a,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38789,continuous,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38790,variable,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38791,using,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38792,restricted,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38793,cubic,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38794,splines,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38795,for,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38796,potential,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38797,non,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38798,-,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38799,linearity,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38800,.,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
39604,Dairy,O,1360.0,Dairy products are important sources of dietary fat in India .
39605,products,B-AG.01.e,1360.0,Dairy products are important sources of dietary fat in India .
39606,are,O,1360.0,Dairy products are important sources of dietary fat in India .
39607,important,O,1360.0,Dairy products are important sources of dietary fat in India .
39608,sources,O,1360.0,Dairy products are important sources of dietary fat in India .
39609,of,O,1360.0,Dairy products are important sources of dietary fat in India .
39610,dietary,O,1360.0,Dairy products are important sources of dietary fat in India .
39611,fat,O,1360.0,Dairy products are important sources of dietary fat in India .
39612,in,O,1360.0,Dairy products are important sources of dietary fat in India .
39613,India,O,1360.0,Dairy products are important sources of dietary fat in India .
39614,.,O,1360.0,Dairy products are important sources of dietary fat in India .
40151,In,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40152,conclusion,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40153,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40154,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40155,middle,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40156,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40157,aged,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40158,and,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40159,elderly,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40160,moderately,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40161,hypercholesterolemic,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40162,subjects,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40163,",",O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40164,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40165,consumption,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40166,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40167,reduced,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40168,-,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40169,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40170,diets,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40171,enriched,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40172,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40173,animal,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40174,fat,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40175,or,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40176,vegetable,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40177,oils,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40178,with,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40179,a,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40180,relatively,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40181,wide,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40182,range,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40183,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40184,fatty,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40185,acid,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40186,profiles,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40187,did,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40188,not,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40189,alter,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40190,the,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40191,in,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40192,vitro,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40193,susceptibility,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40194,of,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40195,LDL,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40196,to,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40197,oxidation,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40198,.,O,1377.0,"In conclusion , in middle - aged and elderly moderately hypercholesterolemic subjects , the consumption of reduced - fat diets enriched in animal fat or vegetable oils with a relatively wide range of fatty acid profiles did not alter the in vitro susceptibility of LDL to oxidation ."
40324,Cox,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40325,proportional,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40326,hazard,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40327,models,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40328,were,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40329,used,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40330,to,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40331,estimate,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40332,hazard,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40333,ratios,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40334,and,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40335,95,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40336,%,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40337,confidence,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40338,intervals,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40339,for,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40340,mortality,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40341,using,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40342,the,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40343,non,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40344,-,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40345,consumers,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40346,as,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40347,reference,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40348,groups,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40349,and,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40350,three,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40351,categories,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40352,of,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40353,consumption,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40354,.,O,1383.0,Cox proportional hazard models were used to estimate hazard ratios and 95 % confidence intervals for mortality using the non - consumers as reference groups and three categories of consumption .
40432,Height,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40433,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40434,weight,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40435,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40436,and,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40437,triceps,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40438,skinfolds,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40439,were,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40440,measured,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40441,.,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40537,More,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40538,overweight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40539,than,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40540,thin,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40541,and,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40542,normal,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40543,-,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40544,weight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40545,children,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40546,indicated,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40547,that,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40548,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40549,to,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40550,prevent,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40551,obesity,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40552,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40553,all,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40554,kinds,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40555,of,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40556,food,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40557,are,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40558,permissible,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40559,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40560,but,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40561,only,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40562,in,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40563,limited,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40564,amounts,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40565,.,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40620,Overweight,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40621,children,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40622,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40623,particularly,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40624,girls,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40625,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40626,reported,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40627,eating,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40628,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40629,bread,B-AG.01.n.11,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40630,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40631,cake,B-AG.01.n.13,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40632,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40633,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40634,cream,B-AG.01.e,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40635,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40636,adding,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40637,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40638,sugar,B-AG.01.l.02,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40639,to,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40640,beverages,B-AG.01.y,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40641,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40642,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40643,eating,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40644,sweets,B-AG.01.n.17.a,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40645,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40646,ice,B-AG.01.n.17.b,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40647,cream,B-AG.01.e,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40648,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40649,frequently,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40650,than,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40651,thin,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40652,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40653,normal,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40654,-,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40655,weight,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40656,children,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40657,.,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
41006,We,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41007,report,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41008,on,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41009,an,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41010,association,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41011,between,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41012,coffee,B-AG.01.ad,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41013,consumption,B-X,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41014,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41015,the,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41016,concentration,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41017,of,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41018,total,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41019,homocysteine,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41020,(,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41021,tHcy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41022,),O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41023,in,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41024,plasma,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41025,",",O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41026,a,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41027,risk,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41028,factor,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41029,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41030,cardiovascular,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41031,disease,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41032,and,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41033,for,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41034,adverse,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41035,pregnancy,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41036,outcome,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41037,.,O,1406.0,"We report on an association between coffee consumption and the concentration of total homocysteine ( tHcy ) in plasma , a risk factor for cardiovascular disease and for adverse pregnancy outcome ."
41107,There,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41108,was,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41109,a,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41110,marked,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41111,positive,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41112,dose,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41113,-,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41114,response,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41115,relation,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41116,between,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41117,coffee,B-AG.01.ad,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41118,consumption,B-X,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41119,and,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41120,plasma,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41121,tHcy,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41122,",",O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41123,which,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41124,was,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41125,stronger,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41126,than,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41127,the,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41128,relation,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41129,between,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41130,coffee,B-AG.01.ad,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41131,and,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41132,total,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41133,serum,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41134,cholesterol,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41135,.,O,1410.0,"There was a marked positive dose - response relation between coffee consumption and plasma tHcy , which was stronger than the relation between coffee and total serum cholesterol ."
41228,The,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41229,combination,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41230,of,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41231,cigarette,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41232,smoking,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41233,and,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41234,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41235,coffee,B-AG.01.ad,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41236,intake,B-X,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41237,was,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41238,associated,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41239,with,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41240,particularly,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41241,high,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41242,tHcy,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41243,concentrations,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41244,.,O,1413.0,The combination of cigarette smoking and high coffee intake was associated with particularly high tHcy concentrations .
41392,We,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41393,obtained,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41394,blood,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41395,samples,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41396,at,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41397,baseline,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41398,and,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41399,for,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41400,4,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41401,h,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41402,postprandially,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41403,.,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41812,Although,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41813,other,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41814,flavonoid,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41815,-,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41816,rich,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41817,foods,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41818,and,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41819,beverages,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41820,were,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41821,not,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41822,associated,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41823,",",O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41824,red,B-AG.01.y.01.a,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41825,wine,I-AG.01.y.01.a,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41826,was,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41827,inversely,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41828,associated,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41829,with,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41830,diabetes,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
41831,.,O,1434.0,"Although other flavonoid - rich foods and beverages were not associated , red wine was inversely associated with diabetes ."
42274,The,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42275,purpose,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42276,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42277,this,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42278,study,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42279,was,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42280,to,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42281,assess,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42282,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42283,effect,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42284,of,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42285,garlic,B-AG.01.h.02.e,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42286,on,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42287,the,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42288,liver,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42289,phosphatidate,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42290,phosphohydrolase,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42291,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42292,PAP,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42293,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42294,activity,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42295,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42296,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42297,lipid,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42298,levels,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42299,",",O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42300,malondialdehyde,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42301,(,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42302,MDA,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42303,),O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42304,and,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42305,plasma,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42306,antioxidant,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42307,in,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42308,rats,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42309,fed,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42310,either,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42311,by,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42312,normal,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42313,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42314,high,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42315,-,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42316,lipogenic,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42317,diet,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42318,with,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42319,or,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42320,without,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42321,garlic,B-AG.01.h.02.e,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
42322,.,O,1450.0,"The purpose of this study was to assess the effect of garlic on the liver phosphatidate phosphohydrolase ( PAP ) activity , plasma lipid levels , malondialdehyde ( MDA ) and plasma antioxidant in rats fed either by normal or high - lipogenic diet with or without garlic ."
43068,The,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43069,phenolics,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43070,antioxidant,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43071,index,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43072,(,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43073,PAI,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43074,),O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43075,was,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43076,proposed,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43077,to,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43078,evaluate,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43079,the,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43080,quality,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43081,/,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43082,quantity,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43083,of,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43084,phenolic,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43085,contents,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43086,in,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43087,these,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43088,vegetables,B-AG.01.h.02,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43089,and,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43090,was,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43091,calculated,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43092,from,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43093,the,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43094,corrected,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43095,total,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43096,antioxidant,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43097,activities,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43098,by,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43099,eliminating,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43100,vitamin,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43101,C,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43102,contributions,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43103,.,O,1478.0,The phenolics antioxidant index ( PAI ) was proposed to evaluate the quality / quantity of phenolic contents in these vegetables and was calculated from the corrected total antioxidant activities by eliminating vitamin C contributions .
43174,The,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43175,BI,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43176,could,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43177,be,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43178,a,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43179,new,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43180,alternative,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43181,biomarker,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43182,for,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43183,future,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43184,epidemiological,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43185,studies,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43186,in,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43187,dietary,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43188,cancer,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43189,prevention,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43190,and,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43191,health,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43192,promotion,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43193,.,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43595,A,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43596,total,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43597,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43598,13,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43599,%,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43600,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43601,participants,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43602,consumed,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43603,≥1,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43604, ,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43605,serving,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43606,of,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43607,rice,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43608,/,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43609,day,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43610,.,O,1498.0,A total of 13 % of participants consumed ≥1   serving of rice / day .
43739,Understanding,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43740,the,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43741,role,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43742,of,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43743,low,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43744,-,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43745,level,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43746,arsenic,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43747,as,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43748,it,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43749,relates,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43750,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43751,subclinical,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43752,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43753,may,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43754,contribute,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43755,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43756,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43757,prevention,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43758,and,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43759,control,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43760,.,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43915,Peanuts,B-AG.01.h.01.f,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43916,(,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43917,a,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43918,legume,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43919,),O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43920,also,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43921,contribute,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43922,significantly,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43923,to,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43924,dietary,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43925,intake,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43926,of,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43927,antioxidants,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43928,.,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
44801,),O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44802,",",O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44803,then,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44804,randomized,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44805,to,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44806,10,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44807,different,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44808,AIN-76,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44809,-,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44810,based,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44811,diets,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44812,.,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44813,Five,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44814,diets,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44815,were,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44816,adjusted,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44817,to,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44818,14,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44819,%,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44820,fat,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44821,and,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44822,23,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44823,%,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44824,protein,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44825,and,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44826,five,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44827,other,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44828,diets,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44829,to,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44830,28,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44831,%,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44832,fat,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44833,and,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44834,40,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44835,%,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44836,protein,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
44837,.,O,1547.0,Five diets were adjusted to 14 % fat and 23 % protein and five other diets to 28 % fat and 40 % protein .
45253,Results,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45254,showed,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45255,that,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45256,the,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45257,beverage,B-AG.01.y,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45258,has,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45259,lower,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45260,lactose,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45261,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45262,higher,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45263,Ca,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45264,than,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45265,untreated,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45266,milk,B-AG.01.e,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45267,and,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45268,milk,B-AG.01.e,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45269,with,I-AG.01.e,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45270,kefir,I-AG.01.e,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45271,.,O,1564.0,Results showed that the beverage has lower lactose and higher Ca than untreated milk and milk with kefir .
45316,It,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45317,has,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45318,been,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45319,suggested,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45320,that,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45321,diet,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45322,may,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45323,influence,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45324,the,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45325,risk,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45326,of,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45327,melanoma,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45328,",",O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45329,but,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45330,few,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45331,studies,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45332,are,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45333,available,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45334,on,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45335,this,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45336,topic,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45337,.,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45495,etc,O,1573.0,etc .
45496,.,O,1573.0,etc .
45702,This,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45703,glycolipids,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45704,fraction,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45705,was,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45706,an,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45707,inhibitor,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45708,of,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45709,DNA,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45710,polymerase,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45711,alpha,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45712,(,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45713,pol,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45714,alpha,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45715,),O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45716,in,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45717,vitro,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45718,and,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45719,also,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45720,the,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45721,proliferation,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45722,of,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45723,human,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45724,cancer,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45725,cells,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45726,.,O,1580.0,This glycolipids fraction was an inhibitor of DNA polymerase alpha ( pol alpha ) in vitro and also the proliferation of human cancer cells .
45799,Spinach,B-AG.01.h.02.c,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45800,had,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45801,the,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45802,strongest,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45803,inhibitory,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45804,effect,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45805,on,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45806,pol,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45807,alpha,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45808,activity,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45809,and,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45810,human,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45811,cancer,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45812,cell,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45813,proliferation,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
45814,.,O,1584.0,Spinach had the strongest inhibitory effect on pol alpha activity and human cancer cell proliferation .
46030,Compared,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46031,with,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46032,rice,B-AG.01.i,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46033,reference,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46034,",",O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46035,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46036,PA+R,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46037,achieved,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46038,a,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46039,50,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46040,%,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46041,reduction,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46042,of,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46043,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46044,iAUC,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46045,Cardiovascular,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46046,disease,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46047,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46048,cancer,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46049,are,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46050,ranked,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46051,as,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46052,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46053,first,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46054,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46055,second,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46056,leading,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46057,causes,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46058,of,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46059,death,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46060,in,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46061,the,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46062,United,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46063,States,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46064,and,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46065,in,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46066,most,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46067,industrialized,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46068,countries,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46069,.,O,1592.0,"Compared with rice reference , the PA+R achieved a 50 % reduction of the iAUC Cardiovascular disease and cancer are ranked as the first and second leading causes of death in the United States and in most industrialized countries ."
46220,We,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46221,propose,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46222,that,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46223,the,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46224,additive,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46225,and,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46226,synergistic,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46227,effects,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46228,of,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46229,phytochemicals,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46230,in,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46231,fruit,B-AG.01.h.01,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46232,and,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46233,vegetables,B-AG.01.h.02,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46234,are,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46235,responsible,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46236,for,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46237,their,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46238,potent,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46239,antioxidant,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46240,and,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46241,anticancer,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46242,activities,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46243,",",O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46244,and,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46245,that,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46246,the,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46247,benefit,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46248,of,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46249,a,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46250,diet,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46251,rich,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46252,in,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46253,fruit,B-AG.01.h.01,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46254,and,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46255,vegetables,B-AG.01.h.02,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46256,is,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46257,attributed,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46258,to,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46259,the,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46260,complex,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46261,mixture,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46262,of,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46263,phytochemicals,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46264,present,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46265,in,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46266,whole,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46267,foods,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46268,.,O,1598.0,"We propose that the additive and synergistic effects of phytochemicals in fruit and vegetables are responsible for their potent antioxidant and anticancer activities , and that the benefit of a diet rich in fruit and vegetables is attributed to the complex mixture of phytochemicals present in whole foods ."
46580,We,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46581,examined,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46582,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46583,Barilla,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46584,Center,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46585,for,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46586,Food,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46587,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46588,Nutrition,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46589,'s,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46590,double,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46591,pyramid,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46592,to,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46593,describe,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46594,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46595,carbon,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46596,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46597,water,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46598,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46599,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46600,ecological,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46601,footprints,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46602,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46603,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46604,components,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46605,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46606,a,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46607,cardio,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46608,-,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46609,protective,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46610,diet,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46611,.,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46892,The,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46893,higher,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46894,oxalate,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46895,content,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46896,in,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46897,whole,B-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46898,grain,I-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46899,than,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46900,in,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46901,refined,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46902,grain,B-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46903,cereals,I-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46904,suggests,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46905,that,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46906,oxalic,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46907,acid,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46908,is,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46909,primarily,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46910,located,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46911,in,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46912,the,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46913,outer,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46914,layers,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46915,of,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46916,cereal,B-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46917,grains,I-AG.01.i,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
46918,.,O,1621.0,The higher oxalate content in whole grain than in refined grain cereals suggests that oxalic acid is primarily located in the outer layers of cereal grains .
47323,Among,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47324,traditional,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47325,treatments,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47326,",",O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47327,dietary,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47328,habits,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47329,represent,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47330,one,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47331,of,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47332,the,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47333,most,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47334,difficult,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47335,and,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47336,controversial,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47337,aspects,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47338,to,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47339,implement,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47340,in,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47341,handling,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47342,metabolic,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47343,disturbances,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
47344,.,O,1638.0,"Among traditional treatments , dietary habits represent one of the most difficult and controversial aspects to implement in handling metabolic disturbances ."
48188,The,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48189,aim,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48190,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48191,our,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48192,study,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48193,was,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48194,to,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48195,identify,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48196,dietary,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48197,factors,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48198,influencing,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48199,the,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48200,risk,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48201,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48202,oesophageal,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48203,cancer,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48204,in,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48205,France,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48206,and,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48207,to,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48208,determine,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48209,whether,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48210,certain,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48211,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48212,these,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48213,could,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48214,explain,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48215,some,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48216,of,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48217,the,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48218,geographical,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48219,variations,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48220,.,O,1666.0,The aim of our study was to identify dietary factors influencing the risk of oesophageal cancer in France and to determine whether certain of these could explain some of the geographical variations .
48459,There,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48460,is,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48461,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48462,lack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48463,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48464,information,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48465,on,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48466,sodium,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48467,reduction,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48468,in,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48469,potato,B-AG.01.n.09,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48470,chips,I-AG.01.n.09,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48471,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48472,puffed,B-AG.01.n.10,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48473,rice,I-AG.01.n.10,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48474,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48475,which,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48476,comprise,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48477,a,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48478,large,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48479,percentage,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48480,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48481,salty,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48482,snack,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48483,sales,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48484,",",O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48485,and,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48486,the,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48487,use,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48488,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48489,flavor,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48490,enhancers,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48491,to,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48492,maintain,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48493,consumer,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48494,acceptability,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48495,of,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48496,these,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48497,products,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48498,.,O,1675.0,"There is a lack of information on sodium reduction in potato chips and puffed rice , which comprise a large percentage of salty snack sales , and the use of flavor enhancers to maintain consumer acceptability of these products ."
48623,For,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48624,puffed,B-AG.01.n.10,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48625,rice,I-AG.01.n.10,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48626,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48627,consumers,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48628,liked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48629,samples,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48630,with,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48631,attributes,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48632,of,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48633,crunchy,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48634,texture,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48635,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48636,garlic,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48637,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48638,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48639,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48640,savory,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48641,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48642,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48643,disliked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48644,bitter,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48645,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48646,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48647,chili,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48648,powder,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48649,aroma,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48650,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48651,by,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48652,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48653,mouth,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48654,.,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48918,The,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48919,test,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48920,carbohydrate,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48921,represented,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48922,66,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48923,%,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48924,of,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48925,total,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48926,carbohydrate,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
48927,.,O,1689.0,The test carbohydrate represented 66 % of total carbohydrate .
49176,Overall,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49177,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49178,MedDiets,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49179,have,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49180,direct,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49181,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49182,mono,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49183,-,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49184,unsaturated,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49185,fatty,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49186,acids,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49187,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49188,MUFAs,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49189,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49190,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49191,tocopherols,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49192,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49193,polyphenols,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49194,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49195,and,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49196,indirect,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49197,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49198,low,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49199,saturated,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49200,fats,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49201,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49202,well,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49203,-,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49204,balanced,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49205,linoleic,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49206,/,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49207,alpha,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49208,linolenic,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49209,acid,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49210,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49211,effects,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49212,on,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49213,the,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49214,immune,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49215,system,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49216,and,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49217,inflammatory,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49218,responses,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49219,.,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49533,The,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49534,milk,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49535,prolactin,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49536,concentrations,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49537,were,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49538,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49539,dissimilar,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49540,between,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49541,NAS,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49542,-,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49543,infected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49544,and,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49545,noninfected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49546,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49547,and,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49548,thus,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49549,can,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49550,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49551,explain,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49552,why,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49553,NAS,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49554,-,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49555,infected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49556,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49557,do,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49558,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49559,produce,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49560,less,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49561,than,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49562,noninfected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49563,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49564,.,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49636,The,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49637,impact,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49638,of,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49639,the,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49640,PEF,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49641,on,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49642,the,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49643,diffusion,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49644,of,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49645,oil,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49646,and,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49647,microconstituents,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49648,",",O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49649,determined,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49650,by,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49651,the,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49652,disruption,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49653,effects,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49654,on,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49655,olive,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49656,cell,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49657,tissues,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49658,carried,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49659,out,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49660,by,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49661,the,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49662,non,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49663,-,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49664,thermal,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49665,method,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49666,",",O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49667,was,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49668,evaluated,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
49669,.,O,1713.0,"The impact of the PEF on the diffusion of oil and microconstituents , determined by the disruption effects on olive cell tissues carried out by the non - thermal method , was evaluated ."
50225,In,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50226,other,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50227,word,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50228,",",O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50229,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50230,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50231,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50232,miso,B-AG.01.n.02,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50233,dose,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50234,not,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50235,increase,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50236,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50237,blood,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50238,pressure,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50239,compared,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50240,to,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50241,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50242,equivalent,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50243,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50244,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50245,salt,B-AG.01.l.01,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50246,.,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50324,Therefore,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50325,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50326,this,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50327,review,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50328,focused,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50329,on,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50330,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50331,differences,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50332,between,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50333,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50334,effects,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50335,of,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50336,miso,B-AG.01.n.02,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50337,intake,B-X,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50338,and,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50339,those,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50340,of,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50341,the,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50342,equivalent,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50343,salt,B-AG.01.l.01,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50344,intake,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50345,on,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50346,sympathetic,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50347,nerve,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50348,activity,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50349,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50350,blood,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50351,pressure,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50352,",",O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50353,and,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50354,heart,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50355,rate,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50356,.,O,1737.0,"Therefore , this review focused on the differences between the effects of miso intake and those of the equivalent salt intake on sympathetic nerve activity , blood pressure , and heart rate ."
50839,Broccoli,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50840,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50841,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50842,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50843,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50844,ratio=5.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50845,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50846,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50847,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50848,ratio=2.3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50849,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50850,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50851,calcot,B-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50852,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50853,Allium,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50854,cepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50855,L.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50856,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50857,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50858,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50859,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50860,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50861,ratio=4.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50862,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50863,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50864,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50865,ratio=.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50866,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50867,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50868,green,B-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50869,onion,I-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50870,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50871,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50872,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50873,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50874,ratio=4.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50875,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50876,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50877,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50878,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50879,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50880,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50881,green,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50882,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50883,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50884,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50885,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50886,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50887,ratio=3.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50888,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50889,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50890,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50891,ratio=2.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50892,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50893,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50894,purple,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50895,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50896,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50897,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50898,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50899,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50900,ratio=3.4,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50901,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50902,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50903,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50904,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50905,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50906,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50907,and,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50908,black,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50909,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50910,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50911,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50912,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50913,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50914,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50915,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50916,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50917,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50918,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50919,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50920,were,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50921,active,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50922,NQO1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50923,inducers,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50924,in,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50925,both,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50926,murine,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50927,hepatoma,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50928,cell,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50929,lines,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50930,.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
51317,The,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51318,study,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51319,results,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51320,support,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51321,the,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51322,ideas,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51323,that,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51324,choosing,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51325,the,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51326,right,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51327,foods,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51328,may,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51329,be,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51330,important,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51331,in,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51332,weight,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51333,control,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51334,and,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51335,that,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51336,food,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51337,-,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51338,based,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51339,dietary,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51340,patterns,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51341,may,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51342,be,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51343,useful,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51344,in,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51345,dietary,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51346,counseling,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51347,.,O,1761.0,The study results support the ideas that choosing the right foods may be important in weight control and that food - based dietary patterns may be useful in dietary counseling .
51488,Aqueous,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51489,/,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51490,alcohol,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51491,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51492,soluble,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51493,prolamins,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51494,(,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51495,kafirins,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51496,),O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51497,from,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51498,different,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51499,sorghum,B-AG.01.i,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51500,varieties,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51501,",",O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51502,including,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51503,pure,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51504,lines,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51505,and,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51506,hybrids,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51507,",",O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51508,were,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51509,evaluated,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51510,by,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51511,SDS,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51512,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51513,PAGE,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51514,and,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51515,HPLC,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51516,analyses,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51517,as,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51518,well,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51519,as,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51520,an,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51521,established,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51522,enzyme,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51523,-,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51524,linked,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51525,immunosorbent,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51526,assay,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51527,(,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51528,ELISA,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51529,),O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51530,based,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51531,on,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51532,the,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51533,R5,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51534,antibody,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51535,.,O,1768.0,"Aqueous / alcohol - soluble prolamins ( kafirins ) from different sorghum varieties , including pure lines and hybrids , were evaluated by SDS - PAGE and HPLC analyses as well as an established enzyme - linked immunosorbent assay ( ELISA ) based on the R5 antibody ."
51536,These,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51537,analyses,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51538,provide,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51539,molecular,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51540,evidence,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51541,for,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51542,the,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51543,absence,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51544,of,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51545,toxic,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51546,gliadin,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51547,-,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51548,like,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51549,peptides,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51550,in,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51551,sorghum,B-AG.01.i,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51552,",",O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51553,confirming,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51554,that,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51555,sorghum,B-AG.01.i,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51556,can,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51557,be,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51558,definitively,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51559,considered,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51560,safe,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51561,for,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51562,consumption,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51563,by,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51564,people,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51565,with,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51566,celiac,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51567,disease,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51568,.,O,1769.0,"These analyses provide molecular evidence for the absence of toxic gliadin - like peptides in sorghum , confirming that sorghum can be definitively considered safe for consumption by people with celiac disease ."
51958,The,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51959,prefortification,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51960,folate,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51961,status,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51962,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51963,751,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51964,healthy,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51965,women,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51966,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51967,reproductive,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51968,age,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51969,was,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51970,assessed,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51971,.,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
52400,Finally,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52401,",",O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52402,the,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52403,assessment,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52404,of,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52405,tea,B-AG.01.ac,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52406,in,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52407,most,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52408,of,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52409,these,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52410,studies,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52411,was,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52412,based,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52413,on,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52414,a,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52415,single,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52416,question,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52417,and,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52418,therefore,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52419,may,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52420,have,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52421,significant,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52422,measurement,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52423,error,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52424,compared,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52425,with,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52426,more,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52427,recent,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52428,studies,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52429,specifically,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52430,aimed,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52431,at,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52432,assessing,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52433,tea,B-AG.01.ac,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52434,consumption,B-X,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52435,.,O,1798.0,"Finally , the assessment of tea in most of these studies was based on a single question and therefore may have significant measurement error compared with more recent studies specifically aimed at assessing tea consumption ."
52436,The,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52437,Mediterranean,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52438,diet,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52439,is,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52440,a,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52441,healthy,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52442,eating,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52443,pattern,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52444,with,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52445,protective,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52446,effects,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52447,on,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52448,chronic,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52449,diseases,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52450,.,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52574,An,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52575,increase,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52576,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52577,5,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52578,U,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52579,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52580,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52581,dietary,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52582,score,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52583,was,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52584,associated,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52585,with,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52586,a,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52587,change,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52588,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52589,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52590,BMI,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52591,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52592,0.43,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52593,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52594,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52595,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52596,0.030,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52597,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52598,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52599,0.68,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52600,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52601,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52602,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52603,0.007,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52604,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52605,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52606,after,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52607,controlling,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52608,for,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52609,potential,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52610,confounders,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52611,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52612,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52613,men,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52614,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52615,women,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52616,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52617,respectively,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52618,.,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52975,The,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52976,identification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52977,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52978,quantification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52979,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52980,spice,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52981,-,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52982,specific,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52983,phytochemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52984,provided,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52985,insight,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52986,into,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52987,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52988,potential,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52989,influence,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52990,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52991,these,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52992,chemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52993,on,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52994,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52995,gut,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52996,microbial,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52997,communities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52998,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52999,activities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53000,.,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53029,Potatoes,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53030,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53031,especially,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53032,mashed,B-AG.01.n,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53033,potatoes,I-AG.01.n,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53034,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53035,are,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53036,known,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53037,to,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53038,result,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53039,in,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53040,high,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53041,glycaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53042,and,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53043,insulinaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53044,responses,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53045,.,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53227,The,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53228,insulinaemic,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53229,indices,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53230,of,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53231,the,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53232,mashed,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53233,potato,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53234,-,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53235,based,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53236,meals,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53237,varied,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53238,between,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53239,94,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53240,and,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53241,148,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53242,.,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53356,The,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53357,aim,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53358,of,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53359,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53360,study,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53361,was,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53362,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53363,investigate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53364,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53365,nutritional,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53366,status,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53367,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53368,adherence,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53369,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53370,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53371,Mediterranean,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53372,Diet,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53373,(,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53374,MD,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53375,),O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53376,in,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53377,GEP,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53378,-,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53379,NET,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53380,patients,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53381,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53382,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53383,correlate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53384,them,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53385,with,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53386,tumor,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53387,aggressiveness,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53388,.,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
66361,In,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66362,strawberries,B-AG.01.h.01.b,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66363,",",O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66364,the,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66365,most,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66366,abundant,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66367,of,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66368,these,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66369,are,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66370,ellagic,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66371,acid,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66372,",",O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66373,and,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66374,certain,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66375,flavonoids,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66376,:,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66377,anthocyanin,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66378,",",O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66379,catechin,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66380,",",O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66381,quercetin,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66382,and,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66383,kaempferol,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66384,.,O,2316.0,"In strawberries , the most abundant of these are ellagic acid , and certain flavonoids : anthocyanin , catechin , quercetin and kaempferol ."
66385,These,O,2317.0,These compounds in strawberries have potent antioxidant power .
66386,compounds,O,2317.0,These compounds in strawberries have potent antioxidant power .
66387,in,O,2317.0,These compounds in strawberries have potent antioxidant power .
66388,strawberries,B-AG.01.h.01.b,2317.0,These compounds in strawberries have potent antioxidant power .
66389,have,O,2317.0,These compounds in strawberries have potent antioxidant power .
66390,potent,O,2317.0,These compounds in strawberries have potent antioxidant power .
66391,antioxidant,O,2317.0,These compounds in strawberries have potent antioxidant power .
66392,power,O,2317.0,These compounds in strawberries have potent antioxidant power .
66393,.,O,2317.0,These compounds in strawberries have potent antioxidant power .
66507,The,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66508,agents,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66509,capable,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66510,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66511,causing,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66512,damage,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66513,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66514,genetic,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66515,material,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66516,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66517,known,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66518,as,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66519,genotoxins,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66520,and,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66521,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66522,according,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66523,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66524,their,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66525,mode,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66526,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66527,action,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66528,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66529,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66530,classified,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66531,into,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66532,mutagens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66533,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66534,carcinogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66535,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66536,or,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66537,teratogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66538,.,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66594,Several,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66595,studies,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66596,have,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66597,shown,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66598,the,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66599,antigenotoxic,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66600,potential,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66601,of,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66602,different,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66603,fruits,B-AG.01.h.01,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66604,and,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66605,plants,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66606,(,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66607,Part,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66608,1,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66609,),O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66610,.,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66611,In,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66612,this,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66613,review,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66614,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66615,Part,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66616,2,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66617,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66618,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66619,we,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66620,present,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66621,a,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66622,research,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66623,overview,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66624,conducted,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66625,on,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66626,some,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66627,plants,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66628,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66629,vegetables,B-AG.01.h.02,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66630,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66631,spirulina,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66632,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66633,broccoli,B-AG.01.h.02.d,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66634,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66635,chamomile,B-AG.01.h.02.i,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66636,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66637,cocoa,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66638,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66639,ginger,B-AG.01.l.03,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66640,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66641,laurel,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66642,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66643,marigold,B-AG.01.h.02,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66644,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66645,roselle,B-AG.01,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66646,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66647,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66648,rosemary,B-AG.01.h.02.i,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66649,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66650,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66651,which,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66652,are,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66653,frequently,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66654,consumed,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66655,by,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66656,humans,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66657,.,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66721,Although,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66722,some,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66723,studies,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66724,have,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66725,found,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66726,that,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66727,heavy,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66728,alcohol,B-AG.01.y.01,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66729,consumption,B-X,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66730,is,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66731,associated,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66732,with,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66733,increased,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66734,risk,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66735,",",O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66736,a,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66737,recent,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66738,study,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66739,reported,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66740,that,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66741,red,B-AG.01.y.01.a,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66742,wine,I-AG.01.y.01.a,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66743,consumption,B-X,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66744,is,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66745,associated,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66746,with,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66747,reduced,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66748,risk,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66749,.,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66943,More,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66944,detailed,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66945,assessment,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66946,of,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66947,specific,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66948,alcoholic,B-AG.01.y.01,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66949,beverages,I-AG.01.y.01,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66950,is,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66951,warranted,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66952,in,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66953,future,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66954,studies,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66955,.,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
67084,Adding,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67085,oil,B-AG.01.f,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67086,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67087,after,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67088,"""",O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67089,(,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67090,stir,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67091,-,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67092,frying,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67093,),O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67094,to,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67095,white,B-AG.01.i,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67096,or,I-AG.01.i,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67097,red,I-AG.01.i,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67098,rice,I-AG.01.i,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67099,resulted,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67100,in,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67101,higher,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67102,slowly,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67103,digestible,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67104,starch,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67105,.,O,2343.0,"Adding oil "" after "" ( stir - frying ) to white or red rice resulted in higher slowly digestible starch ."
67664,Recent,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67665,animal,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67666,studies,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67667,have,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67668,investigated,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67669,tomatoes,B-AG.01.h.02.f,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67670,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67671,lycopene,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67672,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67673,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67674,prostate,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67675,cancer,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67676,using,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67677,the,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67678,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67679,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67680,methyl,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67681,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67682,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67683,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67684,nitrosourea,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67685,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67686,Dunning,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67687,rat,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67688,models,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67689,.,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67832,In,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67833,addition,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67834,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67835,the,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67836,increase,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67837,of,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67838,celiac,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67839,patients,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67840,worldwide,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67841,has,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67842,motivated,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67843,the,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67844,development,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67845,of,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67846,gluten,B-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67847,-,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67848,free,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67849,foods,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67850,using,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67851,alternative,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67852,flour,B-AG.01.k,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67853,types,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67854,to,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67855,wheat,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67856,such,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67857,as,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67858,rice,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67859,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67860,corn,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67861,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67862,cassava,B-AG.01.h.02.a,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67863,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67864,soybean,B-AG.01.h.02.g,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67865,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67866,and,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67867,pseudocereals,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67868,(,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67869,amaranth,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67870,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67871,quinoa,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67872,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67873,and,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67874,buckwheat,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67875,),O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67876,.,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
68054,The,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68055,numerous,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68056,beneficial,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68057,effects,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68058,of,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68059,lactic,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68060,fermentation,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68061,of,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68062,pseudocereals,B-AG.01.i,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68063,can,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68064,be,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68065,exploited,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68066,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68067,design,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68068,novel,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68069,and,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68070,healthier,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68071,foods,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68072,or,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68073,grain,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68074,ingredients,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68075,destined,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68076,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68077,general,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68078,population,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68079,and,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68080,especially,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68081,to,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68082,patients,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68083,with,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68084,coeliac,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68085,disease,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68086,.,O,2377.0,The numerous beneficial effects of lactic fermentation of pseudocereals can be exploited to design novel and healthier foods or grain ingredients destined to general population and especially to patients with coeliac disease .
68356,Egg,B-AG.01.g,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68357,consumption,B-X,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68358,included,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68359,hardboiled,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68360,eggs,B-AG.01.g,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68361,and,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68362,eggs,B-AG.01.g,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68363,consumed,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68364,in,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68365,an,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68366,omelette,B-AG.01.n.16,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68367,or,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68368,a,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68369,mixed,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68370,dish,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68371,",",O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68372,and,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68373,dietary,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68374,cholesterol,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68375,was,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68376,estimated,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68377,using,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68378,a,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68379,French,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68380,nutrient,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68381,database,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
68382,.,O,2386.0,"Egg consumption included hardboiled eggs and eggs consumed in an omelette or a mixed dish , and dietary cholesterol was estimated using a French nutrient database ."
69088,Raw,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69089,materials,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69090,used,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69091,as,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69092,ingredients,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69093,of,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69094,gluten,B-AG.01,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69095,-,I-AG.01,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69096,free,I-AG.01,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69097,products,I-AG.01,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69098,were,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69099,limited,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69100,to,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69101,five,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69102,varieties,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69103,:,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69104,rice,B-AG.01.i,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69105,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69106,cassava,B-AG.01.h.02.a,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69107,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69108,corn,B-AG.01.i,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69109,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69110,soy,B-AG.01.h.02.g,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69111,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69112,and,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69113,potato,B-AG.01.h.02.a,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69114,.,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69115,Sugar,B-AG.01.l.02,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69116,was,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69117,the,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69118,most,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69119,frequently,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69120,mentioned,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69121,ingredient,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69122,on,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69123,both,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69124,types,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69125,of,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69126,products,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69127,',O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69128,labels,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69129,.,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69182,Nutritional,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69183,quality,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69184,of,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69185,gluten,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69186,-,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69187,free,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69188,diets,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69189,and,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69190,health,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69191,of,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69192,celiac,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69193,patients,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69194,may,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69195,be,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69196,compromised,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69197,.,O,2411.0,Nutritional quality of gluten - free diets and health of celiac patients may be compromised .
69391,The,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69392,glycemic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69393,index,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69394,concept,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69395,remains,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69396,discriminating,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69397,",",O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69398,even,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69399,in,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69400,the,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69401,context,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69402,of,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69403,an,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69404,iso,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69405,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69406,glucido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69407,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69408,lipido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69409,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69410,protidic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69411,meal,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69412,.,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69767,The,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69768,ability,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69769,of,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69770,L.,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69771,monocytogenes,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69772,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69773,grow,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69774,at,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69775,refrigeration,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69776,temperatures,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69777,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69778,coupled,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69779,with,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69780,appearance,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69781,of,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69782,the,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69783,pathogen,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69784,in,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69785,raw,B-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69786,and,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69787,processed,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69788,meats,I-AG.01.d,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69789,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69790,as,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69791,well,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69792,as,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69793,poultry,B-AG.01.d.06,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69794,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69795,vegetables,B-AG.01.h.02,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69796,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69797,and,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69798,seafood,B-AG.01.d.07,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69799,",",O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69800,makes,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69801,this,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69802,bacterium,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69803,a,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69804,serious,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69805,threat,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69806,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69807,susceptible,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69808,consumers,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69809,and,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69810,to,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69811,the,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69812,entire,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69813,food,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69814,industry,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69815,.,O,2432.0,"The ability of L. monocytogenes to grow at refrigeration temperatures , coupled with appearance of the pathogen in raw and processed meats , as well as poultry , vegetables , and seafood , makes this bacterium a serious threat to susceptible consumers and to the entire food industry ."
69891,Although,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69892,known,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69893,for,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69894,many,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69895,years,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69896,",",O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69897,Campylobacter,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69898,jejuni,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69899,has,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69900,only,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69901,recently,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69902,been,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69903,recognized,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69904,as,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69905,a,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69906,food,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69907,-,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69908,borne,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69909,pathogen,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69910,and,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69911,a,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69912,leading,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69913,cause,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69914,of,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69915,gastroenteritis,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69916,in,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69917,the,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69918,United,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69919,States,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69920,.,O,2436.0,"Although known for many years , Campylobacter jejuni has only recently been recognized as a food - borne pathogen and a leading cause of gastroenteritis in the United States ."
69993,Asians,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69994,and,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69995,vegetarians,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69996,consume,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69997,higher,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69998,amounts,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
69999,of,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70000,PS,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70001,than,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70002,Western,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70003,societies,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70004,.,O,2438.0,Asians and vegetarians consume higher amounts of PS than Western societies .
70158,Peanut,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70159,butter,I-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70160,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70161,which,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70162,represents,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70163,50,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70164,%,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70165,of,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70166,the,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70167,peanuts,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70168,consumed,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70169,in,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70170,the,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70171,United,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70172,States,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70173,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70174,contains,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70175,144,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70176,-,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70177,157,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70178,mg,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70179,PS/100,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70180,g.,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70181,Peanut,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70182,flour,I-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70183,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70184,which,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70185,results,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70186,from,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70187,partial,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70188,removal,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70189,of,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70190,oil,B-AG.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70191,from,I-AG.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70192,peanuts,I-AG.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70193,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70194,contains,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70195,55,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70196,-,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70197,60,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70198,mg,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70199,PS/100,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70200,g.,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70201,The,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70202,data,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70203,suggest,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70204,that,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70205,peanuts,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70206,and,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70207,its,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70208,products,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70209,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70210,such,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70211,as,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70212,peanut,B-AG.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70213,oil,I-AG.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70214,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70215,peanut,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70216,butter,I-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70217,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70218,and,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70219,peanut,B-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70220,flour,I-AG.01.h.01.f,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70221,",",O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70222,are,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70223,good,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70224,sources,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70225,of,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70226,PS,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70227,.,O,2447.0,"Peanut butter , which represents 50 % of the peanuts consumed in the United States , contains 144 - 157 mg PS/100 g. Peanut flour , which results from partial removal of oil from peanuts , contains 55 - 60 mg PS/100 g. The data suggest that peanuts and its products , such as peanut oil , peanut butter , and peanut flour , are good sources of PS ."
70228,Glycemic,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70229,effect,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70230,of,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70231,adding,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70232,10,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70233,-,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70234,g,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70235,carbohydrate,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70236,portions,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70237,of,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70238,apple,B-AG.01.h.01.c,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70239,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70240,banana,B-AG.01.h.01,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70241,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70242,grapes,B-AG.01.h.01.b,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70243,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70244,honeydew,B-AG.01.h.01,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70245,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70246,orange,B-AG.01.h.01.a,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70247,",",O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70248,or,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70249,strawberries,B-AG.01.h.01.b,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70250,to,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70251,a,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70252,standard,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70253,meal,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70254,on,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70255,separate,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70256,occasions,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70257,was,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70258,measured,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70259,in,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70260,10,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70261,insulin,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70262,-,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70263,dependent,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70264,diabetics,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70265,monitored,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70266,at,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70267,home,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70268,.,O,2448.0,"Glycemic effect of adding 10 - g carbohydrate portions of apple , banana , grapes , honeydew , orange , or strawberries to a standard meal on separate occasions was measured in 10 insulin - dependent diabetics monitored at home ."
70455,In,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70456,addition,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70457,",",O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70458,dietary,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70459,EW,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70460,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70461,EWH,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70462,decreased,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70463,stearoyl,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70464,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70465,CoA,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70466,desaturase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70467,(,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70468,SCD,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70469,),O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70470,indices,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70471,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70472,glucose-6,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70473,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70474,phosphate,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70475,dehydrogenase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70476,activity,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70477,of,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70478,the,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70479,liver,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70480,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70481,gastrocnemius,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70482,muscle,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70483,.,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70790,Additional,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70791,study,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70792,of,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70793,lactose,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70794,and,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70795,ovarian,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70796,cancer,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70797,risk,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70798,involving,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70799,careful,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70800,control,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70801,for,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70802,confounding,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70803,is,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70804,needed,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
70805,.,O,2467.0,Additional study of lactose and ovarian cancer risk involving careful control for confounding is needed .
71018,Among,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71019,the,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71020,major,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71021,food,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71022,sources,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71023,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71024,flavonols,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71025,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71026,we,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71027,found,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71028,a,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71029,significant,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71030,inverse,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71031,association,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71032,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71033,intake,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71034,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71035,beans,B-AG.01.h.02.g,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71036,or,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71037,lentils,B-AG.01.h.02.g,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71038,but,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71039,not,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71040,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71041,tea,B-AG.01.ac,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71042,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71043,onions,B-AG.01.h.02.e,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71044,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71045,apples,B-AG.01.h.01.c,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71046,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71047,string,B-AG.01.h.02.g,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71048,beans,I-AG.01.h.02.g,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71049,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71050,broccoli,B-AG.01.h.02.d,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71051,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71052,green,B-AG.01.h.02.f,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71053,pepper,I-AG.01.h.02.f,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71054,and,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71055,blueberries,B-AG.01.h.01.b,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71056,.,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
72049,Aqueous,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72050,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72051,methanol,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72052,extracts,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72053,of,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72054,dry,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72055,sage,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72056,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72057,rosemary,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72058,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72059,basil,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72060,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72061,parsley,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72062,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72063,chili,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72064,",",O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72065,garlic,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72066,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72067,onion,B-AG.01.l.03,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72068,were,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72069,analyzed,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72070,to,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72071,investigate,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72072,their,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72073,anti,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72074,-,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72075,oxidant,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72076,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72077,anti,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72078,-,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72079,glycant,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72080,activities,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72081,and,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72082,in,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72083,vitro,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72084,inhibitory,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72085,potential,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72086,against,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72087,enzymes,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72088,involved,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72089,in,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72090,glycemic,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72091,regulation,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72092,.,O,2506.0,"Aqueous and methanol extracts of dry sage , rosemary , basil , parsley , chili , garlic and onion were analyzed to investigate their anti - oxidant and anti - glycant activities and in vitro inhibitory potential against enzymes involved in glycemic regulation ."
72223,Quality,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72224,of,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72225,life,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72226,(,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72227,QoL,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72228,),O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72229,is,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72230,an,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72231,important,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72232,clinical,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72233,outcome,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72234,in,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72235,cancer,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72236,patients,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72237,.,O,2511.0,Quality of life ( QoL ) is an important clinical outcome in cancer patients .
72505,Proximate,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72506,and,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72507,mineral,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72508,analyses,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72509,were,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72510,conducted,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72511,on,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72512,the,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72513,leaves,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72514,of,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72515,Momordica,B-AG.01.h.02,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72516,balsamina,I-AG.01.h.02,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72517,L.,I-AG.01.h.02,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72518,",",O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72519,an,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72520,under,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72521,-,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72522,utilized,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72523,wild,B-AG.01.h.02,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72524,vegetable,I-AG.01.h.02,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72525,in,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72526,Botswana,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
72527,.,O,2520.0,"Proximate and mineral analyses were conducted on the leaves of Momordica balsamina L. , an under - utilized wild vegetable in Botswana ."
73023,Within,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73024,a,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73025,sample,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73026,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73027,obese,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73028,adults,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73029,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73030,consumption,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73031,of,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73032,dairy,B-AG.01.e,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73033,products,I-AG.01.e,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73034,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73035,dairy,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73036,protein,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73037,",",O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73038,and,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73039,calcium,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73040,was,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73041,associated,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73042,with,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73043,more,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73044,favourable,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73045,body,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73046,composition,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73047,.,O,2535.0,"Within a sample of obese adults , consumption of dairy products , dairy protein , and calcium was associated with more favourable body composition ."
73068,Numerous,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73069,animal,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73070,studies,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73071,as,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73072,well,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73073,as,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73074,in,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73075,vitro,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73076,ones,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73077,have,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73078,demonstrated,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73079,the,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73080,hypolipidemic,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73081,effects,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73082,of,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73083,garlic,B-AG.01.h.02.e,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73084,",",O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73085,while,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73086,clinical,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73087,trials,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73088,are,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73089,highly,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73090,inconsistent,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73091,.,O,2537.0,"Numerous animal studies as well as in vitro ones have demonstrated the hypolipidemic effects of garlic , while clinical trials are highly inconsistent ."
73395,We,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73396,estimated,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73397,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73398,coefficients,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73399,(,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73400,or,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73401,percentage,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73402,differences,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73403,),O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73404,and,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73405,their,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73406,95,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73407,%,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73408,CI,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73409,using,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73410,multiple,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73411,linear,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73412,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73413,models,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73414,.,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73620,The,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73621,purpose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73622,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73623,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73624,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73625,was,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73626,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73627,1,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73628,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73629,systematically,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73630,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73631,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73632,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73633,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73634,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73635,several,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73636,different,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73637,high,B-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73638,-,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73639,starch,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73640,foods,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73641,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73642,2,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73643,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73644,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73645,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73646,this,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73647,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73648,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73649,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73650,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73651,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73652,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73653,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73654,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73655,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73656,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73657,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73658,3,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73659,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73660,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73661,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73662,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73663,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73664,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73665,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73666,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73667,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73668,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73669,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73670,physical,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73671,structure,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73672,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73673,digestibility,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73674,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73675,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73676,ingested,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73677,carbohydrate,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73678,.,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73802,Although,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73803,not,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73804,statistically,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73805,significant,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73806,",",O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73807,the,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73808,mean,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73809,was,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73810,greater,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73811,than,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73812,predicted,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73813,for,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73814,every,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73815,other,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73816,food,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73817,except,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73818,potatoes,B-AG.01.h.02.a,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73819,when,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73820,the,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73821,insulin,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73822,response,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73823,to,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73824,50,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73825,g,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73826,glucose,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73827,was,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73828,used,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73829,as,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73830,a,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73831,standard,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73832,.,O,2563.0,"Although not statistically significant , the mean was greater than predicted for every other food except potatoes when the insulin response to 50 g glucose was used as a standard ."
73849,Maternal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73850,nutrition,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73851,can,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73852,have,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73853,a,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73854,profound,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73855,effect,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73856,on,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73857,fetal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73858,growth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73859,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73860,development,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73861,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73862,and,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73863,subsequent,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73864,infant,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73865,birth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73866,weight,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73867,.,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73907,Preconception,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73908,food,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73909,frequency,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73910,data,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73911,were,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73912,collected,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73913,retrospectively,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73914,in,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73915,309,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73916,women,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73917,.,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
74279,An,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74280,association,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74281,between,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74282,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74283,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74284,latex,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74285,and,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74286,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74287,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74288,various,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74289,fruits,B-AG.01.h.01,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74290,has,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74291,been,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74292,reported,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74293,.,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74933,Food,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74934,Standards,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74935,Australia,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74936,New,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74937,Zealand,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74938,'s,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74939,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74940,FSANZ,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74941,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74942,custom,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74943,-,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74944,built,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74945,dietary,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74946,modelling,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74947,program,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74948,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74949,DIAMOND,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74950,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74951,was,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74952,used,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74953,for,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74954,the,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74955,estimates,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74956,.,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
75222,Also,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75223,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75224,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75225,MRP,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75226,showed,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75227,higher,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75228,antioxidant,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75229,activities,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75230,than,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75231,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75232,intact,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75233,milk,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75234,protein,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75235,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75236,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75237,they,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75238,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75239,intracellular,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75240,reactive,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75241,oxygen,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75242,species,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75243,production,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75244,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75245,inhibited,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75246,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75247,depletion,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75248,of,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75249,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75250,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75251,glutathione,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75252,concentrations,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75253,in,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75254,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75255,HepG2,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75256,cells,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75257,.,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75508,In,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75509,all,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75510,cases,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75511,",",O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75512,both,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75513,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75514,clinical,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75515,and,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75516,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75517,laboratory,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75518,features,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75519,remitted,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75520,in,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75521,≤7,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75522,days,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75523,when,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75524,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75525,infants,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75526,were,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75527,fed,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75528,on,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75529,formula,B-AG.01,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75530,milk,I-AG.01,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75531,with,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75532,a,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75533,normal,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75534,chloride,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75535,content,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75536,.,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75881,The,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75882,diet,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75883,is,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75884,characterized,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75885,by,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75886,abundant,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75887,plant,B-AG.01,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75888,foods,I-AG.01,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75889,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75890,fruit,B-AG.01.h.01,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75891,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75892,vegetables,B-AG.01.h.02,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75893,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75894,breads,B-AG.01.n.11,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75895,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75896,other,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75897,forms,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75898,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75899,cereals,B-AG.01.i,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75900,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75901,potatoes,B-AG.01.h.02.a,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75902,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75903,beans,B-AG.01.h.02.g,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75904,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75905,nuts,B-AG.01.h.01.f,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75906,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75907,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75908,seeds,B-AG.01,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75909,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75910,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75911,fresh,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75912,fruit,B-AG.01.h.01,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75913,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75914,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75915,typical,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75916,daily,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75917,dessert,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75918,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75919,olive,B-AG.01.f,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75920,oil,I-AG.01.f,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75921,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75922,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75923,principal,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75924,source,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75925,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75926,fat,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75927,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75928,dairy,B-AG.01.e,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75929,products,I-AG.01.e,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75930,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75931,principally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75932,cheese,B-AG.01.e.02,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75933,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75934,yogurt,B-AG.01.e,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75935,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75936,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75937,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75938,fish,B-AG.01.d.07,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75939,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75940,poultry,B-AG.01.d.06,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75941,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75942,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75943,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75944,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75945,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75946,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75947,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75948,zero,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75949,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75950,four,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75951,eggs,B-AG.01.g,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75952,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75953,weekly,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75954,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75955,red,B-AG.01.d,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75956,meat,I-AG.01.d,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75957,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75958,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75959,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75960,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75961,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75962,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75963,wine,B-AG.01.y.01.a,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75964,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75965,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75966,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75967,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75968,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75969,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75970,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75971,normally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75972,with,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75973,meals,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75974,.,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
76854,A,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76855,total,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76856,of,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76857,"1,501",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76858,individuals,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76859,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76860,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76861,197,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76862,households,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76863,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76864,from,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76865,35,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76866,villages,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76867,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76868,different,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76869,regions,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76870,were,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76871,studied,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76872,.,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78066,We,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78067,identified,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78068,7,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78069,cohort,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78070,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78071,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78072,27,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78073,case,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78074,-,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78075,control,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78076,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78077,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78078,consumption,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78079,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78080,major,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78081,food,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78082,groups,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78083,(,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78084,fruits,B-AG.01.h.01,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78085,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78086,vegetables,B-AG.01.h.02,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78087,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78088,meats,B-AG.01.d,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78089,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78090,eggs,B-AG.01.g,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78091,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78092,fish,B-AG.01.d.07,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78093,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78094,dairy,B-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78095,products,I-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78096,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78097,grains,B-AG.01.i,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78098,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78099,fats,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78100,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78101,oils,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78102,),O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78103,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78104,EOC,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78105,risk,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78106,.,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78333,The,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78334,present,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78335,study,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78336,investigated,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78337,the,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78338,hypothesis,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78339,that,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78340,a,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78341,healthy,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78342,dietary,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78343,pattern,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78344,was,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78345,negatively,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78346,associated,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78347,with,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78348,risk,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78349,of,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78350,TNBC,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78351,in,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78352,women,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78353,with,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78354,dense,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78355,breasts,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78356,(,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78357,density,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78358,types,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78359,3,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78360,and,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78361,4,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78362,),O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78363,.,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78364,After,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78365,total,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78366,mastectomy,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78367,or,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78368,breast,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78369,conserving,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78370,surgery,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78371,",",O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78372,patients,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78373,with,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78374,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78375,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78376,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78377,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78378,38,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78379,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78380,and,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78381,non,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78382,-,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78383,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78384,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78385,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78386,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78387,178,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78388,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78389,were,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78390,recruited,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78391,.,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
79242,Moreover,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79243,",",O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79244,gut,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79245,microbiota,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79246,could,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79247,be,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79248,affected,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79249,by,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79250,the,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79251,prebiotic,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79252,content,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79253,of,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79254,raisins,B-AG.01.n.08,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79255,.,O,2745.0,"Moreover , gut microbiota could be affected by the prebiotic content of raisins ."
79402,PD,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79403,cases,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79404,were,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79405,identified,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79406,through,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79407,linkage,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79408,with,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79409,the,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79410,Swedish,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79411,National,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79412,Patient,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79413,and,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79414,Cause,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79415,of,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79416,Death,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79417,Registers,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79418,.,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
80195,Patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80196,with,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80197,RA,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80198,frequently,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80199,ask,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80200,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80201,doctors,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80202,about,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80203,which,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80204,diets,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80205,to,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80206,follow,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80207,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80208,and,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80209,even,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80210,in,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80211,the,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80212,absence,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80213,of,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80214,advice,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80215,from,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80216,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80217,physicians,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80218,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80219,many,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80220,patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80221,are,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80222,undertaking,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80223,various,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80224,dietary,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80225,interventions,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80226,.,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80324,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80325,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80326,light,B-AG.01.e,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80327,yogurt,I-AG.01.e,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80328,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80329,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80330, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80331,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80332,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80333,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80334,skim,B-AG.01.e,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80335,milk,I-AG.01.e,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80336,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80337,200,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80338, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80339,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80340,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80341,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80342,1,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80343,glass,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80344,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80345,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80346, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80347,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80348,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80349,of,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80350,wine,B-AG.01.y.01.a,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80351,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80352,extra,B-AG.01.f,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80353,virgin,I-AG.01.f,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80354,olive,I-AG.01.f,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80355,oil,I-AG.01.f,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80356,;,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80357,weekly,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80358,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80359,fish,B-AG.01.d.07,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80360,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80361,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80362,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80363,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80364,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80365,white,B-AG.01.d.06,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80366,meat,I-AG.01.d.06,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80367,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80368,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80369,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80370,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80371,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80372,legumes,B-AG.01.h.02.g,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80373,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80374,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80375,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80376,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80377,eggs,B-AG.01.g,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80378,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80379,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80380,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80381,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80382,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80383,seasoned,B-AG.01.e.02,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80384,cheeses,I-AG.01.e.02,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80385,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80386,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80387,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80388,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80389,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80390,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80391,red,B-AG.01.d,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80392,or,I-AG.01.d,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80393,processed,I-AG.01.d,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80394,meats,I-AG.01.d,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80395,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80396,once,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80397,a,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80398,week,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80399,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80400,.,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80534,For,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80535,oil,B-AG.01.f,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80536,consumption,B-X,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80537,",",O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80538,we,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80539,enquired,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80540,about,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80541,monthly,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80542,consumption,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80543,of,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80544,11,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80545,different,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80546,types,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80547,of,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80548,cooking,B-AG.01.f,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80549,oil,I-AG.01.f,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80550,per,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80551,family,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80552,and,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80553,the,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80554,number,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80555,of,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80556,individuals,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80557,usually,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80558,sharing,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80559,the,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80560,meal,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80561,to,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80562,estimate,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80563,per,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80564,-,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80565,individual,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80566,consumption,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80567,of,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80568,oil,B-AG.01.f,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80569,.,O,2788.0,"For oil consumption , we enquired about monthly consumption of 11 different types of cooking oil per family and the number of individuals usually sharing the meal to estimate per - individual consumption of oil ."
80929,However,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80930,",",O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80931,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80932,masticated,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80933,and,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80934,digesta,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80935,particle,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80936,sizes,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80937,were,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80938,not,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80939,related,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80940,to,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80941,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80942,integrity,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80943,of,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80944,cell,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80945,walls,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80946,or,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80947,lipid,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80948,release,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80949,.,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80950,The,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80951,total,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80952,lipid,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80953,release,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80954,was,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80955,comparable,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80956,between,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80957,nuts,B-AG.01.h.01.f,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80958,after,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80959,the,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80960,in,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80961,vitro,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80962,intestinal,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80963,phase,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80964,(,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80965,P,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80966,>,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80967,0·05,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80968,),O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
80969,.,O,2804.0,The total lipid release was comparable between nuts after the in vitro intestinal phase ( P > 0·05 ) .
81144,An,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81145,attempt,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81146,was,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81147,made,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81148,to,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81149,detect,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81150,key,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81151,components,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81152,in,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81153,wine,B-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81154,/,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81155,must,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81156,that,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81157,through,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81158,inhibition,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81159,of,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81160,PAF,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81161,action,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81162,may,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81163,contribute,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81164,to,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81165,the,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81166,protective,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81167,role,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81168,of,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81169,white,B-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81170,wine,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81171,/,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81172,must,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81173,against,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81174,atherosclerosis,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81175,.,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81258,A,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81259,significant,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81260,number,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81261,of,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81262,biological,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81263,active,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81264,lipids,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81265,were,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81266,detected,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81267,",",O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81268,and,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81269,structural,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81270,data,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81271,for,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81272,the,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81273,most,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81274,active,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81275,lipids,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81276,are,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81277,provided,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81278,.,O,2815.0,"A significant number of biological active lipids were detected , and structural data for the most active lipids are provided ."
81309,However,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81310,",",O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81311,the,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81312,extent,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81313,to,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81314,which,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81315,food,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81316,intake,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81317,varies,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81318,according,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81319,to,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81320,salt,B-AG.01.l.01,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81321,",",O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81322,fat,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81323,and,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81324,sugar,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81325,content,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81326,is,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81327,imperfectly,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81328,known,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81329,.,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81991,This,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81992,article,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81993,reviews,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81994,the,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81995,current,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81996,data,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81997,related,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81998,to,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81999,key,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82000,nutrients,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82001,for,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82002,vegetarians,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82003,including,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82004,protein,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82005,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82006,n-3,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82007,fatty,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82008,acids,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82009,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82010,iron,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82011,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82012,zinc,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82013,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82014,iodine,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82015,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82016,calcium,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82017,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82018,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82019,vitamins,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82020,D,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82021,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82022,B-12,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82023,.,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82053,An,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82054,evidence-,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82055,based,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82056,review,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82057,showed,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82058,that,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82059,vegetarian,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82060,diets,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82061,can,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82062,be,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82063,nutritionally,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82064,adequate,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82065,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82066,pregnancy,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82067,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82068,result,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82069,in,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82070,positive,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82071,maternal,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82072,and,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82073,infant,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82074,health,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82075,outcomes,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82076,.,O,2844.0,An evidence- based review showed that vegetarian diets can be nutritionally adequate in pregnancy and result in positive maternal and infant health outcomes .
82471,It,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82472,was,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82473,concluded,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82474,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82475,malic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82476,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82477,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82478,white,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82479,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82480,and,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82481,succinic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82482,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82483,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82484,red,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82485,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82486,are,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82487,key,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82488,organic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82489,acids,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82490,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82491,contribute,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82492,to,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82493,gastric,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82494,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82495,stimulation,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82496,.,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82675,Groundnuts,B-AG.01.h.01.f,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82676,have,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82677,the,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82678,lowest,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82679,Fe,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82680,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82681,1.3,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82682,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82683,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82684,1.1,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82685,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82686,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82687,",",O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82688,Zn,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82689,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82690,7.9,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82691,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82692,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82693,1.3,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82694,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82695,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82696,and,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82697,Ca,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82698,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82699,14.6,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82700,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82701,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82702,2.8,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82703,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82704,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82705,availability,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82706,.,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82893,Rats,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82894,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82895,made,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82896,moderately,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82897,anemic,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82898,(,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82899,Hb,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82900,7.8,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82901,+,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82902,/-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82903,0.7,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82904,g,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82905,/,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82906,dL,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82907,),O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82908,by,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82909,feeding,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82910,an,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82911,iron,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82912,-,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82913,deficient,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82914,diet,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82915,and,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82916,were,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82917,then,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82918,fed,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82919,one,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82920,of,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82921,the,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82922,16,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82923,experimental,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82924,diets,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82925,.,O,2870.0,Rats were made moderately anemic ( Hb 7.8 + /- 0.7 g / dL ) by feeding an iron - deficient diet and were then fed one of the 16 experimental diets .
82983,Both,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82984,heme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82985,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82986,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82987,and,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82988,nonheme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82989,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82990,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82991,were,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82992,higher,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82993,when,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82994,high,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82995,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82996,30,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82997,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82998,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82999,rather,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83000,than,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83001,low,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83002,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83003,5,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83004,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83005,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83006,dietary,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83007,fat,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83008,was,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83009,fed,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83010,.,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83011,The,O,2875.0,The type of fat had no effect .
83012,type,O,2875.0,The type of fat had no effect .
83013,of,O,2875.0,The type of fat had no effect .
83014,fat,O,2875.0,The type of fat had no effect .
83015,had,O,2875.0,The type of fat had no effect .
83016,no,O,2875.0,The type of fat had no effect .
83017,effect,O,2875.0,The type of fat had no effect .
83018,.,O,2875.0,The type of fat had no effect .
83342,The,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83343,highest,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83344,values,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83345,above,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83346,the,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83347,50th,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83348,percentile,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83349,of,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83350,these,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83351,minerals,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83352,",",O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83353,especially,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83354,lead,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83355,",",O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83356,were,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83357,observed,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83358,in,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83359,the,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83360,Borgo,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83361,area,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83362,.,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83693,Addition,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83694,levels,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83695,of,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83696,brown,B-AG.01.k,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83697,rice,I-AG.01.k,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83698,flour,I-AG.01.k,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83699,(,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83700,0,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83701,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83702,to,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83703,100,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83704,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83705,),O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83706,and,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83707,sugar,B-AG.01.l.02,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83708,(,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83709,5,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83710,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83711,to,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83712,20,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83713,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83714,),O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83715,not,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83716,only,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83717,enriched,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83718,flavor,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83719,",",O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83720,but,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83721,also,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83722,lessened,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83723,chewiness,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83724,of,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83725,Seolgitteok,B-AG.01.n.13,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83726,",",O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83727,thereby,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83728,increasing,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83729,an,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83730,overall,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83731,hedonic,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83732,impression,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83733,.,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
84574,SCFA,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84575,were,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84576,probably,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84577,not,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84578,responsible,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84579,for,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84580,this,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84581,effect,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84582,",",O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84583,as,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84584,SCFA,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84585,concentrations,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84586,and,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84587,profiles,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84588,did,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84589,not,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84590,change,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84591,significantly,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84592,.,O,2935.0,"SCFA were probably not responsible for this effect , as SCFA concentrations and profiles did not change significantly ."
84850,The,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84851,"""",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84852,healthy,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84853,/,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84854,Mediterranean,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84855,"""",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84856,pattern,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84857,was,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84858,negatively,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84859,associated,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84860,with,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84861,breast,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84862,cancer,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84863,risk,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84864,(,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84865,hazard,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84866,ratio,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84867,=,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84868,0.85,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84869,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84870,95,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84871,%,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84872,CI,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84873,:,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84874,0.75,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84875,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84876,0.95,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84877,;,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84878,P,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84879,=,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84880,0.003,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84881,for,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84882,linear,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84883,trend,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84884,),O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84885,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84886,especially,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84887,when,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84888,tumors,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84889,were,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84890,estrogen,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84891,receptor,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84892,-,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84893,positive,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84894,/,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84895,progesterone,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84896,receptor,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84897,-,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84898,negative,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84899,.,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
85190,These,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85191,results,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85192,support,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85193,the,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85194,hypothesis,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85195,that,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85196,intakes,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85197,of,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85198,meat,B-AG.01.d,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85199,and,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85200,its,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85201,associated,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85202,fat,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85203,are,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85204,risk,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85205,factors,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85206,for,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85207,colon,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85208,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85209,rectal,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85210,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85211,prostate,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85212,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85213,and,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85214,female,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85215,breast,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85216,cancers,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85217,.,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85218,Recent,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85219,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85220,by,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85221,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85222,American,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85223,Diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85224,Association,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85225,suggest,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85226,that,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85227,children,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85228,with,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85229,type,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85230,1,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85231,diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85232,should,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85233,follow,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85234,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85235,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85236,for,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85237,age,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85238,",",O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85239,sex,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85240,and,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85241,body,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85242,size,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85243,of,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85244,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85245,general,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85246,population,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85247,.,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85693,Subsequent,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85694,16th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85695,to,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85696,early,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85697,20th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85698,century,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85699,manuscripts,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85700,produced,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85701,in,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85702,Europe,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85703,and,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85704,New,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85705,Spain,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85706,revealed,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85707,>,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85708,100,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85709,medicinal,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85710,uses,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85711,for,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85712,cacao,B-AG.01,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85713,/,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85714,chocolate,B-AG.01.n.17.a,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85715,.,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85819,Chocolate,B-AG.01.n.17.a,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85820,paste,I-AG.01.n.17.a,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85821,was,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85822,a,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85823,medium,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85824,used,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85825,to,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85826,administer,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85827,drugs,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85828,and,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85829,to,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85830,counter,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85831,the,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85832,taste,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85833,of,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85834,bitter,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85835,pharmacological,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85836,additives,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
85837,.,O,2972.0,Chocolate paste was a medium used to administer drugs and to counter the taste of bitter pharmacological additives .
86199,A,O,2986.0,A synergistic effect was seen when given with glucose .
86200,synergistic,O,2986.0,A synergistic effect was seen when given with glucose .
86201,effect,O,2986.0,A synergistic effect was seen when given with glucose .
86202,was,O,2986.0,A synergistic effect was seen when given with glucose .
86203,seen,O,2986.0,A synergistic effect was seen when given with glucose .
86204,when,O,2986.0,A synergistic effect was seen when given with glucose .
86205,given,O,2986.0,A synergistic effect was seen when given with glucose .
86206,with,O,2986.0,A synergistic effect was seen when given with glucose .
86207,glucose,O,2986.0,A synergistic effect was seen when given with glucose .
86208,.,O,2986.0,A synergistic effect was seen when given with glucose .
86519,Personal,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86520,interviews,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86521,with,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86522,"1,016",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86523,histologically,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86524,confirmed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86525,GC,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86526,cases,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86527,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86528,"1,159",O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86529,population,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86530,controls,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86531,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86532,similar,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86533,age,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86534,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86535,sex,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86536,revealed,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86537,that,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86538,the,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86539,patients,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86540,were,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86541,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86542,often,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86543,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86544,lower,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86545,social,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86546,class,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86547,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86548,resident,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86549,in,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86550,rural,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86551,areas,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86552,and,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86553,more,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86554,frequently,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86555,reported,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86556,a,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86557,familial,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86558,history,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86559,of,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86560,gastric,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86561,(,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86562,but,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86563,not,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86564,other,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86565,),O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86566,cancer,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
86567,.,O,2998.0,"Personal interviews with 1,016 histologically confirmed GC cases and 1,159 population controls of similar age and sex revealed that the patients were more often of lower social class and resident in rural areas and more frequently reported a familial history of gastric ( but not other ) cancer ."
87375,The,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87376,triacylglycerol,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87377,response,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87378,increased,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87379,in,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87380,a,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87381,dose,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87382,-,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87383,dependent,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87384,manner,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87385,with,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87386,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87387,fat,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87388,content,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87389,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87390,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87391,meals,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87392,irrespective,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87393,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87394,the,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87395,type,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87396,of,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87397,fat,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87398,.,O,3024.0,The triacylglycerol response increased in a dose - dependent manner with the fat content of the meals irrespective of the type of fat .
87635,They,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87636,also,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87637,had,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87638,a,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87639,higher,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87640,NIS,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87641,(,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87642,P,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87643,=,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87644,0.006,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87645,),O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87646,and,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87647,experienced,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87648,greater,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87649,weight,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87650,loss,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87651,(,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87652,P,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87653,<,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87654,0.04,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87655,),O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87656,during,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87657,the,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87658,study,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87659,",",O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87660,despite,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87661,having,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87662,similar,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87663,energy,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87664,intake,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87665,to,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87666,patients,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87667,consuming,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87668,<,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87669,15,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87670,%,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87671,kcal,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87672,from,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87673,ONS,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87674,.,O,3033.0,"They also had a higher NIS ( P = 0.006 ) and experienced greater weight loss ( P < 0.04 ) during the study , despite having similar energy intake to patients consuming < 15 % kcal from ONS ."
87781,The,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87782,subjects,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87783,had,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87784,participated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87785,in,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87786,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87787,previous,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87788,study,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87789,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87790,were,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87791,never,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87792,diagnosed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87793,with,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87794,breast,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87795,cancer,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87796,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87797,provided,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87798,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87799,screening,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87800,mammogram,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87801,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87802,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87803,blood,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87804,sample,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87805,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87806,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87807,completed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87808,validated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87809,food,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87810,-,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87811,frequency,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87812,questionnaires,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87813,.,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87838,We,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87839,estimated,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87840,covariate,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87841,-,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87842,adjusted,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87843,mean,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87844,IGF,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87845,-,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87846,I,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87847,and,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87848,IGFBP-3,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87849,levels,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87850,by,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87851,tofu,B-AG.01.n,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87852,intake,B-X,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
87853,.,O,3041.0,We estimated covariate - adjusted mean IGF - I and IGFBP-3 levels by tofu intake .
88072,Flavanols,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88073,have,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88074,been,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88075,described,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88076,to,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88077,exert,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88078,favorable,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88079,effects,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88080,on,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88081,endothelium,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88082,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88083,derived,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88084,vasodilation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88085,via,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88086,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88087,stimulation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88088,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88089,nitric,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88090,oxide,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88091,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88092,synthase,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88093,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88094,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88095,increased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88096,availability,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88097,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88098,l,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88099,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88100,arginine,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88101,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88102,and,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88103,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88104,decreased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88105,degradation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88106,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88107,NO,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88108,.,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88109,Cocoa,B-AG.01,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88110,may,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88111,also,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88112,have,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88113,a,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88114,beneficial,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88115,effect,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88116,by,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88117,protecting,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88118,against,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88119,oxidative,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88120,stress,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88121,alterations,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88122,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88123,via,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88124,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88125,platelet,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88126,aggregation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88127,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88128,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88129,lipid,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88130,oxidation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88131,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88132,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88133,insulin,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88134,resistance,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88135,.,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88159,Previous,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88160,meta,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88161,-,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88162,analyses,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88163,have,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88164,shown,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88165,that,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88166,cocoa,B-AG.01,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88167,-,I-AG.01,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88168,rich,I-AG.01,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88169,foods,I-AG.01,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88170,may,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88171,reduce,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88172,blood,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88173,pressure,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
88174,.,O,3053.0,Previous meta - analyses have shown that cocoa - rich foods may reduce blood pressure .
89177,Greater,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89178,concentrations,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89179,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89180,monounsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89181,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89182,14.94,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89183,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89184,11.96,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89185,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89186,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89187,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89188,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89189,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89190,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89191,and,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89192,polyunsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89193,fatty,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89194,acids,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89195,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89196,4.53,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89197,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89198,4.03,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89199,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89200,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89201,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89202,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89203,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89204,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89205,were,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89206,detected,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89207,in,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89208,the,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89209,milk,B-AG.01.e,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89210,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89211,goats,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89212,fed,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89213,LRS,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89214,compared,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89215,with,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89216,CON,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89217,.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89417,For,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89418,food,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89419,groups,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89420,",",O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89421,increased,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89422,consumption,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89423,of,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89424,fruit,B-AG.01.h.01,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89425,",",O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89426,citrus,B-AG.01.h.01.a,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89427,fruit,I-AG.01.h.01.a,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89428,",",O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89429,cheese,B-AG.01.e.02,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89430,and,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89431,whole,B-AG.01.n.11,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89432,-,I-AG.01.n.11,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89433,meal,I-AG.01.n.11,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89434,bread,I-AG.01.n.11,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89435,were,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89436,associated,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89437,with,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89438,decreased,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89439,risk,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89440,.,O,3094.0,"For food groups , increased consumption of fruit , citrus fruit , cheese and whole - meal bread were associated with decreased risk ."
89805,This,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89806,review,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89807,aims,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89808,to,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89809,provide,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89810,some,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89811,insights,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89812,on,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89813,dough,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89814,functionality,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89815,and,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89816,process,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89817,conditions,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89818,regarding,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89819,bread,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89820,quality,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89821,and,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89822,to,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89823,point,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89824,out,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89825,recent,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89826,research,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89827,dealing,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89828,with,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89829,the,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89830,nutritional,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89831,composition,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89832,of,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89833,those,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89834,products,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
89835,.,O,3111.0,This review aims to provide some insights on dough functionality and process conditions regarding bread quality and to point out recent research dealing with the nutritional composition of those products .
90035,Once,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90036,a,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90037,strategy,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90038,for,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90039,balancing,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90040,undesirable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90041,bitterness,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90042,and,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90043,health,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90044,concerns,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90045,regarding,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90046,added,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90047,sugars,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90048,has,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90049,been,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90050,developed,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90051,",",O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90052,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90053,task,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90054,becomes,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90055,determining,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90056,whether,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90057,that,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90058,product,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90059,will,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90060,be,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90061,acceptable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90062,to,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90063,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90064,consumer,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90065,.,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90307,The,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90308,consumption,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90309,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90310,dairy,B-AG.01.e,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90311,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90312,including,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90313,milk,B-AG.01.e,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90314,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90315,cheese,B-AG.01.e.02,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90316,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90317,yogurt,B-AG.01.e,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90318,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90319,has,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90320,been,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90321,associated,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90322,with,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90323,better,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90324,quality,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90325,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90326,diet,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90327,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90328,reduced,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90329,risk,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90330,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90331,cardiovascular,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90332,disease,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90333,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90334,the,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90335,leading,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90336,cause,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90337,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90338,death,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90339,globally,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90340,.,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90341,The,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90342,purpose,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90343,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90344,this,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90345,review,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90346,is,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90347,to,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90348,examine,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90349,recent,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90350,literature,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90351,on,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90352,the,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90353,relationship,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90354,between,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90355,dairy,B-AG.01.e,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90356,consumption,B-X,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90357,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90358,risk,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90359,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90360,cardiovascular,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90361,disease,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90362,incidence,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90363,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90364,mortality,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90365,.,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90472,Future,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90473,research,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90474,need,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90475,not,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90476,replicate,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90477,the,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90478,body,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90479,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90480,literature,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90481,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90482,total,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90483,dairy,B-AG.01.e,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90484,consumption,B-X,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90485,and,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90486,associated,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90487,risk,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90488,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90489,disease,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90490,",",O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90491,but,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90492,rather,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90493,should,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90494,focus,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90495,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90496,the,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90497,effects,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90498,of,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90499,individual,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90500,dairy,B-AG.01.e,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90501,foods,I-AG.01.e,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90502,on,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90503,cardiovascular,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90504,events,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90505,in,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90506,male,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90507,and,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90508,female,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90509,populations,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90510,.,O,3135.0,"Future research need not replicate the body of literature on total dairy consumption and associated risk of disease , but rather should focus on the effects of individual dairy foods on cardiovascular events in male and female populations ."
90620,The,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90621,flow,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90622,behavior,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90623,of,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90624,the,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90625,film,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90626,suspensions,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90627,showed,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90628,shear,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90629,-,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90630,thinning,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90631,behavior,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90632,as,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90633,calculated,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90634,by,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90635,the,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90636,Power,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90637,Law,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90638,model,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90639,.,O,3139.0,The flow behavior of the film suspensions showed shear - thinning behavior as calculated by the Power Law model .
90977,Factor,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90978,1,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90979,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90980,characterized,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90981,by,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90982,olive,B-AG.01.f,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90983,oil,I-AG.01.f,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90984,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90985,salad,B-AG.01.h.02,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90986,vegetables,I-AG.01.h.02,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90987,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90988,and,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90989,legumes,B-AG.01.h.02.g,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90990,and,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90991,by,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90992,avoidance,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90993,of,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90994,sweet,B-AG.01.n.17.a,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90995,bakery,I-AG.01.n.17.a,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90996,items,I-AG.01.n.17.a,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90997,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90998,margarine,B-AG.01.f,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
90999,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91000,and,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91001,tea,B-AG.01.ac,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91002,",",O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91003,was,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91004,associated,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91005,with,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91006,country,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91007,of,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91008,birth,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91009,but,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91010,not,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91011,with,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91012,diabetes,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91013,.,O,3153.0,"Factor 1 , characterized by olive oil , salad vegetables , and legumes and by avoidance of sweet bakery items , margarine , and tea , was associated with country of birth but not with diabetes ."
91091,Polyunsaturated,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91092,meat,B-AG.01.d,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91093,and,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91094,dairy,B-AG.01.e,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91095,products,I-AG.01.e,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91096,were,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91097,compared,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91098,with,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91099,their,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91100,saturated,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91101,counterparts,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91102,to,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91103,determine,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91104,their,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91105,usefulness,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91106,in,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91107,a,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91108,fat,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91109,-,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91110,modified,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91111,diet,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91112,for,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91113,hyperlipidemic,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91114,persons,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91115,and,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91116,their,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91117,spouses,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91118,.,O,3158.0,Polyunsaturated meat and dairy products were compared with their saturated counterparts to determine their usefulness in a fat - modified diet for hyperlipidemic persons and their spouses .
91200,In,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91201,the,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91202,fourteen,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91203,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91204,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91205,study,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91206,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91207,an,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91208,adjustment,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91209,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91210,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91211,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91212,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91213,was,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91214,followed,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91215,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91216,two,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91217,consecutive,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91218,experimental,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91219,periods,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91220,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91221,four,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91222,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91223,each,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91224,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91225,then,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91226,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91227,a,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91228,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91229,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91230,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91231,follow,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91232,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91233,up,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91234,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91235,.,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91621,Intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91622,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91623,vitamin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91624,C,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91625,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91626,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91627,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91628,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91629,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91630,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91631,folate,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91632,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91633,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91634,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91635,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91636,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91637,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91638,riboflavin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91639,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91640,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91641,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91642,0.03,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91643,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91644,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91645,thiamine,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91646,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91647,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91648,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91649,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91650,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91651,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91652,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91653,magnesium,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91654,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91655,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91656,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91657,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91658,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91659,per,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91660,megajoule,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91661,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91662,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91663,quartile,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91664,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91665,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91666,fat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91667,intake,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91668,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91669,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91670,a,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91671,%,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91672,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91673,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91674,energy,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91675,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91676,decreased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91677,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91678,reflecting,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91679,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91680,intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91681,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91682,cereals,B-AG.01.i,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91683,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91684,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91685,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91686,0.002,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91687,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91688,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91689,pasta,B-AG.01.i,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91690,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91691,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91692,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91693,0.01,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91694,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91695,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91696,fruit,B-AG.01.h.01,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91697,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91698,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91699,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91700,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91701,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91702,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91703,pure,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91704,meat,B-AG.01.d,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91705,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91706,not,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91707,minced,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91708,or,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91709,meat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91710,products,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91711,;,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91712,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91713,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91714,0.047,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91715,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91716,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91717,skim,B-AG.01.e,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91718,milk,I-AG.01.e,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91719,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91720,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91721,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91722,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91723,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91724,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91725,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91726,skim,B-AG.01.e.02,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91727,cheese,I-AG.01.e.02,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91728,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91729,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91730,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91731,0.005,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91732,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91733,.,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91902,This,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91903,paper,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91904,provides,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91905,an,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91906,overview,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91907,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91908,available,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91909,sensors,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91910,",",O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91911,ongoing,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91912,research,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91913,",",O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91914,and,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91915,areas,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91916,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91917,application,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91918,for,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91919,analysis,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91920,of,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91921,milk,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91922,constituents,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
91923,.,O,3185.0,"This paper provides an overview of available sensors , ongoing research , and areas of application for analysis of milk constituents ."
92092,Their,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92093,calibration,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92094,and,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92095,maintenance,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92096,requirements,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92097,have,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92098,to,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92099,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92100,checked,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92101,thoroughly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92102,before,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92103,they,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92104,can,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92105,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92106,regularly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92107,implemented,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92108,on,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92109,dairy,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92110,farms,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92111,.,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92448,The,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92449,allergens,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92450,of,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92451,fruits,B-AG.01.h.01,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92452,and,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92453,vegetables,B-AG.01.h.02,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92454,might,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92455,be,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92456,proteins,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92457,(,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92458,enzymes,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92459,),O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92460,.,O,3205.0,The allergens of fruits and vegetables might be proteins ( enzymes ) .
92479,Yogurt,B-AG.01.e,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92480,is,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92481,a,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92482,nutrient,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92483,-,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92484,dense,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92485,food,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92486,that,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92487,may,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92488,benefit,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92489,individuals,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92490,with,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92491,lactose,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92492,intolerance,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92493,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92494,constipation,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92495,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92496,diarrheal,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92497,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92498,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92499,hypertension,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92500,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92501,cardiovascular,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92502,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92503,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92504,diabetes,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92505,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92506,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92507,certain,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92508,types,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92509,of,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92510,cancer,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92511,.,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92796,Bones,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92797,are,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92798,better,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92799,served,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92800,by,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92801,attending,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92802,to,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92803,calcium,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92804,balance,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92805,and,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92806,focusing,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92807,efforts,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92808,on,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92809,increasing,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92810,fruit,B-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92811,and,I-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92812,vegetable,I-AG.01.h,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92813,intakes,B-X,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92814,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92815,limiting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92816,animal,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92817,protein,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92818,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92819,exercising,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92820,regularly,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92821,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92822,getting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92823,adequate,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92824,sunshine,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92825,or,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92826,supplemental,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92827,vitamin,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92828,D,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92829,",",O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92830,and,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92831,getting,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92832,approximately,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92833,500,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92834,mg,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92835,Ca,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92836,/,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92837,d,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92838,from,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92839,plant,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92840,sources,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92841,.,O,3219.0,"Bones are better served by attending to calcium balance and focusing efforts on increasing fruit and vegetable intakes , limiting animal protein , exercising regularly , getting adequate sunshine or supplemental vitamin D , and getting approximately 500 mg Ca / d from plant sources ."
92856,In,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92857,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92858,domain,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92859,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92860,nutrition,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92861,",",O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92862,exploring,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92863,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92864,diet,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92865,-,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92866,health,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92867,linkages,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92868,is,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92869,major,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92870,area,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92871,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92872,research,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92873,.,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
93203,Because,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93204,it,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93205,has,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93206,been,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93207,suggested,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93208,that,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93209,caffeine,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93210,enhances,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93211,mammary,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93212,carcinogenesis,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93213,in,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93214,rats,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93215,fed,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93216,high,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93217,polyunsaturated,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93218,fat,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93219,diets,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93220,",",O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93221,analysis,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93222,was,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93223,done,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93224,also,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93225,in,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93226,relation,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93227,to,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93228,fat,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93229,consumption,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
93230,.,O,3234.0,"Because it has been suggested that caffeine enhances mammary carcinogenesis in rats fed high polyunsaturated fat diets , analysis was done also in relation to fat consumption ."
94688,A,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94689,subgroup,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94690,of,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94691,patients,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94692,(,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94693,n,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94694,=,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94695,18,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94696,),O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94697,also,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94698,performed,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94699,TG,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94700,determinations,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94701,2,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94702,hours,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94703,after,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94704,the,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94705,test,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94706,meals,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94707,.,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
95100,Many,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95101,people,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95102,erroneously,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95103,believe,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95104,they,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95105,are,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95106,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95107,intolerant,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95108,or,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95109,develop,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95110,gastrointestinal,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95111,symptoms,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95112,after,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95113,intake,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95114,of,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95115,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95116,.,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
96110,The,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96111,knowledge,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96112,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96113,uranium,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96114,concentration,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96115,",",O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96116,in,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96117,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96118,products,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96119,entering,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96120,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96121,human,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96122,diet,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96123,is,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96124,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96125,extreme,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96126,importance,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96127,because,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96128,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96129,their,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96130,chemical,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96131,hazard,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96132,to,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96133,health,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96134,.,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96444,Among,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96445,the,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96446,various,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96447,types,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96448,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96449,animal,B-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96450,-,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96451,based,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96452,protein,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96453,foods,I-AG.01,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96454,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96455,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96456,higher,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96457,intake,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96458,of,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96459,dairy,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96460,products,I-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96461,(,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96462,such,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96463,as,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96464,milk,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96465,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96466,yogurt,B-AG.01.e,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96467,",",O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96468,cheese,B-AG.01.e.02,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96469,and,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96470,whey,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96471,protein,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96472,),O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96473,consistently,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96474,shows,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96475,a,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96476,beneficial,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96477,relationship,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96478,with,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96479,glucose,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96480,regulation,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96481,and/or,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96482,type,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96483,2,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96484,diabetes,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96485,risk,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96486,reduction,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96487,.,O,3342.0,"Among the various types of animal - based protein foods , a higher intake of dairy products ( such as milk , yogurt , cheese and whey protein ) consistently shows a beneficial relationship with glucose regulation and/or type 2 diabetes risk reduction ."
96747,Further,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96748,challenge,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96749,arises,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96750,because,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96751,the,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96752,health,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96753,benefits,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96754,of,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96755,wine,B-AG.01.y.01.a,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96756,address,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96757,the,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96758,prevention,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96759,of,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96760,slowly,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96761,developing,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96762,diseases,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96763,for,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96764,which,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96765,validated,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96766,biomarkers,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96767,are,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96768,rare,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96769,.,O,3351.0,Further challenge arises because the health benefits of wine address the prevention of slowly developing diseases for which validated biomarkers are rare .
96882,The,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96883,aim,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96884,of,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96885,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96886,present,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96887,narrative,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96888,review,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96889,is,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96890,to,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96891,integrate,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96892,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96893,available,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96894,information,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96895,on,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96896,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96897,relationship,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96898,between,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96899,the,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96900,most,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96901,studied,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96902,FD,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96903,products,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96904,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96905,which,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96906,are,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96907,yogurt,B-AG.01.e,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96908,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96909,cheese,B-AG.01.e.02,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96910,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96911,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96912,cardiometabolic,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96913,risk,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96914,factors,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96915,obtained,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96916,from,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96917,meta,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96918,-,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96919,analysis,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96920,",",O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96921,systematic,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96922,reviews,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96923,of,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96924,prospective,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96925,cohort,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96926,studies,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96927,(,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96928,PCSs,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96929,),O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96930,and,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96931,PCSs,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96932,published,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96933,up,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96934,to,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96935,2,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96936,November,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96937,2019,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
96938,.,O,3356.0,"The aim of the present narrative review is to integrate the available information on the relationship between the most studied FD products , which are yogurt and cheese , and cardiometabolic risk factors obtained from meta - analysis , systematic reviews of prospective cohort studies ( PCSs ) and PCSs published up to 2 November 2019 ."
97058,Moreover,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97059,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97060,the,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97061,association,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97062,of,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97063,FD,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97064,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97065,cheese,B-AG.01.e.02,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97066,and,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97067,yogurt,B-AG.01.e,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97068,with,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97069,hypertension,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97070,needs,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97071,further,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97072,evidence,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97073,.,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97586,Today,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97587,",",O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97588,tens,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97589,of,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97590,millions,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97591,of,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97592,elderly,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97593,individuals,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97594,worldwide,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97595,suffer,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97596,from,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97597,dementia,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97598,.,O,3380.0,"Today , tens of millions of elderly individuals worldwide suffer from dementia ."
97713,Fruit,B-AG.01.ab,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97714,juices,I-AG.01.ab,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97715,and,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97716,extracts,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97717,are,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97718,under,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97719,investigation,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97720,as,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97721,treatments,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97722,for,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97723,cognitive,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97724,impairment,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
97725,.,O,3386.0,Fruit juices and extracts are under investigation as treatments for cognitive impairment .
98132,Participants,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98133,ranged,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98134,in,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98135,age,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98136,from,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98137,25,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98138,to,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98139,64,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98140,years,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98141,and,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98142,resided,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98143,in,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98144,three,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98145,socioeconomically,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98146,distinct,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98147,neighborhoods,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98148,of,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98149,San,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98150,Antonio,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98151,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98152,TX,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98153,:,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98154,low,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98155,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98156,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98157,middle,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98158,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98159,",",O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98160,and,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98161,upper,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98162,income,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98163,.,O,3400.0,"Participants ranged in age from 25 to 64 years and resided in three socioeconomically distinct neighborhoods of San Antonio , TX : low income , middle income , and upper income ."
98422,Information,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98423,on,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98424,coffee,B-AG.01.ad,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98425,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98426,green,B-AG.01.ac,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98427,tea,I-AG.01.ac,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98428,consumption,B-X,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98429,and,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98430,other,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98431,lifestyle,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98432,factors,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98433,was,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98434,collected,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98435,via,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98436,a,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98437,self,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98438,-,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98439,administered,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98440,questionnaire,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98441,.,O,3411.0,Information on coffee and green tea consumption and other lifestyle factors was collected via a self - administered questionnaire .
98567,No,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98568,change,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98569,in,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98570,these,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98571,associations,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98572,was,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98573,seen,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98574,on,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98575,stratification,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98576,by,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98577,each,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98578,confounding,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98579,factors,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98580,.,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98779,Milk,B-AG.01.e,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98780,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98781,soups,B-AG.01.n.02,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98782,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98783,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98784,stews,B-AG.01.n,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98785,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98786,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98787,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98788,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98789,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98790,all,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98791,nutrients,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98792,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98793,tortillas,B-AG.01.n.12,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98794,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98795,eggs,B-AG.01.g,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98796,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98797,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98798,egg,B-AG.01.n.16,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98799,dishes,I-AG.01.n.16,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98800,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98801,among,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98802,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98803,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98804,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98805,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98806,iron,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98807,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98808,zinc,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98809,.,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98810,This,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98811,study,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98812,showed,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98813,that,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98814,low,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98815,nutrient,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98816,-,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98817,dense,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98818,cookies,B-AG.01.n.14,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98819,",",O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98820,sweetened,B-AG.01.n.17.a,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98821,breads,I-AG.01.n.17.a,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98822,",",O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98823,and,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98824,traditional,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98825,beverages,B-AG.01.y,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98826,were,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98827,among,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98828,the,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98829,core,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98830,foods,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98831,consumed,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98832,early,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98833,in,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98834,life,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98835,in,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98836,Mexico,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
98837,.,O,3427.0,"This study showed that low nutrient - dense cookies , sweetened breads , and traditional beverages were among the core foods consumed early in life in Mexico ."
99572,Concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99573,of,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99574,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99575,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99576,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99577,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99578,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99579,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99580,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99581,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99582,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99583,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99584,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99585,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99586,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99587,calving,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99588,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99589,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99590,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99591,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99592,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99593,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99594,not,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99595,affected,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99596,by,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99597,treatment,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99598,",",O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99599,but,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99600,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99601,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99602,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99603,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99604,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99605,isolated,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99606,from,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99607,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99608,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99609,about,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99610,3,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99611,times,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99612,greater,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99613,than,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99614,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99615,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99616,blood,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99617,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99618,.,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99619,The,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99620,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99621,infusion,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99622,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99623,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99624,alter,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99625,concentrations,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99626,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99627,vitamin,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99628,C,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99629,in,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99630,plasma,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99631,or,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99632,milk,B-AG.01.e,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99633,",",O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99634,suggesting,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99635,that,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99636,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99637,LPS,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99638,model,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99639,did,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99640,not,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99641,produce,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99642,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99643,same,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99644,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99645,as,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99646,a,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99647,bacterial,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99648,infection,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99649,of,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99650,the,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99651,mammary,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99652,gland,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99653,with,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99654,respect,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99655,to,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99656,antioxidant,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99657,effects,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99658,.,O,3451.0,"The LPS infusion did not alter concentrations of vitamin C in plasma or milk , suggesting that the LPS model did not produce the same effects as a bacterial infection of the mammary gland with respect to antioxidant effects ."
99977,The,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99978,objective,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99979,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99980,this,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99981,review,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99982,was,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99983,to,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99984,give,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99985,an,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99986,overview,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99987,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99988,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99989,state,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99990,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99991,art,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99992,epidemiological,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99993,evidence,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99994,concerning,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99995,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99996,relationship,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99997,between,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99998,olive,B-AG.01.f,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99999,oil,I-AG.01.f,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100000,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100001,key,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100002,public,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100003,health,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100004,outcomes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100005,including,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100006,mortality,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100007,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100008,CVD,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100009,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100010,diabetes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100011,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100012,metabolic,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100013,syndrome,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100014,(,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100015,MetS,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100016,),O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100017,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100018,obesity,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100019,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100020,cancer,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100021,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100022,with,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100023,a,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100024,particular,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100025,focus,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100026,on,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100027,recent,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100028,results,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100029,from,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100030,cohort,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100031,studies,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100032,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100033,dietary,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100034,intervention,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100035,trials,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100036,.,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100453,Food,O,3480.0,Food allergy and allergen management are important global public health issues .
100454,allergy,O,3480.0,Food allergy and allergen management are important global public health issues .
100455,and,O,3480.0,Food allergy and allergen management are important global public health issues .
100456,allergen,O,3480.0,Food allergy and allergen management are important global public health issues .
100457,management,O,3480.0,Food allergy and allergen management are important global public health issues .
100458,are,O,3480.0,Food allergy and allergen management are important global public health issues .
100459,important,O,3480.0,Food allergy and allergen management are important global public health issues .
100460,global,O,3480.0,Food allergy and allergen management are important global public health issues .
100461,public,O,3480.0,Food allergy and allergen management are important global public health issues .
100462,health,O,3480.0,Food allergy and allergen management are important global public health issues .
100463,issues,O,3480.0,Food allergy and allergen management are important global public health issues .
100464,.,O,3480.0,Food allergy and allergen management are important global public health issues .
100976,Excessive,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100977,energy,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100978,intake,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100979,and,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100980,obesity,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100981,are,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100982,major,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100983,causes,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100984,of,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100985,hypertension,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100986,.,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
101443,Lymphoid,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101444,cancers,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101445,were,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101446,analyzed,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101447,by,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101448,multiple,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101449,polytomous,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101450,regression,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
101451,.,O,3518.0,Lymphoid cancers were analyzed by multiple polytomous regression .
102055,Cocoa,B-AG.01,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102056,consumption,B-X,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102057,is,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102058,correlated,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102059,with,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102060,reduced,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102061,health,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102062,risks,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102063,of,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102064,cardiovascular,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102065,diseases,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102066,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102067,hypertension,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102068,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102069,atherosclerosis,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102070,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102071,and,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102072,cancer,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102073,",",O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102074,and,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102075,the,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102076,health,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102077,-,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102078,promoting,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102079,effects,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102080,of,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102081,cocoa,B-AG.01,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102082,are,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102083,mediated,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102084,by,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102085,cocoa,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102086,-,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102087,driven,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102088,phytochemicals,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102089,.,O,3542.0,"Cocoa consumption is correlated with reduced health risks of cardiovascular diseases , hypertension , atherosclerosis , and cancer , and the health - promoting effects of cocoa are mediated by cocoa - driven phytochemicals ."
102106,Among,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102107,the,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102108,phytochemicals,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102109,present,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102110,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102111,consumed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102112,cocoa,B-AG.01,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102113,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102114,theobromine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102115,is,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102116,most,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102117,available,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102118,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102119,human,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102120,plasma,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102121,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102122,followed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102123,by,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102124,caffeine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102125,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102126,(,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102127,-)-epicatechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102128,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102129,catechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102130,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102131,and,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102132,procyanidins,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102133,.,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102134,It,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102135,has,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102136,been,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102137,reported,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102138,that,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102139,cocoa,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102140,phytochemicals,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102141,specifically,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102142,modulate,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102143,or,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102144,interact,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102145,with,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102146,specific,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102147,molecular,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102148,targets,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102149,linked,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102150,to,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102151,the,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102152,pathogenesis,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102153,of,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102154,chronic,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102155,human,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102156,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102157,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102158,including,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102159,cardiovascular,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102160,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102161,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102162,cancer,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102163,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102164,neurodegenerative,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102165,diseases,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102166,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102167,obesity,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102168,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102169,diabetes,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102170,",",O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102171,and,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102172,skin,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102173,aging,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102174,.,O,3545.0,"It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases , including cardiovascular diseases , cancer , neurodegenerative diseases , obesity , diabetes , and skin aging ."
102208,However,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102209,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102210,consumption,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102211,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102212,fruit,B-AG.01.h.01,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102213,in,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102214,the,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102215,form,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102216,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102217,juice,B-AG.01.ab,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102218,is,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102219,positively,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102220,associated,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102221,with,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102222,type,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102223,2,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102224,diabetes,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102225,risk,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102226,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102227,possibly,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102228,due,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102229,to,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102230,resulting,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102231,hyperglycemia,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102232,.,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102449,In,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102450,this,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102451,review,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102452,",",O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102453,we,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102454,analyzed,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102455,the,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102456,effects,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102457,of,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102458,each,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102459,dietary,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102460,factor,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102461,on,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102462,nephrolithiasis,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102463,incidence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102464,and,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102465,recurrence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102466,rate,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102467,.,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,B-AG.01.l.01,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,B-X,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102609,The,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102610,objective,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102611,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102612,this,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102613,study,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102614,was,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102615,to,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102616,describe,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102617,and,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102618,compare,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102619,the,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102620,KAP,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102621,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102622,adults,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102623,related,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102624,to,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102625,salt,B-AG.01.l.01,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102626,in,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102627,urban,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102628,areas,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102629,of,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102630,five,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102631,countries,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102632,in,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102633,sub,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102634,-,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102635,Saharan,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102636,Africa,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102637,.,O,3561.0,The objective of this study was to describe and compare the KAP of adults related to salt in urban areas of five countries in sub - Saharan Africa .
102789,However,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102790,",",O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102791,slightly,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102792,over,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102793,half,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102794,(,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102795,56,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102796,%,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102797,),O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102798,of,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102799,the,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102800,respondents,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102801,regularly,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102802,tried,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102803,to,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102804,limit,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102805,their,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102806,salt,B-AG.01.l.01,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102807,intake,B-X,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102808,while,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102809,only,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102810,8,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102811,%,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102812,of,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102813,the,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102814,respondents,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102815,thought,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102816,that,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102817,they,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102818,consumed,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102819,too,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102820,much,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102821,salt,B-AG.01.l.01,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
102822,.,O,3568.0,"However , slightly over half ( 56 % ) of the respondents regularly tried to limit their salt intake while only 8 % of the respondents thought that they consumed too much salt ."
103096,A,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103097,total,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103098,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103099,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103100,incident,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103101,gastric,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103102,cancer,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103103,cases,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103104,were,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103105,identified,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103106,from,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103107,the,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103108,Melbourne,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103109,Collaborative,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103110,Cohort,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103111,Study,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103112,(,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103113,N,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103114, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103115,=,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103116, ,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103117,"41,513",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103118,),O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103119,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103120,matched,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103121,with,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103122,159,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103123,controls,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103124,on,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103125,year,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103126,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103127,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103128,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103129,sex,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103130,",",O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103131,and,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103132,country,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103133,of,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103134,birth,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103135,using,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103136,incidence,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103137,density,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103138,sampling,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103139,.,O,3579.0,"A total of 159 incident gastric cancer cases were identified from the Melbourne Collaborative Cohort Study ( N   =   41,513 ) and matched with 159 controls on year of birth , sex , and country of birth using incidence density sampling ."
103162,Odds,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103163,ratios,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103164,(,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103165,ORs,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103166,),O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103167,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103168,95,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103169,%,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103170,confidence,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103171,intervals,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103172,were,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103173,estimated,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103174,using,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103175,conditional,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103176,logistic,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103177,regression,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103178,models,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103179,adjusting,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103180,for,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103181,Helicobacter,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103182,pylori,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103183,infection,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103184,",",O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103185,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103186,other,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103187,potential,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103188,confounders,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103189,.,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
104028,CLA,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104029,has,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104030,been,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104031,shown,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104032,to,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104033,inhibit,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104034,chemically,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104035,-,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104036,induced,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104037,skin,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104038,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104039,stomach,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104040,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104041,mammary,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104042,or,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104043,colon,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104044,tumours,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104045,in,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104046,mice,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104047,and,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104048,rats,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104049,.,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104154,Its,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104155,effect,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104156,on,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104157,growth,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104158,(,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104159,less,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104160,fat,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104161,",",O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104162,more,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104163,protein,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104164,),O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104165,is,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104166,also,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104167,a,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104168,subject,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104169,of,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104170,active,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104171,research,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104172,.,O,3620.0,"Its effect on growth ( less fat , more protein ) is also a subject of active research ."
104388,The,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104389,Dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104390,Quality,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104391,Index,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104392,was,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104393,reduced,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104394,from,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104395,42.4,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104396,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104397,4.1,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104398,to,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104399,37.8,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104400,±,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104401,4.7,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104402,(,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104403,Low,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104404,dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104405,fat,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104406,intake,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104407,may,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104408,reduce,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104409,the,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104410,risk,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104411,of,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104412,developing,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104413,atherosclerosis,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104414,.,O,3629.0,The Dietary Quality Index was reduced from 42.4 ± 4.1 to 37.8 ± 4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
105856,The,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105857,requirement,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105858,of,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105859,quantity,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105860,and,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105861,quality,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105862,for,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105863,gluten,B-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105864,-,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105865,free,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105866,packaged,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105867,foods,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105868,is,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105869,increasing,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105870,consistently,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105871,at,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105872,a,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105873,faster,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105874,rate,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105875,than,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105876,lactose,B-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105877,-,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105878,free,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105879,and,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105880,diabetic,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105881,-,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105882,friendly,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105883,foods,I-AG.01,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105884,.,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
106475,Prior,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106476,studies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106477,by,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106478,our,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106479,group,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106480,have,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106481,suggested,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106482,that,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106483,expanded,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106484,supplementation,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106485,and,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106486,food,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106487,fortification,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106488,would,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106489,be,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106490,effective,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106491,in,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106492,addressing,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106493,micronutrient,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106494,inadequacies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106495,;,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106496,these,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106497,strategies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106498,should,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106499,be,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106500,coupled,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106501,with,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106502,measures,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106503,to,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106504,mitigate,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106505,the,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106506,growing,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106507,burden,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106508,of,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106509,chronic,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106510,disease,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106511,.,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106597,The,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106598,authors,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106599,identified,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106600,four,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106601,dietary,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106602,patterns,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106603,:,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106604,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106605,healthy,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106606,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106607,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106608,vegetables,B-AG.01.h.02,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106609,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106610,fruit,B-AG.01.h.01,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106611,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106612,yogurt,B-AG.01.e,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106613,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106614,sea,B-AG.01.d.07,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106615,products,I-AG.01.d.07,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106616,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106617,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106618,olive,B-AG.01.f,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106619,oil,I-AG.01.f,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106620,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106621,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106622,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106623,Western,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106624,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106625,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106626,potatoes,B-AG.01.h.02.a,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106627,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106628,pizzas,B-AG.01.n,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106629,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106630,pies,B-AG.01.n.15,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106631,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106632,sandwiches,B-AG.01.n.11,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106633,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106634,sweets,B-AG.01.n.17.a,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106635,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106636,cakes,B-AG.01.n.13,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106637,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106638,cheese,B-AG.01.e.02,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106639,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106640,cereal,B-AG.01.i,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106641,products,I-AG.01.i,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106642,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106643,processed,B-AG.01.d,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106644,meat,I-AG.01.d,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106645,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106646,eggs,B-AG.01.g,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106647,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106648,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106649,butter,B-AG.01.e.01,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106650,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106651,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106652,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106653,drinker,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106654,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106655,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106656,sandwiches,B-AG.01.n.11,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106657,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106658,snacks,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106659,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106660,processed,B-AG.01.d,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106661,meat,I-AG.01.d,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106662,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106663,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106664,alcoholic,B-AG.01.y.01,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106665,beverages,I-AG.01.y.01,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106666,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106667,;,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106668,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106669,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106670,meat,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106671,eaters,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106672,"""",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106673,(,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106674,meat,B-AG.01.d,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106675,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106676,poultry,B-AG.01.d.06,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106677,",",O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106678,and,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106679,margarine,B-AG.01.f,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106680,),O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
106681,.,O,3709.0,"The authors identified four dietary patterns : "" healthy "" ( vegetables , fruit , yogurt , sea products , and olive oil ) ; "" Western "" ( potatoes , pizzas and pies , sandwiches , sweets , cakes , cheese , cereal products , processed meat , eggs , and butter ) ; "" drinker "" ( sandwiches , snacks , processed meat , and alcoholic beverages ) ; and "" meat eaters "" ( meat , poultry , and margarine ) ."
107036,Nutrition,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107037,is,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107038,far,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107039,more,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107040,important,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107041,in,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107042,stroke,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107043,risk,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107044,than,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107045,most,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107046,physcians,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107047,suppose,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107048,.,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107097,The,O,3723.0,The situation is probably not much better in most other countries .
107098,situation,O,3723.0,The situation is probably not much better in most other countries .
107099,is,O,3723.0,The situation is probably not much better in most other countries .
107100,probably,O,3723.0,The situation is probably not much better in most other countries .
107101,not,O,3723.0,The situation is probably not much better in most other countries .
107102,much,O,3723.0,The situation is probably not much better in most other countries .
107103,better,O,3723.0,The situation is probably not much better in most other countries .
107104,in,O,3723.0,The situation is probably not much better in most other countries .
107105,most,O,3723.0,The situation is probably not much better in most other countries .
107106,other,O,3723.0,The situation is probably not much better in most other countries .
107107,countries,O,3723.0,The situation is probably not much better in most other countries .
107108,.,O,3723.0,The situation is probably not much better in most other countries .
107233,It,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107234,has,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107235,serious,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107236,neurological,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107237,consequences,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107238,",",O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107239,including,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107240,an,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107241,increase,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107242,in,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107243,the,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107244,risk,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107245,of,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107246,stroke,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107247,.,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107248,It,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107249,now,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107250,clear,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107251,that,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107252,B,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107253,vitamins,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107254,to,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107255,lower,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107256,homocysteine,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107257,reduce,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107258,the,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107259,risk,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107260,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107261,stroke,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107262,",",O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107263,but,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107264,we,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107265,should,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107266,probably,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107267,be,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107268,using,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107269,methylcobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107270,instead,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107271,of,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107272,cyanocobalamin,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107273,.,O,3730.0,"It now clear that B vitamins to lower homocysteine reduce the risk of stroke , but we should probably be using methylcobalamin instead of cyanocobalamin ."
107274,Recently,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107275,",",O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107276,we,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107277,demonstrated,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107278,that,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107279,spaghetti,B-AG.01.n,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107280,caused,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107281,a,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107282,significantly,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107283,lower,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107284,glycemic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107285,response,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107286,in,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107287,isoinsulinemic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107288,insulin,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107289,-,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107290,dependent,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107291,diabetic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107292,(,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107293,IDDM,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107294,),O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107295,subjects,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107296,than,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107297,an,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107298,exchangeable,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107299,amount,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107300,of,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107301,potato,B-AG.01.h.02.a,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107302,.,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107580,Affected,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107581,commodities,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107582,include,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107583,oats,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107584,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107585,wheat,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107586,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107587,maize,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107588,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107589,barley,B-AG.01.i,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107590,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107591,raisins,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107592,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107593,other,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107594,dried,B-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107595,vine,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107596,fruits,I-AG.01.n.08,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107597,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107598,wine,B-AG.01.y.01.a,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107599,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107600,beer,B-AG.01.y.01.b,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107601,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107602,coffee,B-AG.01.ad,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107603,",",O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107604,and,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107605,cocoa,B-FOOD,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
107606,.,O,3740.0,"Affected commodities include oats , wheat , maize , barley , raisins and other dried vine fruits , wine , beer , coffee , and cocoa ."
108117,Seventeen,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108118,of,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108119,the,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108120,25,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108121,reported,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108122,good,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108123,tolerance,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108124,to,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108125,the,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108126,ingestion,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108127,of,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108128,egg,B-AG.01.g,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108129,and,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108130,chicken,B-AG.01.d.06,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108131,meat,I-AG.01.d.06,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108132,.,O,3758.0,Seventeen of the 25 reported good tolerance to the ingestion of egg and chicken meat .
108166,The,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108167,remaining,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108168,eight,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108169,patients,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108170,had,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108171,intolerance,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108172,to,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108173,egg,B-AG.01.g,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108174,",",O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108175,and,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108176,three,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108177,of,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108178,them,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108179,also,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108180,to,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108181,chicken,B-AG.01.d.06,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108182,meat,I-AG.01.d.06,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108183,ingestion,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108184,;,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108185,in,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108186,seven,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108187,of,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108188,the,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108189,eight,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108190,cases,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108191,allergic,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108192,to,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108193,egg,B-AG.01.g,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108194,",",O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108195,the,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108196,alimentary,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108197,intolerance,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108198,began,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108199,after,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108200,the,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108201,clinical,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108202,symptoms,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108203,of,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108204,bird,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108205,feather,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108206,sensitization,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
108207,.,O,3761.0,"The remaining eight patients had intolerance to egg , and three of them also to chicken meat ingestion ; in seven of the eight cases allergic to egg , the alimentary intolerance began after the clinical symptoms of bird feather sensitization ."
109154,It,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109155,is,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109156,well,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109157,known,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109158,that,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109159,variations,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109160,in,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109161,MEC,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109162,number,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109163,are,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109164,due,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109165,to,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109166,cell,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109167,proliferation,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109168,and,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109169,apoptosis,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109170,.,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109435,Several,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109436,studies,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109437,have,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109438,investigated,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109439,the,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109440,role,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109441,of,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109442,diet,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109443,as,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109444,a,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109445,risk,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109446,and/or,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109447,protective,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109448,factor,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109449,against,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109450,thyroid,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109451,cancer,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109452,",",O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109453,both,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109454,considering,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109455,individual,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109456,foods,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109457,",",O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109458,groups,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109459,of,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109460,foods,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109461,and,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109462,dietary,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109463,patterns,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109464,",",O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109465,but,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109466,the,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109467,results,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109468,are,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109469,not,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109470,consistent,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109471,.,O,3813.0,"Several studies have investigated the role of diet as a risk and/or protective factor against thyroid cancer , both considering individual foods , groups of foods and dietary patterns , but the results are not consistent ."
109895,These,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109896,results,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109897,warrant,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109898,further,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109899,investigations,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109900,and,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109901,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109902,if,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109903,confirmed,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109904,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109905,they,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109906,might,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109907,have,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109908,important,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109909,public,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109910,health,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109911,implications,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109912,for,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109913,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109914,reduction,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109915,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109916,thyroid,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109917,cancer,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109918,through,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109919,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109920,improvement,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109921,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109922,dietary,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109923,habits,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109924,.,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109925,Legislation,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109926,requires,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109927,labeling,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109928,of,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109929,foods,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109930,containing,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109931,allergenic,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109932,ingredients,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109933,.,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
110686,In,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110687,an,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110688,effort,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110689,to,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110690,disseminate,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110691,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110692,explore,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110693,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110694,discuss,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110695,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110696,state,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110697,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110698,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110699,science,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110700,on,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110701,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110702,relationship,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110703,between,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110704,regular,B-AG.01.e,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110705,fat,I-AG.01.e,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110706,dairy,I-AG.01.e,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110707,products,I-AG.01.e,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110708,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110709,health,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110710,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110711,symposia,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110712,were,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110713,programmed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110714,by,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110715,dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110716,industry,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110717,organizations,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110718,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110719,Europe,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110720,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110721,North,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110722,America,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110723,at,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110724,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110725,Eurofed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110726,Lipids,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110727,Congress,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110728,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110729,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110730,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110731,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110732,France,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110733,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110734,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110735,Dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110736,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110737,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110738,Symposium,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110739,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110740,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110741,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110742,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110743,Canada,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110744,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110745,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110746,American,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110747,Society,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110748,for,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110749,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110750,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110751,Meeting,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110752,held,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110753,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110754,conjunction,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110755,with,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110756,Experimental,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110757,Biology,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110758,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110759,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110760,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110761,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110762,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110763,United,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110764,States,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110765,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110766,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110767,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110768,Federation,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110769,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110770,European,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110771,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110772,Societies,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110773,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110774,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110775,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110776,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110777,Germany,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110778,.,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
111323,Estimated,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111324,As,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111325,intake,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111326,from,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111327,combined,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111328,exposure,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111329,to,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111330,drinking,B-AG.01.z,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111331,water,I-AG.01.z,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111332,and,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111333,food,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111334,of,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111335,the,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111336,population,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111337,was,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111338,on,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111339,average,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111340,40,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111341,%,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111342,of,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111343,the,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111344,daily,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111345,lower,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111346,limit,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111347,of,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111348,WHO,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111349,on,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111350,the,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111351,benchmark,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111352,dose,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111353,for,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111354,a,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111355,0.5,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111356,%,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111357,increased,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111358,incidence,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111359,of,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111360,lung,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111361,cancer,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111362,(,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111363,BMDL0.5,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111364,),O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111365,for,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111366,As,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111367,.,O,3881.0,Estimated As intake from combined exposure to drinking water and food of the population was on average 40 % of the daily lower limit of WHO on the benchmark dose for a 0.5 % increased incidence of lung cancer ( BMDL0.5 ) for As .
111623,An,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111624,inverse,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111625,association,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111626,was,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111627,also,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111628,observed,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111629,for,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111630,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111631,A,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111632,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111633,carotene,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111634,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111635,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111636,C,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111637,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111638,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111639,E,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111640,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111641,and,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111642,fiber,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111643,intake,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111644,.,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111671,The,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111672,aim,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111673,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111674,this,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111675,study,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111676,was,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111677,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111678,investigate,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111679,if,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111680,grape,B-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111681,or,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111682,apple,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111683,juices,I-AG.01.ab,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111684,are,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111685,able,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111686,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111687,protect,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111688,bone,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111689,tissue,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111690,of,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111691,rats,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111692,exposed,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111693,to,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111694,cadmium,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111695,.,O,3895.0,The aim of this study was to investigate if grape or apple juices are able to protect bone tissue of rats exposed to cadmium .
111758,Control,O,3898.0,Control group received a single intraperitoneal ( i.p .
111759,group,O,3898.0,Control group received a single intraperitoneal ( i.p .
111760,received,O,3898.0,Control group received a single intraperitoneal ( i.p .
111761,a,O,3898.0,Control group received a single intraperitoneal ( i.p .
111762,single,O,3898.0,Control group received a single intraperitoneal ( i.p .
111763,intraperitoneal,O,3898.0,Control group received a single intraperitoneal ( i.p .
111764,(,O,3898.0,Control group received a single intraperitoneal ( i.p .
111765,i.p,O,3898.0,Control group received a single intraperitoneal ( i.p .
111766,.,O,3898.0,Control group received a single intraperitoneal ( i.p .
111846,All,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111847,animals,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111848,were,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111849,euthanized,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111850,30,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111851, ,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111852,days,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111853,after,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111854,the,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111855,beginning,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111856,of,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111857,experiment,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
111858,.,O,3904.0,All animals were euthanized 30   days after the beginning of experiment .
112245,Both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112246,ethanol,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112247,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112248,wine,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112249,treatments,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112250,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112251,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112252,incidence,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112253,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112254,lung,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112255,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112256,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112257,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112258,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112259,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112260,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112261,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112262,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112263,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112264,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112265,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112266,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112267,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112268,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112269,reduced,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112270,the,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112271,frequency,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112272,(,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112273,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112274,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112275,specific,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112276,tumours,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112277,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112278,number,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112279,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112280,tumour,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112281,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112282,bearing,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112283,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112284,),O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112285,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112286,both,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112287,Clara,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112288,-,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112289,cell,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112290,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112291,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112292,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112293,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112294,10,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112295,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112296,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112297,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112298,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112299,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112300,and,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112301,of,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112302,alveolar,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112303,adenomas,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112304,in,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112305,mice,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112306,given,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112307,20,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112308,mg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112309,ethyl,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112310,carbamate,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112311,/,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112312,kg,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112313,.,O,3920.0,Both ethanol and wine treatments reduced the incidence of lung Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and reduced the frequency ( number of specific tumours / number of tumour - bearing mice ) of both Clara - cell adenomas in mice given 10 mg ethyl carbamate / kg and of alveolar adenomas in mice given 20 mg ethyl carbamate / kg .
112314,Wine,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112315,treatments,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112316,also,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112317,reduced,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112318,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112319,frequency,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112320,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112321,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112322,adenomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112323,compared,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112324,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112325,those,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112326,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112327,other,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112328,treatment,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112329,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112330,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112331,and,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112332,no,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112333,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112334,carcinomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112335,developed,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112336,in,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112337,any,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112338,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112339,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112340,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112341,given,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112342,wine,B-AG.01.y.01.a,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112343,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112344,even,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112345,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112346,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112347,20,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112348,-,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112349,mg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112350,/,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112351,kg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112352,ethyl,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112353,carbamate,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112354,dose,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112355,.,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112533,Dietary,O,3927.0,Dietary data were obtained from 24 - h recalls .
112534,data,O,3927.0,Dietary data were obtained from 24 - h recalls .
112535,were,O,3927.0,Dietary data were obtained from 24 - h recalls .
112536,obtained,O,3927.0,Dietary data were obtained from 24 - h recalls .
112537,from,O,3927.0,Dietary data were obtained from 24 - h recalls .
112538,24,O,3927.0,Dietary data were obtained from 24 - h recalls .
112539,-,O,3927.0,Dietary data were obtained from 24 - h recalls .
112540,h,O,3927.0,Dietary data were obtained from 24 - h recalls .
112541,recalls,O,3927.0,Dietary data were obtained from 24 - h recalls .
112542,.,O,3927.0,Dietary data were obtained from 24 - h recalls .
112761,An,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112762,interviewer,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112763,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112764,administered,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112765,questionnaire,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112766,was,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112767,used,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112768,to,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112769,ascertain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112770,major,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112771,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112772,events,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112773,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112774,obtain,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112775,estimates,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112776,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112777,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112778,(,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112779,ever,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112780,-,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112781,never,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112782,),O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112783,and,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112784,frequency,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112785,of,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112786,consumption,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112787,throughout,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112788,life,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
112789,.,O,3934.0,An interviewer - administered questionnaire was used to ascertain major life events and obtain estimates of consumption ( ever - never ) and frequency of consumption throughout life .
113171,Increasing,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113172,intake,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113173,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113174,any,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113175,combination,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113176,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113177,HFCS,B-AG.01.aa,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113178,-,I-AG.01.aa,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113179,sweetened,I-AG.01.aa,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113180,soda,I-AG.01.aa,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113181,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113182,fruit,B-AG.01.y,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113183,drinks,I-AG.01.y,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113184,and,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113185,apple,B-AG.01.ab,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113186,juice,I-AG.01.ab,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113187,was,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113188,significantly,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113189,associated,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113190,with,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113191,progressively,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113192,higher,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113193,asthma,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113194,risk,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113195,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113196,plateauing,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113197,at,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113198,5,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113199,-,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113200,7,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113201,times,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113202,/,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113203,week,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113204,v.,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113205,never,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113206,/,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113207,seldom,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113208,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113209,independent,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113210,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113211,potential,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113212,confounders,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113213,(,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113214,hazard,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113215,ratio,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113216,1·91,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113217,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113218,P<0·001,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113219,),O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113220,.,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113938,These,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113939,results,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113940,indicate,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113941,that,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113942,a,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113943,certain,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113944,amount,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113945,of,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113946,PTHrP,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113947,is,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113948,ingested,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113949,when,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113950,milk,B-AG.01.e,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113951,and,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113952,milk,B-AG.01.e,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113953,products,I-AG.01.e,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113954,are,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113955,consumed,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
113956,.,O,3969.0,These results indicate that a certain amount of PTHrP is ingested when milk and milk products are consumed .
114633,Dietary,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114634,patterns,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114635,were,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114636,:,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114637,low,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114638,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114639,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114640,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114641,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114642,32·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114643,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114644,",",O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114645,moderate,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114646,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114647,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114648,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114649,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114650,42·1,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114651,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114652,and,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114653,high,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114654,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114655,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114656,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114657,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114658,26·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114659,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114660,.,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114672,High,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114673,Med,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114674,-,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114675,style,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114676,diet,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114677,was,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114678,independently,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114679,associated,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114680,with,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114681,sepsis,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114682,risk,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114683,;,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114684,low,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114685,Med,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114686,-,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114687,style,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114688,diet,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114689,referent,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114690,",",O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114691,moderate,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114692,Med,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114693,-,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114694,style,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114695,diet,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114696,adjusted,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114697,hazard,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114698,ratio,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114699,(,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114700,HR,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114701,),O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114702,0·93,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114703,(,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114704,95,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114705,%,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114706,CI,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114707,0·81,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114708,",",O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114709,1·08,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114710,),O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114711,",",O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114712,high,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114713,Med,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114714,-,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114715,style,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114716,diet,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114717,adjusted,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114718,HR=0·74,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114719,(,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114720,95,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114721,%,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114722,CI,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114723,0·61,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114724,",",O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114725,0·88,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114726,),O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114727,.,O,3995.0,"High Med - style diet was independently associated with sepsis risk ; low Med - style diet referent , moderate Med - style diet adjusted hazard ratio ( HR ) 0·93 ( 95 % CI 0·81 , 1·08 ) , high Med - style diet adjusted HR=0·74 ( 95 % CI 0·61 , 0·88 ) ."
114994,The,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
114995,composition,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
114996,and,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
114997,processing,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
114998,of,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
114999,dairy,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115000,protein,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115001,has,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115002,an,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115003,impact,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115004,on,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115005,digestion,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115006,",",O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115007,absorption,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115008,",",O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115009,BCAA,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115010,kinetics,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115011,and,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115012,function,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115013,",",O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115014,hence,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115015,the,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115016,optimisation,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115017,of,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115018,dairy,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115019,protein,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115020,composition,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115021,through,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115022,selection,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115023,and,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115024,combination,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115025,of,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115026,specific,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115027,protein,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115028,components,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115029,in,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115030,milk,B-AG.01.e,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115031,may,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115032,provide,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115033,a,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115034,way,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115035,to,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115036,maximize,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115037,benefits,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115038,for,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115039,metabolic,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115040,health,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115041,.,O,4005.0,"The composition and processing of dairy protein has an impact on digestion , absorption , BCAA kinetics and function , hence the optimisation of dairy protein composition through selection and combination of specific protein components in milk may provide a way to maximize benefits for metabolic health ."
115139,The,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115140,phenolic,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115141,compounds,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115142,present,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115143,in,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115144,olive,B-AG.01.f,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115145,oil,I-AG.01.f,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115146,are,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115147,strong,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115148,antioxidants,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115149,and,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115150,radical,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115151,scavengers,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115152,.,O,4011.0,The phenolic compounds present in olive oil are strong antioxidants and radical scavengers .
115221,It,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115222,has,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115223,recently,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115224,been,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115225,found,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115226,that,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115227,hydroxytyosol,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115228,is,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115229,renally,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115230,excreted,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115231,unchanged,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115232,and,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115233,as,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115234,the,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115235,following,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115236,metabolites,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115237,as,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115238,its,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115239,glucuronide,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115240,conjugate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115241,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115242,sulfate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115243,conjugate,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115244,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115245,homovanillic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115246,acid,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115247,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115248,homovanillic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115249,alcohol,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115250,",",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115251,"3,4",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115252,-,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115253,dihydroxyphenylacetic,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115254,acid,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115255,and,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115256,"3,4",O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115257,-,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115258,dihydroxyphenylacetaldehyde,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115259,.,O,4016.0,"It has recently been found that hydroxytyosol is renally excreted unchanged and as the following metabolites as its glucuronide conjugate , sulfate conjugate , homovanillic acid , homovanillic alcohol , 3,4 - dihydroxyphenylacetic acid and 3,4 - dihydroxyphenylacetaldehyde ."
115303,Well,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115304,-,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115305,planned,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115306,vegetarian,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115307,diets,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115308,are,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115309,considered,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115310,adequate,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115311,for,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115312,all,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115313,stages,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115314,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115315,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115316,life,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115317,cycle,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115318,",",O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115319,despite,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115320,limited,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115321,data,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115322,on,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115323,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115324,zinc,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115325,status,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115326,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115327,vegetarians,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115328,during,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115329,early,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115330,childhood,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115331,.,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115476,Some,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115477,vegetarian,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115478,immigrants,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115479,from,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115480,underprivileged,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115481,households,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115482,may,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115483,be,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115484,predisposed,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115485,to,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115486,iron,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115487,and,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115488,zinc,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115489,deficiency,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115490,because,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115491,of,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115492,nondietary,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115493,factors,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115494,such,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115495,as,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115496,chronic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115497,inflammation,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115498,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115499,parasitic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115500,infections,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115501,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115502,overweight,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115503,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115504,and,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115505,genetic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115506,hemoglobin,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115507,disorders,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115508,.,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115577,Additional,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115578,recommended,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115579,practices,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115580,include,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115581,using,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115582,fermented,B-AG.01.n,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115583,soy,I-AG.01.n,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115584,foods,I-AG.01.n,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115585,and,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115586,sprouting,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115587,at,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115588,least,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115589,some,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115590,of,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115591,the,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115592,legumes,B-AG.01.h.02.g,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115593,consumed,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115594,.,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115728,During,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115729,8,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115730,years,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115731,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115732,follow,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115733,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115734,up,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115735,",",O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115736,there,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115737,were,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115738,431,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115739,cases,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115740,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115741,new,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115742,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115743,(,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115744,non,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115745,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115746,fatal,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115747,myocardial,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115748,infarction,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115749,or,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115750,death,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115751,from,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115752,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115753,),O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115754,.,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115844,The,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115845,association,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115846,was,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115847,stronger,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115848,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115849,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115850,"69,181",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115851,women,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115852,whose,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115853,margarine,B-AG.01.f,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115854,consumption,B-X,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115855,over,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115856,the,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115857,previous,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115858,10,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115859,years,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115860,had,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115861,been,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115862,stable,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115863,(,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115864,1.67,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115865,[,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115866,1.05,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115867,-,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115868,2.66,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115869,],O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115870,",",O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115871,p,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115872,for,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115873,trend,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115874,=,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115875,0.002,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115876,),O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
115877,.,O,4035.0,"The association was stronger for the 69,181 women whose margarine consumption over the previous 10 years had been stable ( 1.67 [ 1.05 - 2.66 ] , p for trend = 0.002 ) ."
116593,High,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116594,blood,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116595,pressure,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116596,is,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116597,a,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116598,significant,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116599,public,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116600,health,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116601,problem,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116602,worldwide,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116603,which,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116604,is,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116605,associated,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116606,with,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116607,increased,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116608,risk,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116609,of,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116610,cardiovascular,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116611,disease,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116612,",",O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116613,stroke,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116614,",",O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116615,and,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116616,renal,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116617,disease,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116618,.,O,4066.0,"High blood pressure is a significant public health problem worldwide which is associated with increased risk of cardiovascular disease , stroke , and renal disease ."
116676,Peptides,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116677,formed,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116678,during,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116679,the,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116680,digestion,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116681,of,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116682,milk,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116683,proteins,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116684,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116685,also,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116686,been,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116687,demonstrated,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116688,to,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116689,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116690,a,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116691,blood,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116692,pressure,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116693,lowering,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116694,effect,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116695,.,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116696,Other,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116697,components,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116698,in,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116699,milk,B-AG.01.e,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116700,that,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116701,have,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116702,been,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116703,examined,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116704,for,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116705,their,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116706,effects,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116707,on,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116708,blood,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116709,pressure,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116710,have,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116711,been,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116712,less,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116713,promising,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
116714,.,O,4071.0,Other components in milk that have been examined for their effects on blood pressure have been less promising .
117576,Despite,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117577,their,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117578,sweet,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117579,taste,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117580,",",O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117581,dried,B-AG.01.n.08,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117582,plums,I-AG.01.n.08,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117583,do,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117584,not,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117585,cause,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117586,large,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117587,postprandial,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117588,rise,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117589,in,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117590,blood,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117591,glucose,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117592,and,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117593,insulin,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117594,.,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117610,The,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117611,characteristic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117612,phenolic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117613,compounds,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117614,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117615,their,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117616,metabolites,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117617,may,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117618,also,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117619,act,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117620,as,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117621,antibacterial,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117622,agents,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117623,in,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117624,both,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117625,gastrointestinal,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117626,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117627,urinary,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117628,tracts,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117629,.,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117695,Histamine,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117696,release,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117697,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117698,HR,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117699,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117700,studies,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117701,were,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117702,performed,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117703,in,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117704,40,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117705,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117706,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117707,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117708,allergic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117709,patients,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117710,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117711,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117712,case,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117713,history,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117714,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117715,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117716,SPT,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117717,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117718,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117719,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117720,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117721,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117722,specific,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117723,serum,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117724,IgE,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117725,:,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117726,RAST,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117727,>,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117728,or,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117729,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117730,3,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117731,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117732,with,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117733,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117734,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117735,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117736,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117737,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117738,A,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117739,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117740,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117741,without,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117742,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117743,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117744,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117745,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117746,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117747,B,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117748,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117749,fruit,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117750,hypersensitivity,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117751,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117752,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117753,10,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117754,nonatopic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117755,volunteers,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117756,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117757,C,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117758,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117759,.,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
118058,Most,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118059,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118060,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118061,accumulated,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118062,in,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118063,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118064,vacuoles,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118065,of,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118066,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118067,cells,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118068,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118069,except,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118070,what,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118071,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118072,absorbed,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118073,by,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118074,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118075,cell,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118076,wall,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118077,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118078,allowing,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118079,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118080,to,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118081,be,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118082,released,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118083,from,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118084,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118085,tissues,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118086,under,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118087,moderate,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118088,conditions,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118089,.,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118154,Extensive,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118155,research,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118156,within,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118157,the,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118158,past,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118159,two,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118160,decades,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118161,has,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118162,revealed,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118163,that,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118164,obesity,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118165,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118166,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118167,major,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118168,risk,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118169,factor,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118170,for,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118171,type,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118172,2,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118173,diabetes,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118174,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118175,atherosclerosis,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118176,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118177,cancer,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118178,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118179,and,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118180,other,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118181,chronic,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118182,diseases,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118183,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118184,is,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118185,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118186,proinflammatory,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118187,disease,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118188,.,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118574,Raw,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118575,shellfish,B-AG.01.d.07,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118576,consumption,B-X,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118577,may,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118578,cause,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118579,gastroenteritis,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118580,and,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118581,other,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118582,diseases,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118583,infected,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118584,by,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118585,bacteria,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118586,or,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118587,viruses,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118588,.,O,4135.0,Raw shellfish consumption may cause gastroenteritis and other diseases infected by bacteria or viruses .
118636,The,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118637,analysis,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118638,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118639,food,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118640,patterns,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118641,can,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118642,contribute,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118643,to,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118644,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118645,understanding,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118646,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118647,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118648,association,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118649,between,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118650,eating,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118651,habits,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118652,and,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118653,anthropometric,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118654,indicators,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118655,.,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118992,Human,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118993,randomized,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118994,controlled,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118995,studies,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118996,were,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118997,selected,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118998,according,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118999,to,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119000,PRISMA,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119001,guidelines,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119002,.,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119038,Findings,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119039,from,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119040,individual,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119041,studies,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119042,confirm,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119043,that,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119044,acute,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119045,and,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119046,chronic,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119047,cocoa,B-AG.01,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119048,intake,B-X,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119049,have,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119050,a,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119051,positive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119052,effect,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119053,on,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119054,several,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119055,cognitive,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119056,outcomes,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119057,.,O,4151.0,Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes .
119196,Weighed,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119197,/,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119198,semi,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119199,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119200,weighed,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119201,food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119202,records,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119203,from,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119204,three,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119205,cross,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119206,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119207,sectional,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119208,surveys,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119209,(,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119210,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119211,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119212,Children,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119213,'s,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119214,Food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119215,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119216,",",O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119217,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119218,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119219,Teens,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119220,',O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119221,Food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119222,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119223,and,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119224,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119225,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119226,Adult,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119227,Nutrition,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119228,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119229,),O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119230,were,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119231,collated,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119232,to,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119233,estimate,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119234,habitual,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119235,dietary,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119236,intakes,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119237,for,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119238,a,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119239,nationally,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119240,representative,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119241,sample,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119242,of,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119243,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119244,Irish,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119245,population,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119246,",",O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119247,aged,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119248,5,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119249,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119250,90,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119251,years,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119252,(,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119253,n,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119254,2535,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119255,),O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119256,.,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119605,The,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119606,source,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119607,of,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119608,monounsaturated,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119609,fatty,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119610,acids,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119611,was,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119612,olive,B-AG.01.f,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119613,oil,I-AG.01.f,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119614,in,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119615,all,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119616,four,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119617,experiments,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
119618,.,O,4169.0,The source of monounsaturated fatty acids was olive oil in all four experiments .
120214,Our,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120215,technique,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120216,measures,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120217,direct,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120218,stimulation,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120219,of,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120220,cellular,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120221,glucose,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120222,metabolism,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120223,",",O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120224,so,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120225,it,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120226,may,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120227,be,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120228,that,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120229,the,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120230,active,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120231,phytochemicals,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120232,in,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120233,these,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120234,plants,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120235,improve,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120236,glucose,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120237,metabolism,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120238,via,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120239,other,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120240,mechanisms,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120241,or,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120242,that,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120243,this,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120244,in,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120245,vitro,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120246,screening,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120247,is,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120248,not,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120249,a,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120250,reliable,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120251,predictor,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120252,of,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120253,hypoglycemic,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120254,effects,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120255,in,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120256,vivo,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120257,for,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120258,some,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120259,products,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120260,.,O,4188.0,"Our technique measures direct stimulation of cellular glucose metabolism , so it may be that the active phytochemicals in these plants improve glucose metabolism via other mechanisms or that this in vitro screening is not a reliable predictor of hypoglycemic effects in vivo for some products ."
120940,In,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120941,addition,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120942,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120943,cheese,B-AG.01.e.02,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120944,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120945,fish,B-AG.01.d.07,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120946,and,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120947,tea,B-AG.01.ac,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120948,had,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120949,a,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120950,protective,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120951,effect,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120952,during,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120953,adolescence,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120954,.,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
121402,Blood,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121403,glucose,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121404,and,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121405,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121406,levels,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121407,were,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121408,used,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121409,for,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121410,the,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121411,homoeostasis,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121412,model,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121413,assessment,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121414,of,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121415,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121416,resistance,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121417,(,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121418,HOMA,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121419,-,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121420,IR,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121421,),O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121422,.,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121461,Chocolate,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121462,consumers,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121463,(,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121464,81·8,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121465,%,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121466,),O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121467,were,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121468,more,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121469,likely,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121470,to,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121471,be,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121472,younger,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121473,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121474,physically,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121475,active,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121476,",",O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121477,affluent,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121478,people,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121479,with,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121480,higher,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121481,education,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121482,levels,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121483,and,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121484,fewer,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121485,chronic,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121486,co,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121487,-,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121488,morbidities,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
121489,.,O,4234.0,"Chocolate consumers ( 81·8 % ) were more likely to be younger , physically active , affluent people with higher education levels and fewer chronic co - morbidities ."
122050,Plasma,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122051,cholesterol,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122052,and,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122053,triglyceride,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122054,concentrations,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122055,were,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122056,lower,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122057,in,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122058,groups,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122059,that,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122060,consumed,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122061,PE,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122062,.,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122222,Ethanol,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122223,significantly,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122224,reduced,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122225,AFSA,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122226,by,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122227,60,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122228,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122229,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122230,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122231,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122232,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122233,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122234,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122235,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122236,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122237,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122238,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122239,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122240,or,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122241,62,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122242,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122243,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122244,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122245,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122246,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122247,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122248,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122249,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122250,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122251,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122252,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122253,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122254,.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122510,Likewise,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122511,",",O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122512,tea,B-AG.01.ac,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122513,consumption,B-X,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122514,in,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122515,non,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122516,-,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122517,cigarette,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122518,smokers,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122519,increased,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122520,bladder,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122521,cancer,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122522,risk,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122523,(,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122524,OR,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122525,=,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122526,2.25,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122527,),O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122528,.,O,4268.0,"Likewise , tea consumption in non - cigarette smokers increased bladder cancer risk ( OR = 2.25 ) ."
122969,The,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122970,"""",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122971,western,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122972,"""",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122973,DP,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122974,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122975,meat,B-AG.01.d,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122976,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122977,appetizers,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122978,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122979,cheese,B-AG.01.e.02,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122980,",",O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122981,alcohol,B-AG.01.y.01,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122982,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122983,was,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122984,positively,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122985,associated,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122986,with,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122987,BMI,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122988,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122989,men,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122990,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122991,and,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122992,being,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122993,a,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122994,former,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122995,/,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122996,current,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122997,smoker,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122998,;,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
122999,it,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123000,was,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123001,negatively,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123002,associated,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123003,with,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123004,age,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123005,75,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123006,+,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123007,years,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123008,(,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123009,women,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123010,),O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123011,and,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123012,living,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123013,alone,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123014,.,O,4284.0,"The "" western "" DP ( meat , appetizers , cheese , alcohol ) was positively associated with BMI ( men ) and being a former / current smoker ; it was negatively associated with age 75 + years ( women ) and living alone ."
123096,Future,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123097,studies,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123098,could,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123099,replicate,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123100,the,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123101,models,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123102,in,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123103,longitudinal,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123104,and,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123105,international,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123106,contexts,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123107,.,O,4288.0,Future studies could replicate the models in longitudinal and international contexts .
123390,These,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123391,results,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123392,suggest,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123393,diets,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123394,high,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123395,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123396,meat,B-AG.01.d,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123397,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123398,RS,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123399,could,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123400,influence,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123401,cancer,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123402,initiation,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123403,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123404,progression,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123405,by,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123406,changes,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123407,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123408,circulating,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123409,levels,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123410,of,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123411,hormones,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123412,and,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123413,other,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123414,factors,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123415,.,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123688,Our,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123689,study,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123690,highlighted,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123691,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123692,importance,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123693,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123694,evaluating,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123695,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123696,utility,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123697,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123698,various,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123699,ELISAs,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123700,for,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123701,specific,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123702,food,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123703,matrices,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123704,and,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123705,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123706,recovery,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123707,as,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123708,a,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123709,function,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123710,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123711,product,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123712,storage,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123713,.,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123714,The,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123715,relationship,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123716,between,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123717,intake,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123718,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123719,various,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123720,indicator,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123721,foods,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123722,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123723,beverages,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123724,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123725,risk,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123726,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123727,prostatic,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123728,cancer,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123729,was,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123730,assessed,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123731,in,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123732,271,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123733,cases,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123734,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123735,prostatic,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123736,cancer,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123737,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123738,685,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123739,hospital,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123740,controls,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123741,recruited,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123742,in,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123743,two,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123744,areas,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123745,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123746,northern,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123747,Italy,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123748,",",O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123749,the,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123750,province,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123751,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123752,Pordenone,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123753,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123754,the,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123755,greater,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123756,Milan,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123757,area,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123758,.,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123841,After,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123842,allowance,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123843,for,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123844,the,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123845,reciprocal,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123846,confounding,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123847,effect,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123848,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123849,various,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123850,dietary,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123851,habits,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123852,",",O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123853,only,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123854,frequent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123855,intake,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123856,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123857,milk,B-AG.01.e,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123858,seemed,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123859,to,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123860,be,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123861,a,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123862,significant,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123863,independent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123864,indicator,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123865,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123866,prostatic,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123867,cancer,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123868,risk,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123869,.,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
124310,Among,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124311,the,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124312,identified,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124313,constituents,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124314,are,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124315,several,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124316,proteins,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124317,considered,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124318,to,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124319,influence,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124320,wine,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124321,stability,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124322,and,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124323,previously,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124324,described,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124325,potential,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124326,grape,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124327,allergens,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124328,.,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124329,The,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124330,pathogenesis,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124331,-,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124332,related,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124333,proteins,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124334,represent,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124335,the,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124336,main,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124337,proteins,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124338,in,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124339,all,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124340,of,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124341,the,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124342,wines,B-AG.01.y.01.a,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124343,",",O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124344,but,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124345,only,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124346,some,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124347,red,B-AG.01.y.01.a,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124348,wines,I-AG.01.y.01.a,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124349,show,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124350,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124351,band,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124352,with,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124353,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124354,molecular,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124355,mass,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124356,of,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124357,12,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124358,kDa,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124359,",",O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124360,identified,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124361,as,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124362,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124363,lipid,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124364,transfer,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124365,protein,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124366,(,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124367,LTP,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124368,),O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124369,.,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124382,We,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124383,have,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124384,recently,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124385,reported,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124386,that,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124387,patients,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124388,with,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124389,fibromyalgia,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124390,(,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124391,FM,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124392,),O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124393,may,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124394,be,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124395,at,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124396,increased,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124397,risk,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124398,for,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124399,cardiovascular,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124400,disease,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124401,.,O,4337.0,We have recently reported that patients with fibromyalgia ( FM ) may be at increased risk for cardiovascular disease .
124768,Hepatocellular,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124769,carcinoma,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124770,(,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124771,HCC,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124772,),O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124773,",",O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124774,the,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124775,most,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124776,prevalent,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124777,form,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124778,of,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124779,primary,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124780,liver,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124781,cancer,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124782,and,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124783,the,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124784,6th,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124785,most,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124786,common,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124787,cancer,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124788,type,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124789,overall,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124790,",",O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124791,is,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124792,expected,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124793,to,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124794,become,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124795,the,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124796,3rd,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124797,leading,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124798,cause,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124799,of,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124800,cancer,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124801,mortality,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124802,in,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124803,the,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124804,US,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124805,by,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124806,the,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124807,year,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124808,2030,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124809,.,O,4352.0,"Hepatocellular carcinoma ( HCC ) , the most prevalent form of primary liver cancer and the 6th most common cancer type overall , is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030 ."
124825,For,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124826,instance,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124827,",",O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124828,colorectal,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124829,cancer,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124830,(,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124831,CRC,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124832,),O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124833,metastasizes,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124834,to,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124835,the,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124836,liver,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124837,in,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124838,two,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124839,-,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124840,thirds,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124841,of,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124842,cases,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124843,",",O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124844,and,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124845,CRC,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124846,liver,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124847,metastasis,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124848,is,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124849,the,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124850,leading,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124851,cause,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124852,of,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124853,mortality,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124854,in,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124855,these,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124856,patients,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
124857,.,O,4354.0,"For instance , colorectal cancer ( CRC ) metastasizes to the liver in two - thirds of cases , and CRC liver metastasis is the leading cause of mortality in these patients ."
125422,Pigmented,B-AG.01.i,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125423,sorghum,I-AG.01.i,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125424,grain,I-AG.01.i,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125425,is,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125426,a,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125427,rich,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125428,source,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125429,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125430,antioxidants,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125431,like,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125432,polyphenols,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125433,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125434,mainly,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125435,tannins,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125436,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125437,which,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125438,have,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125439,multiple,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125440,benefits,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125441,on,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125442,human,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125443,health,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125444,such,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125445,as,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125446,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125447,antiproliferative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125448,properties,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125449,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125450,with,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125451,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125452,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125453,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125454,certain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125455,cancers,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125456,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125457,antioxidant,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125458,activities,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125459,related,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125460,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125461,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125462,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125463,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125464,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125465,diseases,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125466,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125467,oxidative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125468,stress,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125469,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125470,antimicrobial,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125471,and,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125472,anti,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125473,-,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125474,inflammatory,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125475,effects,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125476,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125477,it,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125478,also,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125479,improves,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125480,glucose,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125481,metabolism,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125482,.,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125545,Based,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125546,on,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125547,these,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125548,restrictions,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125549,that,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125550,this,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125551,product,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125552,has,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125553,had,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125554,as,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125555,food,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125556,for,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125557,humans,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125558,",",O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125559,the,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125560,analysis,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125561,of,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125562,this,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125563,review,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125564,emphasizes,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125565,the,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125566,valorization,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125567,of,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125568,sorghum,B-AG.01.i,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125569,as,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125570,a,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125571,source,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125572,of,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125573,bioactive,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125574,substances,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125575,and,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125576,the,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125577,importance,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125578,they,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125579,confer,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125580,on,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125581,human,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125582,health,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125583,because,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125584,of,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125585,the,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125586,biological,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125587,potential,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125588,it,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125589,has,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125590,.,O,4379.0,"Based on these restrictions that this product has had as food for humans , the analysis of this review emphasizes the valorization of sorghum as a source of bioactive substances and the importance they confer on human health because of the biological potential it has ."
125615,To,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125616,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125617,the,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125618,association,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125619,between,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125620,fruits,B-AG.01.h.01,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125621,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125622,vegetables,B-AG.01.h.02,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125623,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125624,risk,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125625,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125626,RCC,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125627,in,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125628,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125629,population,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125630,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125631,based,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125632,prospective,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125633,cohort,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125634,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125635,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125636,Swedish,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125637,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125638,",",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125639,we,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125640,collected,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125641,dietary,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125642,information,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125643,from,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125644,"61,000",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125645,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125646,age,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125647,40,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125648,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125649,76,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125650,years,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125651,by,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125652,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125653,food,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125654,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125655,frequency,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125656,questionnaire,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125657,.,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125858,The,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125859,risk,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125860,of,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125861,RCC,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125862,decreased,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125863,with,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125864,increasing,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125865,consumption,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125866,frequencies,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125867,of,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125868,white,B-AG.01.h.02.d,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125869,cabbage,I-AG.01.h.02.d,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125870,(,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125871,p,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125872,for,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125873,trend,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125874,=,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125875,0.07,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125876,),O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125877,.,O,4389.0,The risk of RCC decreased with increasing consumption frequencies of white cabbage ( p for trend = 0.07 ) .
125878,Frequent,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125879,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125880,of,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125881,salad,B-AG.01.h.02,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125882,vegetables,I-AG.01.h.02,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125883,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125884,once,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125885,or,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125886,more,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125887,per,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125888,day,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125889,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125890,decreased,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125891,the,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125892,risk,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125893,by,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125894,40,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125895,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125896,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125897,RR,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125898,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125899,0.60,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125900,;,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125901,95,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125902,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125903,CI,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125904,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125905,0.30,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125906,-,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125907,1.22,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125908,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125909,",",O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125910,in,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125911,comparison,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125912,to,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125913,no,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125914,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125915,.,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
126138,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126139,modified,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126140,the,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126141,association,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126142,of,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126143,alcohol,B-AG.01.y.01,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126144,consumption,B-X,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126145,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126146,rectal,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126147,cancer,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126148,:,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126149,1,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126150,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126151,risk,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126152,associated,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126153,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126154,beer,B-AG.01.y.01.b,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126155,increased,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126156,among,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126157,men,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126158,who,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126159,did,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126160,not,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126161,take,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126162,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126163,and,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126164,had,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126165,a,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126166,high,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126167,beer,B-AG.01.y.01.b,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126168,intake,B-X,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126169,(,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126170,OR,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126171,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126172,1.60,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126173,;,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126174,95,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126175,%,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126176,CI,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126177,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126178,1.08,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126179,",",O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126180,2.39,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126181,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126182,and,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126183,2,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126184,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126185,risk,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126186,associated,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126187,with,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126188,long,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126189,-,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126190,term,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126191,alcohol,B-AG.01.y.01,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126192,intake,B-X,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126193,increased,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126194,in,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126195,a,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126196,linear,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126197,fashion,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126198,in,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126199,women,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126200,who,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126201,did,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126202,not,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126203,use,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126204,NSAIDs,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126205,(,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126206,OR,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126207,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126208,1.98,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126209,;,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126210,95,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126211,%,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126212,CI,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126213,=,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126214,1.15,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126215,",",O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126216,3.40,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126217,),O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126218,.,O,4397.0,"NSAIDs modified the association of alcohol consumption with rectal cancer : 1 ) risk associated with beer increased among men who did not take NSAIDs and had a high beer intake ( OR = 1.60 ; 95 % CI = 1.08 , 2.39 ) and 2 ) risk associated with long - term alcohol intake increased in a linear fashion in women who did not use NSAIDs ( OR = 1.98 ; 95 % CI = 1.15 , 3.40 ) ."
126312,Associations,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126313,of,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126314,alcohol,B-AG.01.y.01,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126315,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126316,risk,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126317,for,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126318,rectal,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126319,cancer,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126320,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126321,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126322,related,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126323,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126324,cellular,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126325,hyperproliferation,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126326,and,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126327,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126328,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126329,modified,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126330,by,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126331,NSAID,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126332,use,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126333,.,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
127110,Anthropometric,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127111,measurements,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127112,",",O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127113,assessments,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127114,of,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127115,body,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127116,composition,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127117,",",O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127118,and,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127119,blood,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127120,sample,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127121,analysis,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127122,were,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127123,performed,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127124,at,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127125,baseline,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127126,and,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127127,at,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127128,follow,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127129,-,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127130,up,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127131,four,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127132,years,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127133,later,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127134,.,O,4423.0,"Anthropometric measurements , assessments of body composition , and blood sample analysis were performed at baseline and at follow - up four years later ."
127229,At,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127230,follow,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127231,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127232,up,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127233,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127234,sugar,B-AG.01.l.02,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127235,intake,B-X,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127236,from,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127237,fruit,B-AG.01.h.01,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127238,at,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127239,baseline,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127240,was,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127241,still,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127242,negatively,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127243,associated,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127244,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127245,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127246,above,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127247,outcomes,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127248,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127249,but,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127250,only,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127251,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127252,relationship,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127253,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127254,BMI,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127255,z,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127256,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127257,scores,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127258,retained,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127259,statistical,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127260,significance,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127261,(,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127262,β,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127263,=,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127264,-0.08,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127265,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127266,p,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127267,<,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127268,0.05,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127269,),O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127270,.,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127852,Treatments,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127853,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127854,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127855,x,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127856,2,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127857,factorial,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127858,arrangement,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127859,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127860,given,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127861,orally,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127862,once,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127863,daily,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127864,for,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127865,the,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127866,first,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127867,3,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127868,d,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127869,postpartum,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127870,were,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127871,water,B-AG.01.z,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127872,(,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127873,control,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127874,),O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127875,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127876,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127877,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127878,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127879,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127880,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127881,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127882,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127883,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127884,fat,B-AG.01.f,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127885,",",O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127886,or,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127887,500,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127888,ml,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127889,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127890,PG,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127891,plus,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127892,454,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127893,g,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127894,of,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127895,fat,B-AG.01.f,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127896,.,O,4450.0,"Treatments ( 2 x 2 factorial arrangement ) given orally once daily for the first 3 d postpartum were water ( control ) , 500 ml of PG , 454 g of fat , or 500 ml of PG plus 454 g of fat ."
127897,All,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127898,treatments,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127899,were,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127900,administered,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127901,as,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127902,a,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127903,total,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127904,volume,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127905,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127906,1.9,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127907,L.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127908,Administration,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127909,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127910,PG,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127911,decreased,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127912,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127913,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127914,nonesterified,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127915,fatty,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127916,acids,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127917,(,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127918,NEFA,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127919,),O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127920,in,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127921,plasma,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127922,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127923,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127924,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127925,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127926,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127927,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127928,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127929,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127930,21,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127931,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127932,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127933,and,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127934,tended,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127935,to,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127936,decrease,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127937,concentrations,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127938,of,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127939,beta,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127940,-,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127941,hydroxybutyrate,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127942,during,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127943,the,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127944,first,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127945,7,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127946,d,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127947,postpartum,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127948,.,O,4451.0,All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids ( NEFA ) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta - hydroxybutyrate during the first 7 d postpartum .
127960,Administration,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127961,of,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127962,either,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127963,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127964,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127965,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127966,increased,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127967,plasma,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127968,glucose,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127969,and,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127970,liver,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127971,glycogen,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127972,concentrations,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127973,compared,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127974,to,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127975,the,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127976,control,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127977,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127978,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127979,plus,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127980,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127981,treatments,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127982,.,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
128381,Case,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128382,histories,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128383,for,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128384,apple,B-AG.01.h.01.c,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128385,",",O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128386,peach,B-AG.01.h.01.e,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128387,",",O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128388,and,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128389,hazelnut,B-AG.01.h.01.f,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128390,were,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128391,positive,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128392,in,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128393,35,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128394,(,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128395,44.3,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128396,%,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128397,),O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128398,",",O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128399,23,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128400,(,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128401,29,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128402,%,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128403,),O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128404,",",O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128405,and,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128406,35,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128407,(,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128408,44.3,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128409,%,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128410,),O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128411,patients,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128412,",",O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128413,respectively,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
128414,.,O,4464.0,"Case histories for apple , peach , and hazelnut were positive in 35 ( 44.3 % ) , 23 ( 29 % ) , and 35 ( 44.3 % ) patients , respectively ."
129298,Multivariate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129299,analyses,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129300,showed,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129301,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129302,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129303,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129304,beef,B-AG.01.d.03,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129305,consumption,B-X,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129306,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129307,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129308,ischemic,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129309,heart,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129310,disease,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129311,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129312,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129313,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129314,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129315,men,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129316,[,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129317,relative,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129318,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129319,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129320,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129321,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129322,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129323,2.31,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129324,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129325,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129326,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129327,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129328,beef,B-AG.01.d.03,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129329,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129330,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129331,=3,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129332,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129333,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129334,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129335,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129336,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129337,vegetarians,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129338,],O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129339,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129340,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129341,protective,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129342,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129343,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129344,nut,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129345,consumption,B-X,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129346,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129347,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129348,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129349,nonfatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129350,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129351,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129352,both,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129353,sexes,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129354,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129355,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129356,approximately,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129357,0.5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129358,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129359,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129360,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129361,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129362,nuts,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129363,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129364,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129365,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129366,5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129367,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129368,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129369,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129370,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129371,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129372,those,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129373,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129374,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129375,nuts,B-AG.01.h.01.f,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129376,<,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129377,1,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129378,time,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129379,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129380,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129381,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129382,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129383,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129384,reduced,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129385,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129386,of,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129387,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129388,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129389,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129390,preferring,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129391,whole,B-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129392,-,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129393,grain,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129394,to,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129395,white,B-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129396,bread,I-AG.01.n.11,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129397,.,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129800,In,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129801,the,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129802,pilot,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129803,study,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129804,",",O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129805,regular,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129806,almond,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129807,ingestion,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129808,for,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129809,12,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129810,weeks,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129811,reduced,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129812,hemoglobin,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129813,A(1c,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129814,),O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129815,by,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129816,4,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129817,%,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129818,(,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129819,P,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129820,=,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129821,.045,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129822,for,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129823,interaction,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129824,),O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129825,but,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129826,did,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129827,not,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129828,influence,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129829,fasting,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129830,glucose,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129831,concentrations,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129832,.,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
130286,Positive,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130287,skin,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130288,test,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130289,reactions,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130290,were,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130291,seen,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130292,almost,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130293,exclusively,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130294,in,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130295,atopics,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130296,.,O,4531.0,Positive skin test reactions were seen almost exclusively in atopics .
130593,Infrared,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130594,thermal,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130595,images,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130596,indicated,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130597,significantly,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130598,greater,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130599,surface,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130600,temperatures,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130601,and,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130602,heat,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130603,loss,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130604,in,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130605,treated,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130606,birds,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130607,following,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130608,external,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130609,oil,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130610,applications,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130611,;,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130612,however,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130613,",",O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130614,measurements,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130615,collected,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130616,by,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130617,coelomically,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130618,implanted,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130619,temperature,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130620,transmitters,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130621,showed,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130622,that,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130623,internal,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130624,body,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130625,temperatures,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130626,were,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130627,stable,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130628,over,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130629,the,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130630,course,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130631,of,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130632,the,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130633,study,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130634,period,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130635,.,O,4543.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
130988,However,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130989,",",O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130990,the,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130991,effect,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130992,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130993,consumption,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130994,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130995,raw,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130996,tomatoes,B-AG.01.h.02.f,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130997,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130998,tomato,B-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130999,sauces,I-AG.01.l.04,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131000,on,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131001,inflammation,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131002,biomarkers,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131003,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131004,adhesion,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131005,molecules,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131006,related,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131007,to,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131008,atherosclerosis,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131009,remains,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131010,unknown,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131011,.,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131260,Cancer,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131261,initiation,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131262,and,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131263,progression,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131264,are,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131265,the,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131266,result,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131267,of,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131268,genetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131269,and/or,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131270,epigenetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131271,alterations,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131272,.,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131646,The,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131647,added,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131648,ingredients,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131649,were,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131650,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131651,1,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131652,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131653,hydrocolloids,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131654,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131655,carboxymethylcellulose,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131656,[,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131657,CMC,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131658,],O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131659,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131660,guar,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131661,gum,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131662,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131663,hydroxypropylmethylcellulose,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131664,[,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131665,HPMC,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131666,],O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131667,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131668,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131669,xanthan,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131670,gum,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131671,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131672,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131673,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131674,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131675,2,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131676,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131677,substitutes,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131678,(,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131679,buckwheat,B-AG.01.k,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131680,flour,I-AG.01.k,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131681,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131682,whole,B-AG.01.g,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131683,egg,I-AG.01.g,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131684,powder,I-AG.01.g,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131685,",",O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131686,and,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131687,whey,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131688,proteins,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131689,),O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131690,.,O,4575.0,"The added ingredients were ( 1 ) hydrocolloids ( carboxymethylcellulose [ CMC ] , guar gum , hydroxypropylmethylcellulose [ HPMC ] , and xanthan gum ) , and ( 2 ) substitutes ( buckwheat flour , whole egg powder , and whey proteins ) ."
131691,The,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131692,bread,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131693,quality,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131694,parameters,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131695,measured,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131696,were,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131697,specific,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131698,volume,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131699,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131700,dry,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131701,matter,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131702,of,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131703,bread,B-AG.01.n.11,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131704,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131705,crust,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131706,color,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131707,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131708,crumb,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131709,hardness,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131710,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131711,and,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131712,gas,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131713,cell,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131714,size,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131715,distribution,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131716,.,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
